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Chapter 1 
 
 General introduction  
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Polyurethanes 
 
Due to a wide range of physical and chemical properties, polyurethanes (PUs) are used in 
numerous applications like coatings, foams, fibers, engineering plastics and 
biomaterials.
1-4 The pioneering work on polyurethane polymers was conducted by Otto 
Bayer and his coworkers in 1937 at the laboratories of I.G. Farben in Leverkusen, 
Germany.
5 They recognized that using the polyaddition principle to produce 
polyurethanes from diisocyanates and polyether or polyester diols (polyols, Scheme 1.1) 
seemed to point to special opportunities, especially when compared to already existing 
plastics that were made by polymerizing olefins or by polycondensation.  
 
 
 
Scheme 1.1 Urethane formation by reaction of an isocyanate with a compound 
comprising a hydroxyl group 
 
The general used reactants for segmented polyurethanes are a diisocyanate, a polyol and 
an extender. Segmented polyurethanes can be considered as multiblock copolymers, 
consisting of a hard and a soft block (segment). The hard segment originates from the 
diisocyanate and the chain extender, whereas the soft segment is the polyol. The 
formation of the urethane linkage allows hydrogen bonding between adjacent polymer 
molecules, where the proton of the carbamate group acts as the hydrogen-bond donor, 
whereas the oxygen atoms in both the hard- and soft segments can act as hydrogen-bond 
acceptors, as shown in Figure 1.1.  
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Figure 1.1 Formation of H-bonds in polyurethanes. (a) H-bonds between two urethane 
groups, (b) H-bond between urethane and ester. 
 
Due to differences in glass-transition temperature, segment polarity, crystalline ability, 
regularity and chemical composition between the hard and soft segments, a micro phase-
segregated morphology will arise as shown in Figure 1.2.
6, 7 Of course the morphology of 
these systems plays an important role in determining the final product properties. Several 
factors can influence the morphology of polyurethanes. Factors like crystallization, 
interphase mixing, and hydrogen bonding in both segments and thermal history, all 
influence the final morphology of a system. A wide variety of literature have been 
dedicated to these aspects.
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Figure 1.2 Schematic representation of microphase separation of polyurethanes, a: 
amorphous mixture of hard and soft segments; b: crystalline hard segment domains; c: 
paracrystalline soft segment; d: disordered soft segment; e: disordered hard segment.
7  8 
 
 
Synthesis of polyurethanes  
 
In industrial- and laboratory-scale syntheses of polyurethanes both bulk and solution 
polymerisation techniques are used. The bulk polymerisation generally offers higher 
reaction rates, whereas a polymerisation in solution is more controllable and usually 
yields higher molecular mass polymers, as the lower viscosity of the reaction mixture 
overcomes problems caused by diffusion rate control towards the end of the reaction.  
On a laboratory scale both methods are used to synthesize polyurethanes via two different 
routes, as depicted in Figure1.4. In the one-step synthesis (with stoichiometric ratios (1:1) 
of polymeric diol and diisocyanate) a hard segment with two carbamate groups is formed 
as shown in the upper part of Figure 1.3.
8 By using the end-cap method with an excess of 
diisocyanate so-called 3-block-polyurethanes can be synthesized; these 3-blocks consist 
of chain extender with two diisocyanate molecules. This is essentially a two-step process, 
in which first a polymeric diol is end-capped with an excess of diisocyanate to avoid 
chain-extension. Pennings et al. used a six-fold excess of the volatile butane diisocyanate 
(BDI), to ensure that chain extension was suppressed maximally.
9 The excess of BDI was 
removed by high vacuum distillation. The isocyanate functional oligomers were chain 
extended with a diol, resulting in the formation of a 3-block-polyurethane with four 
carbamate groups. The increase in hydrogen bond donor and acceptor groups compared 
to the one-block polyurethane described previously generally increases the thermal and 
mechanical properties of the polymer. 
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Figure 1.3 Schematic representation of the reaction of a polyester diol with an excess of 
a diisocyanate and a diol as chain extender
10 
 
Although polyurethanes prepared by industrial methods are similar in reaction 
mechanism they will generally have less well-defined hard segments, because it is 
usually not feasible commercially to use the required six-fold excess of diisocyanate. In 
the usually employed ‘one pot’ production process stoichiometric amounts of polymeric 
diol and chain extender are mixed with a slight excess of diisocyanate. In this process 
chain extension will readily occur from the start of the reaction and one-, three- and 
possibly multi-block urethane segments could be formed. Even when the chain extension 
diol is added after the excess of diisocyanate has reacted with the polymeric diol a certain 
amount of chain extension may have occurred giving rise to single urethane-blocks. The 
detrimental effect the use of stoichiometric amounts has on physicochemical properties is 
usually accepted in favor of a more cost efficient process.
10 
 
Diisocyanates 
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Commonly used diisocyanates are diphenylmethane-4-4’-diisocyanate (MDI), 
toluenediisocyanate (TDI), hexamethylene diisocyanate (HDI) and hydrogenated MDI.
11 
One important reason to use these isocyanates is their low volatility. But, more 
importantly, the polyurethanes based on these diisocyanates have excellent properties.  
There is a vast amount of information of the excellent biocompatibility of polyurethanes, 
making them very suitable for biomedical applications. There are generally two classes in 
use. For long lasting applications, like for tubes, the polymers should be stable under 
physiological conditions. In contrast, for tissue engineering the polymers should be 
biodegradable in a controlled way. Depending on the composition, polyurethanes can 
fulfill all these requirements, but have to be selected accordingly.
12    
The on large scale commercial available diisocyanates (MDI, TDI, HDI, H-MDI) are also 
used for biomedical polyurethanes even though it is known that the corresponding 
polyurethanes release upon degradation toxic and carcinogenic diamines, particularly the 
aromatic diamines, originating from the aromatic diisocyanate.
13 Especially for 
biomedical applications, new aliphatic diisocyanate were developed, for instance 1,4-
butanediisocyanate (BDI) and lysine diisocyanate (LDI). Polyurethanes based on BDI 
and LDI are a good non-toxic alternative since, upon degradation, the formed diamines 
are naturally occurring substances in the body and therefore considered safe to use in vivo. 
Butane diamine and its homologues (spermidine and spermine) are non-toxic polyamines 
that are essential for cell growth and differentiation.
14  
 
Polyurethanes based on LDI 
 
Lysine diisocyanate (LDI) (Figure 1.4) is commercially available only from Kyowa 
Hakko Kogyo Co., (Tokyo, Japan). Numerous studies have been reported on the 
synthesis and properties of a range of polyurethanes based on lysine diisocyanate 
(LDI).
15-50 Those materials are biodegradable and non-toxic, which can be used in the 
plenty of biomedical applications, especially in tissue engineering.
25 
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Figure 1.4 Structure of lysine diisocyanate  
 
Hirt et al.
26 and de Groot et al.
27 reported on the synthesis and properties of degradable 
polyurethanes based on LDI, 2,2,4-trimethyl-hexamethylene diisocyanate and a number 
of polyester and copolyester polyols such as Diorez
®, caprolactone-ethylene glycol 
copolymers and poly hydroxy butyrate and valerate copolymers. The polyurethanes 
ranged from elastomers with elongations at break as high as 780 %, but with low tensile 
strengths (5.8 to 8.1 MPa). Saad et al.
16 reported on the cell and tissue interaction of four 
such polymers prepared from 2,2,4-trimethylhexamethylene diisocyanate and LDI, and 
polyols like  ω-dihydroxy-poly(R-3-hydroxybutyrate-co-(R)-3-hydroxyvalerate)-block-
ethylene glycol] and two commercial diols, Diorez® and PCL-diol. In vitro studies 
indicated that these polyesterurethanes did not activate macrophages and showed good 
level of cell adhesion and growth, which were also confirmed by in vivo results. 
Structure-property relationships of degradable polyurethanes based on LDI, 
polycaprolactone, polyethylene oxide (PEO) and an chain extender have been 
investigated by Skarja and Woodhouse.
17, 49 Their results showed that the strength of PEO 
based polyetherurethane (PEU) were generally weaker but PCL based materials were 
relatively strong. However, no results were reported on the degradation of these 
polyurethanes 
Storey et al.
20, 30 have prepared poly(ester urethane) networks from LDI and a series of 
polyester triols based on dl-lactide, γ-caprolactone and their copolymers. Networks based 
on poly(dl-lactide) were rigid (glass transition temperature Tg = 60ºC) with ultimate 
tensile strengths of 40 to 70 MPa, whereas those based on caprolactone triols were low 
modulus elastomers with tensile strengths of 1 to 4 MPa. Networks based on copolymers 
were more elastomeric (elongation up to 600%) with compressive strengths between 3 to 
25 MPa. Hydrolytic degradation under simulated physiological conditions was dependent 
on the type of triol. Dl-Lactide based networks were the most resistant. No degradation 
was observed after 60 days. Caprolactone based triol networks were resistant up to 40 12 
 
days. The high lactide containing copolymer networks were most susceptible for 
hydrolysis and substantial degradation was observed in about 3 days.  
Bruin et al.
50 have reported on the synthesis of degradable polyurethane networks based 
on star-shaped polyester prepolymers. The star-prepolymers were prepared from 
myoinisitol, a pentahydroxy sugar, as initiator molecule for the ring-opening 
copolymerisation of l-lactide or glycolide with caprolactone. The prepolymers were 
cross-linked using LDI. The degradation products of these PU networks were considered 
to be non-toxic. The resulting network polymers were elastomeric with elongation in the 
range 300 to 500% and tensile strengths varying between 8 to 40 MPa depending on the 
branch length. Preliminary experiments in guinea pigs have shown that the polyurethanes 
biodegrade when implanted subcutaneously. Polyurethane networks based on LDI and 
poly(glycolide-co-γ-caprolactone) macrodiol were evaluated by Bruin et al.
28 as two-
layer artificial skin. The degradation of the skin in vivo was faster than that in vitro. 
Subcutaneous implantation in guinea pigs showed that the porous polyurethane networks 
allowed rapid cell in-growth, degraded almost completely 4-8 weeks after implantation 
and evoked no adverse tissue reaction. Zang et al.
29 have developed a peptide based 
polyurethane scaffold for tissue engineering. LDI reacted first with glycerol to form a 
prepolymer, which upon reaction with water produced a cross-linked porous sponge, due 
to liberation of carbon dioxide. Initial cell growth studies with rabbit bone marrow 
stromal cells have shown that the polymer matrix supported cell growth and was 
phenotypically similar to those grown on tissue culture polystyrene.  
Many diols or polyols (or copolymers thereof) have been used to synthesize 
polyurethanes based on LDI. The most commonly used polydiols are showed in Figure 
1.5.  
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Figure 1.5 The chemical structure of most commonly used hydroxyl functional 
compounds (and copolymers thereof) for synthesizing polyurethanes based on LDI.  
 
Recently, biodegradable LDI based polyurethanes for drug delivery have been 
developed.
36-50 Beckman’s group prepared a new generation of biodegradable 
polyurethane discs and foams based on LDI and glycerol and demonstrated their 
application as long-term drug delivery reservoirs.
36-40 They have previously showed that 
polyurethanes synthesized from LDI and glycerol degrade hydrolytically into the non-
toxic components lysine, glycerol and CO2.
29 The drugs 7-tert-butyldimethylsilyl-10-
hydroxy-camptothecin (DB-67) or Doxorubicin were incorporated into the LDI-glycerol 
polymer network via hydrolysable urethane linkages. For example, Scheme 1.2 illustrates 
the chemical structure of DB-67 contained component and a proposed polymer 
structure.
36  
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Scheme 1.2 Molecular structure of a polyurethane polymer network from DB-67, LDI 
and glycerol.
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During the hydrolysis of polyurethanes, the drugs will be released. Several parameters 
can influence the hydrolysis rate of polymers like molar ratio of monomers, temperature 
and so on. By varying the composition and thereby the hydrolysis rate of polyurethanes, 
the drug release rate can be tuned. However, these systems are essentially based on the 
formulations of polyurethane matrices, of which applications are limited due to their 
burst release effect and localized drug delivery. 
Ding  et al.
40-44 have developed a new group of LDI based cationic biodegradable 
multiblock poly(3-caprolactone urethane)s bearing gemini pendant quaternary 
ammonium groups and methoxy-poly(ethylene glycol) (m-PEG) end chains (Figure 1.6).  15 
 
   
 
Figure 1.6 Schematic structure of multiblock of poly(ε-caprolactone), LDI and cationic 
functional lysine.    represents the poly(ε-caprolactone) soft segment.
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The incorporation of gemini quaternary ammonium groups has significant impacts on the 
properties of multiblock poly(ε-caprolactone urethane)s, such as a decrease of the PCL 
segment crystallinity, enhancement of surface hydrophilicity, and water sorption. Those 
gemini polyurethanes were able to self-assemble into a micellar structure with a diameter 
below 100 nm, at a low critical micelle concentration (CMC) in aqueous solution. These 
nanocarriers with highly tunable micellization characteristics, high drug loading capacity, 
efficient cellular uptake and good biocompatibility were proposed as excellent 
biodegradable candidates in drug and gene delivery as well as for imaging applications. 
 
Polyurethanes based on blocked diisocyanate 
 
It is convenient to synthesize polyurethanes from diisocyanates (DIs) since the DIs are 
reactive with alcohols at low temperature, when catalyzed, and with amines without 
catalysts. However, there are several major drawbacks. The high reactivity and toxicity of 
isocyanates do not allow for their storage and use in one-pack systems, which are not 
desirable in industry and in biomedical applications.
51, 52 More importantly, due to the 
high reactivity, it is not possible to have or introduce moieties that active hydrogens, like 
hydroxyl groups, amine of acids, while keeping the isocyanate groups intact. Blocked 
isocyanates provide a solution for overcoming these drawbacks. The isocyanate 16 
 
functional group can be blocked or protected by a number of methods. Commonly, 
blocked isocyanates are prepared by reacting them with an active hydrogen compound 
Scheme 1.3).
52  
 
 
Scheme 1.3 A blocked isocyanate by reaction with active hydrogen compounds B-H 
(blocking agent). 
 
Upon heating in the presence of a nucleophile (-OH or –NH2), the blocking group is 
released and the desired urethane/urea is obtained (Scheme 1.4). Important review papers 
from Wicks et al.
51 have extensively described the chemistry of blocked isocyanates and 
discussed the mechanisms of the different blocking methods in detail. Following them, 
the uses and applications of blocked isocyanates in coatings and non-coatings fields are 
reviewed.
52, 53 Within the market, blocked isocyanates have wide spread use in many 
coatings areas: automotive, maintenance, and industrial finishing. 
The regenerated isocyanate can react with a coreactant containing hydroxyl functional 
groups to form urethanes, which are thermally stable bonds. A typical scheme for making 
PUs from blocked isocyanates is depicted in Scheme 1.4.  
 
 
 
Scheme 1.4 Formation of linear polyurethane based on a blocked diisocyanate and diol, 
where Td is the deblocking temperature. 
 
Generally, commercial blocking agents include phenol, ε-caprolactam (CL), methyl ethyl 
ketoxime (MEKO), dimethyl pyrazoles, diethyl malonates, sodium bisulfite, and many 
others.
52 The blocking group determines mainly the deblocking temperature, which is 
generally between 50 and 160 
oC. The type of nucleophile has an influence on the 
blocking temperature as well, but less dominant than the blocking group. Polyurethanes 17 
 
based on blocked isocyanates have been described in numerous applications, like 
waterborne, coatings, adhesives, sealants, textile, paper, plastics and so on.  
The use of blocked isocyanates in coatings is exemplified by the work of Shen et al.
54 
who reported a series of water-dispersible blocked polyisocyanates that were synthesized 
from toluene 2,4-diisocyanate (TDI), isophorone diisocyanate (IPDI), dimethylol 
propionic acid, methyl ethyl ketoxime (MEKO), ethyl cellosolve (EC), and ε-caprolactam 
(CL) (Scheme 1.5).  18 
 
 
Scheme 1.5.  Synthesis of the anionic blocked-isocyanate adducts.
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All aqueous dispersions of the blocked polyisocyanates showed good storage stability. In 
this study, both the blocked TDI- and IPDI-based polyisocyanates started to deblock at 
about 55–85
oC. The deblocking temperature increased, in the order: MEKO < EC < CL. 
These blocked-isocyanate adducts deblocked and were crosslinkers of hydroxyl–
polyurethane emulsions (HPUE) at different deblocking temperatures. The excellent 
water resistance and high tensile strength of the composite films confirmed that HPUE 
films were well crosslinked (Scheme 1.6). 
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Scheme 1.6. Function of the blocked polyisocyanate as crosslinker in the PU film.
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Polyurethane based on Isocyanate-free method 
 
So far most of blocked isocyanates are synthesized from isocyanates. To avoid this detour 
and the use of these toxic DIs and to enable the introduction of functional groups 20 
 
researchers have been exploring different ways to prepare polyurethanes via isocyanate-
free strategies. Several routes have been developed to prepare polymers, for example by 
using di-tert-butyltricarbonate (DTBTC), cyclic carbonates, dicarbamates and 
carbonylbiscaprolactam (CBC). 
DTBTC is a reactive compound which can be used to prepare polyurethane/urea, as has 
been described by Versteenen et al.
55-57 DTBTC is a well-known compound used as 
blocking groups of the amines in amino acids. The amino group reacts with DTBTC to 
form an isocyanate, even at room temperature (Scheme 1.7).  
 
 
 
Scheme 1.7 Chemistry of DTBTC to prepare polyurethanes or polyureas.
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If diamine is used in a stoichiometric amount with DTBTC, polyureas are obtained. 
When an amino alcohol is employed to react with DTBTC, an intermediate isocyanate 
alcohol forms, followed by polymerization reaction between the hydroxyl group and the 
isocyanate group, when catalyzed by a lewis acid. The authors also reported that by using 
this technology, segmented poly(ether urea)s with uniform hard segments can be obtained. 
This method is obviously also based on isocyanate chemistry but the toxic compounds 
are formed in situ, thus it can be performed without handling DIs as starting materials. 
However, the residual free isocyanate groups cannot be avoided.  
Another isocyanate-free route to prepare PUs is using cyclic carbonates as starting 
materials. The low toxicity, the biodegradability of cyclic carbonates and their high 
reactivity with amines make them very attractive to researchers in the field of isocyanate-
free PUs, as the review paper from Guan et al.
58 showed. In this cyclic carbonate strategy, 
using only diamines and cyclic carbonates, it is unavoidable that carbonate groups are 
also obtained in the PU due to the presence of hydroxyl groups originating from the 
reaction between cyclic carbonates and amines (Scheme 1.8). This method can result in 21 
 
lower crystallinity because the carbonate groups could hinder the crystallization of hard 
segments.  
O O
O
+R - N H 2 RN
H
O
O
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Scheme 1.8 Reaction between cyclic carbonates and amines. 
 
Dicarbamates can also be employed as the starting materials for the synthesis of PUs, as 
non-toxic substitutes for DIs. As can be concluded when comparing the chemical 
structures of dicarbamates (Scheme 1.9) and diisocyanates, dicarbamates can be obtained 
from diamines by reacting them with dicarbonates, such as dimethylcarbonate. Deepa et 
al.
59 reported that PUs can be prepared by polycondensation of dicarbamates with diols or 
diamines, catalyzed by titanium tetrabutoxide (TBO).  
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Scheme 1.9 Polycondensation process for synthesis of polyurethanes from dicarbamates 
in ref.
59 
  
Loontjens and coworkers
60-63  developed an isocyanate-free route which is based on 
carbonyl biscaprolactam (CBC, Scheme 1.10). In this route, when CBC reacts once with 
an alcohol or an amine, caprolactam blocked isocyanates were formed either by  ring-
opening or  ring-elimination reactions. The caprolactam (CL) ring-opening and the CL 
ring-elimination reactions of CBC can be controlled by the type of nucleophile. 
Furthermore, upon heating, the CBC-end capped amine (blocked isocyanate) can 
eliminate another molecule of CL to form an isocyanate group that resulted in 
polyurethanes or polyurea, which looks promising for powder coating applications.
64 22 
 
 
 
Scheme 1.10 The possible reactions between carbonyl biscaprolactam and hydroxyl (X = 
O) or amino (X = NH) functional compounds (CL = ε-caprolactam). 
 
Using the CL blocked isocyanates allowed to make one–package formulation, with the 
required properties, since there were no volatile (aliphatic) isocyanates present. Most 
diamines can be modified by using this method. The amino acid lysine for example was 
chosen in this thesis.  
  
Biomedical polyurethanes 
 
PUs have been extensively investigated as materials for biomedical devices.
65 They were 
first used in biomedical applications in the late 1950s to construct a composite PU foam 
breast prosthesis. By the early 1960s, catheters and pacemaker lead insulators were being 
made out of PUs. The popularity of PUs for use in medical applications has risen steadily 
ever since. Polyurethanes are generally considered to have an excellent biocompatibility, 23 
 
and PU chemistry is so varied that it enables fine-tuning of the chemical and physical 
properties for any given application. Polyurethane copolymers or segmented PUs 
represent an important subclass of thermoplastic polymers that is frequently used in 
biomedical devices. These materials tend to be elastomeric, making them particularly 
well suited for soft tissue engineering applications, where a matrix is needed that can 
withstand local mechanical forces. The construction of a cardiac patch is one such an 
example.
65 
Avocathane
®, Biomer
®, and Tecoflex
®  are all poly(ether urethanes) based on the 
poly(tetramethylene oxide) (PTMO).
66 They appeared biocompatible and degraded in 
vivo by biologically assisted environmental stress cracking and metal ion-supported 
oxidation leading to calcification.
67 When the extracts during degradation of Pellethane
® 
were analyzed, 4,4’-methylene dianiline (MDA) was detected. MDA is known to be 
carcinogen, mutagen and displays immediate cell toxicity. As mentioned before, upon 
degradation polyurethanes are able to release toxic and carcinogenic aromatic diamines, 
originating from the aromatic diisocyanates. The aliphatic diisocyanate for instance, 1,4-
butanediisocyanate (BDI) and lysine diisocyanate (LDI) obtained from natural occurring 
diamines, are therefore beneficial and were developed for biomedical polyurethanes.  
 
Research aims and scope  
 
The aim of this research was to synthesize linear or crosslinked polyurethanes from 
caprolactam blocked lysine diisocyanate (BLDI), which were provided with functional 
side groups. A novel synthetic methodology to prepare BLDI will be developed. By 
making use of the expected stability of BLDI and the presence of a pendant ester group, 
the introduction bio-functional side groups via that pendant ester group will be studied. 
The synthesis of amorphous polymer networks will be studied to avoid remnant polymer 
crystals after degradation. Some preliminary experiments with human cells will be 
employed to demonstrate the biocompatibility of the resulting polyurethanes.  
 
Chapter 1 give the general introduction to this thesis.  
 24 
 
In chapter 2 an efficient route for the synthesis of caprolactam blocked lysine 
diisocyanate methyl ester (BLDI-OMe), and the modifications and a detailed 
characterization of BLDI-OMe is described.   
 
In chapter 3 the polymerization behavior of the caprolactam blocked lysine diisocyanate 
methyl ester with various diols is reported. 
 
Chapter 4 deals with the synthesis of transparent polyurethane networks, which were 
prepared by using a one shot technique. The novel blocked lysine diisocyanates 
(synthesized as described in chapter 2) were used instead of toxic diisocyanates. The 
polymer networks were fully characterized. 
 
Chapter 5 describes the synthesis of  poly (ester-urethanes), comprising activated N-
hydroxysuccinimide (NHS) pendant esters, which were prepared from the NHS-activated 
ester of caprolactam blocked lysine diisocyanate and polycaprolactone. The NHS-
activated ester offered an enabled technology to prepare bio-active polyurethanes. Hexyl 
amine, as model compounds, and a cell-adhesion promoting peptide, GRGDG, were used 
to substitute the NHS-group, demonstrating the ability of the concept. Human cells 
adhered well on these GRGDG functional surfaces. 
 
Chapter 6 the synthesis of biotinylated blocked lysine diisocyanates with short alkyl and 
long polyoxazolines spacer and corresponding polyurethanes is reported. Making use of 
the strong avidin-biotin binding opportunity, these materials can be easily diversified for 
a variety of different applications.   
 25 
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Chapter 2  
 
Synthesis of Caprolactam Blocked Lysine Diisocyanate Methyl ester 
and its Derivatives  
 
Abstract  
 
An efficient route for the synthesis of caprolactam blocked lysine diisocyanate methyl 
ester (BLDI-OMe), derivatization and a detailed characterization thereof was successfully 
accomplished.  The synthesis of BLDI-OMe was based on the highly selective reaction 
between compounds comprising primary amines and carbonyl biscaprolactam (CBC). In 
a highly selective reaction step only one of the two caprolactam rings of CBC was 
substituted by the amino groups of lysine, yielding the methyl ester of caprolactam 
blocked lysine diisocyanate. The structure and the purity of BLDI-OMe were determined 
by 
1H-NMR, 
13C-NMR, elemental analysis and HPLC. The accordingly determined 
purity was higher than 99%. A successful model reaction showed that octanol substituted 
selectively only the caprolactam blocking groups, while leaving the methyl ester 
unaffected, demonstrating the possibility to make linear polyurethanes with pendant ester 
groups. It was essential to omit the commonly used tin catalyst, as the ester reacted with 
octanol in the presence of this catalyst. Crucial for the aim of this work was that 
conditions were found to hydrolyze the ester group of BLDI-OMe without affecting the 
blocked isocyanate groups. So, depending on the reaction conditions either the blocked 
isocyanate group or the ester was reactive. The free acid group could be converted into 
the N-hydroxysuccinimide (NHS) activated ester. The activated ester allowed further 
modification with various nucleophiles, as was demonstrated by the substitution of the 
NHS-group with hexyl amine, as a model reaction, without affecting the blocked 
isocyanate groups.  30 
 
2.1. Introduction  
 
Due to the aging of the world population and because it is not accepted anymore to live 
with loss of function due to trauma or wear, the use of biomedical implants is rapidly 
growing. Biomedical implants can be divided in short and long lasting applications. For 
instance in hip replacements, the applied polymers should be very stable, resisting 
degradation. In contrast, in tissue engineering only temporarily supports are needed. 
During the recovery of the tissue the polymeric support must degrade in a controlled way. 
In addition, the polymers have to be biocompatible and must fulfill biological 
requirements. Highly biocompatible implants prevent active immune responses. During 
degradation the body will be exposed to the degradation products, which should be non-
toxic as well. The polymers must therefore be composed from compounds that do not 
afford toxic degradation products.  
Polyurethanes (PUs) are prepared from diisocyanates and polyols. They have been shown 
to be very suitable for biomedical implants
1. Moreover, the properties of PU can be 
designed widely, fulfilling the demanding requirements of biomedical materials. 
However, so far the introduction covalently fixed bio-active compounds in polyurethanes 
has shown to be difficult. Due to the high reactivity of isocyanates the presence of bio-
active groups or the introduction thereof is hampered seriously. Blocking the isocyanate 
groups could be an attractive alternative, while still affording the same polyurethanes 
with polyols. They are less reactive and therefore possibly suitable to introduce bio-active 
moieties.  
 
2.1.1. Blocked diisocyanates 
 
Isocyanates are highly toxic due to their ability to react with proteins
2, deactivate 
enzymes
3-5, destroy cells
6 and damage DNA
7. Most aliphatic isocyanates are volatile 
compounds that can invade into the body by inhalation
8. Diisocyanates are the most 
frequently reported cause of chemically induced occupational asthma
9 and deterioration 
of lung function after long-term repeated exposure
10.  31 
 
The high reactivity and high toxicity of isocyanates neither allow their storage or use in 
one-component systems nor tolerate the introduction of functional groups
11. A solution to 
overcome these problems, particularly used in the coating and paint industries, is the use 
of blocked isocyanates.
12 Blocked diisocyanates react with polydiols in exactly the same 
way as unprotected diisocyanates, affording the same polyurethanes, but only with a 
lower rate. Blocked isocyanates are very a versatile class of materials with many 
industrial applications. As many as 90% of the references on blocked isocyanates found 
by Scifinder are patents, which shows their industrial importance.
13,14 Blocked 
isocyanates have a bright future in the field of powder coatings and heat setting 
adhesives.
15,16 Both aliphatic and aromatic isocyanates can be blocked by variety of 
blocked agents.
13,17,18 The most widely commercially used agents are phenols, oximes, ε-
caprolactam and dibutyl malonate.
13,19 The conventional route to prepare blocked 
isocyanates is by the reaction shown in Scheme 1. This procedure depends on the 
(limited) availability of the desired isocyanates. Moreover, due to the high reactivity of 
isocyanates the presence of active hydrogen moieties (-NH-, -OH or -COOH) is not 
feasible. Hence, the preparation of functional  isocyanates via this route is hampered 
seriously.  
In contrast, blocked isocyanates might allow chemical modifications, without destroying 
the isocyanate function. However, the same limitation arises when the blocked 
isocyanates are prepared from isocyanates (Scheme 2.1).  
 
 
 
Scheme 2.1 Reaction of an isocyanate with a blocking agent (BH) to form a blocked  
isocyanate :Tb = blocking temperature; Td = de-blocking temperature  
  
To circumvent these severe limitations, we studied an alternative methodology in which 
blocked isocyanates were prepared by the reaction of primary amino groups with 
carbonyl biscaprolactam (CBC), circumventing the use of free isocyanates. 32 
 
 
2.1.2. Blocked diisocyanates from amines and CBC  
 
Carbonyl biscaprolactam (CBC) is a nontoxic solid derivative of carbonic acid, which 
was for the first time prepared by Meyer in 1956
20 and later commercialized by DSM 
under the brand name Allinco®
21. It is composed of two caprolactam rings connected 
onto carbonic acid, and is described as a chain extender to increase the molecular weight 
of polyamides during reactive processing in an extruder. Early attempts by Meyer to 
prepare high molecular polymers from CBC and diamines failed and only ill-defined 
oligomeric products were obtained. During the 1990s, Mateva et al. and researchers at 
Monsanto used CBC as an activator, together with sodium caprolactamate, in the anionic 
ring opening polymerization of caprolactam for preparing high molecular weight 
polyamides.
22,23 Müller et al. used CBC as a special bleaching agent.
24,25 Loontjens et al., 
revised the potential of CBC and found that, besides being an excellent chain extender for 
polycondensates, it was a versatile reagent for isocyanate- free urethane chemistry. 
21,26 
CBC offered a new general methodology to prepare (functional) blocked isocyanates 
(BIs). Two novel routes were discovered to prepare caprolactam-blocked isocyanates. 
One was based on the reaction of amino groups and CBC, whereas the other was from the 
reaction of hydroxyl groups and CBC.   
 
2.1.3. Chemistry of CBC 
 
N-acyl lactams are activated (di) acids derivatives, reacting readily with hydroxyl and 
amino functional compounds, yielding esters and amides respectively. The simplest 
member of this class is carbonyl biscaprolactam (CBC), in which two caprolactam rings 
are linked onto carbonic acid. CBC belongs to the class of caprolactam activated diacids, 
which yield normally ester and amides in the reaction with hydroxyl or amino functional 
compounds. However in contrast, the reaction of amino and hydroxyl groups with CBC 
yields blocked isocyanates. This opens an alternative route towards blocked isocyanates 
that are not obtainable by using isocyanates. 
 33 
 
Reactions of the caprolactam ring  
 
According to Loontjens et al. caprolactam-blocked isocyanates (CBIs) can be obtained 
from reactions of amines and alcohols with CBC.
26 If the reaction goes to completion 
four different consecutive reactions can occur: 1. ring substitution-ring substitution, 2. 
ring substitution-ring opening, 3. ring opening-ring substitution, 4. ring opening-ring 
opening (Scheme 2.2).  
 
Scheme 2.2 The possible reactions between carbonyl biscaprolactam and hydroxyl (X = 
O) or amino (X = NH) functional end groups (CL = ε-caprolactam).
20 
 
Some of the possible intermediate products, after the first reaction steps, are blocked 
isocyanates. Interestingly, it was found that, at temperatures below 100 
oC, primary 
amines substitute quantitatively only one of the caprolactam rings of CBC, yielding 
blocked isocyanates.  
When using alcohols, the first caprolactam ring of CBC opens, yielding blocked 
isocyanates as well. In that case the nitrogen atom of isocyanate group originates from 34 
 
caprolactam. Due to the less activity of hydroxyl groups compared to the amino groups, a 
higher temperature (125 
oC) is needed. The reaction is not only less reactive, but also less 
selective than with primary amines. To have reasonable yields, catalysts (example Mg
2+) 
are necessary. Molecular modeling has shown that the coordination of two of the three 
carbonyl groups of CBC with metal ions is energetically favorable. The central carbonyl 
group and one of the ring carbonyl groups operate as a bi-dental ligand, forming a 
complex with the metal ion. According to the calculations the carbon-nitrogen bond 
length in the second, non-complexed caprolactam ring is enlarged from 1.41Å to 1.50 Å, 
suggesting that this bond is weakened. Due to this weakening it is reasonable to expect 
that this caprolactam ring is more inclined to open in the presence of a catalyst. So far it 
was found that the second caprolactam ring will always be substituted by hydroxyl of 
amino groups, which is the common reaction with blocked isocyanates.
20, 26  
 
 
 
Scheme 2.3 The calculated atom-atom distances (in Å) in the complex of CBC with Mg
2+ 
ions.
20 
 
Thus, the reaction with hydroxyl comprising compounds yield blocked isocyanates, 
which could be used to make useful derivatives. However, the yields are much less than 
with amines. Hence, in this thesis only compounds comprising amines are used as high 
yields were anticipated.   
Here we describe the synthesis of caprolactam blocked lysine diisocyanates methyl ester 
(BLDI-OMe) and its derivatives, as building blocks for the preparation of bio-active 
polyurethanes. Conditions to modify independently either with the blocked isocyanate or 
with the methyl ester group will be discussed. The hydrolysis of the methyl ester, the 35 
 
conversion of the acid into the NHS-activated ester and the further modifications thereof 
are reported.
 
 
2.2. Materials and Methods 
 
2.2.1. Materials 
 
CBC (carbonyl biscaprolactam),  ALLINCO®, was kindly obtained from DSM 
Innovation Center,  (> 99 % pure according to HPLC) and used without purification. 
 L-Lysine monohydrochloride, thionylchloride, calciumchloride dihydrate, hexyl amine, 
dibutyltin dilaurate (DBTDL, 95 %), 1-octanol, anhydrous magnesium sulfate, 
dicyclohexyl-carbodiimide (DCC), N-hydroxysuccinimide (NHS), chloroform-d (CDCl3-
D, 99.8 atom % D) and dimethyl sulfoxide-d6 (DMSO-d6, 99.5 atom % D)  were 
purchased from Sigma-Aldrich.  
Ethyl acetate, potassium hydroxide and anhydrous N,N-dimethylformamide (DMF),   
were purchased from Acros Organics.  
Methanol, acetone, chloroform, triethylamine (TEA), n-hexane, hydrochloric acid fuming 
37%, tetrahydrofuran (THF), dichloromethane (DCM), were purchased from Lab-Scan 
Analytical Science. 
 
2.2.2. Analysis   
 
Column chromatography was performed on silica gel (Silica-P flash silica gel from 
Silicycle, size 40-63 μm).  TLC was performed on silica gel 60/Kieselguhr F254. 
Components were visualized by UV and staining with a solution of a mixture of KMnO4 
(5g) and K2CO3 (20 g) in H2O (500 mL). 
High performance liquid chromatography (HPLC) was carried out on a Shimadzu LC-
10ADVP HPLC equipped with a Shimadzu SPD-M10AVP diode array detector. (non-
chiral column, heptane/i-PrOH 95:5, gradient 30:70, 30 min, 0.5 mL / min, 254 nm). 
Element analysis (EA) was performed on a HEKAtech Gmbh Euro-EA CHNanalyzer.  
Mass spectra were recorded on a LTQ Orbitrap XL (ESI+). 36 
 
 
1H- and 
13C-NMR were recorded on a Varian AMX400 using CDCl3 or d6-DMSO as 
solvent. Chemical shift values are reported in ppm with the solvent resonance as the 
internal standard (CHCl3:  7.26 for 
1H,  77.0 for 
13C; d6-DMSO:  3.3 and 2.5 for 
1H,  
39.5 and 40.5 for 
13C). Data are reported as follows: chemical shifts, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet). 
 
2.2.3. Synthesis of blocked diisocyanates 
 
2.2.3.1. Synthesis of lysine methylester dihydrochloride (1)
27  
 
Lysine monohydrochloride (78.59g, 0.43mol) were suspended in 600mL methanol, 
whilst being cooled at 0
oC by using an ice bath. Thionyl chloride (45mL, 0.62mol) was 
added drop wise whilst maintaining the temperature below 20
oC. The mixture was then 
refluxed for 18 hours at 63
oC under the nitrogen atmosphere. After the clear solution was 
cooled to room temperature within 4 hours, the L-lysine methylester dihydrochloride 
crystals precipitated and were isolated by filtration and washed with acetone. The filtrate 
was concentrated by evaporation and cooled in ice to form an additional quantity of 
crystals. This fraction was filtered as well and washed with acetone and added to the 
fraction crystals that had already been obtained. The combined product was dried at 50
 oC 
for 48 hours in a vacuum oven, yielding a white powder product. The purity was over 
99% based on HPLC, the yield 96.8%. 
1H-NMR (400 MHz, DMSO-d6): δ =1.38 to 1.61 (4H, m, CH2CH2CH2CH2), 1.84 (2H, m, 
CH2CH), 2.74 (2H, m, NH3ClCH2), 3.75 (3H, s, OCH3), 3.97(1H, t, CH), 8.29 (3H, s, 
CH2NH3Cl), 8.82 (3H, s, CHNH3Cl). 
 
2.2.3.2. Synthesis of caprolactam blocked lysine methylester diisocyanate (2) (BLDI-
OMe)
27   
 
CBC (79.46g, 0.32mol) were dissolved in 150 mL chloroform at ambient temperature by 
stirring. To this solution L-lysine methylester dihydrochloride (36.63g, 0.16mol) were 
added. The resultant mixture was heated to 40
 o C, after which 45mL (0.32mol) 37 
 
triethylamine were added. The resultant mixture was refluxed at 76
 oC for 60 hours in the 
nitrogen atmosphere. Next the mixture was cooled to ambient temperature within 1 hour, 
during which triethylamine hydrochloride crystals were formed. The crystals were 
removed by filtration. The filtrate was concentrated by evaporation to obtain viscous 
turbid orange oil liquid. This liquid was dissolved in 300mL of a mixture of ethyl acetate 
and hexane (2:1, v:v). The resultant solution was extracted with 400mL of a 0.5N HCl 
aqueous solution, which contained 5% (w/w) CaCl2 and 5% (w/w) NaCl. Thereafter with 
400mL 5% (w/w) CaCl2 (aq), and subsequently with 400mL 1mol/L Na2CO3 (aq). The 
organic solution was died over anhydrous magnesium sulfate. After removing MgSO4 by 
filtration, the solvent was removed by evaporation to yield a light yellow viscous oily 
substance in a yield of 97.5%.  
Traces of CBC were removed by column chromatography with a mixture of hexane and 
THF (3:1, v: v). The compound was then dried in vacuum oven at 100
oC for 4 days to 
remove THF, yielding a colorless viscous oily product. The purity was over 99.5% 
according to HPLC measurements, and the yield was over 80%. 
1H-NMR (DMSO-d6): δ = 1.37 to 1.84 (18H, m, CH2CH2CH2 ring + CHCH2CH2CH2), 
2.66 (4H, m, CH2CO), 3.22 (2H, m, NHCH2), 3.69 (3H, s, OCH3), 3.92 (4H, m, NCH2), 
4.42 (1H, q, CH), 9.21 (1H, t, CH2NH), 9.66 (1H, d, CHNH).  
13C-NMR (DMSO-d6): δ = 179.94 (NCOCH2, ring), 172.77 (CHCOOCH3),        154.56 
(NHCON), 52.53(COOCH3).  
ESI-MS m/z: (M+1)
+ 439.25, (M+Na)
+ 461.24  
 EA:  Cal: N, 12.78%; C, 57.52%; H, 7.81%; Exp: N, 12.60%; C, 57.49%; H, 7.89% 
 
2.2.4. Model reaction of BLDI-OMe with 1-octanol  
 
A 100 mL glass flask was fitted with a reflux condenser, a nitrogen inlet and an outlet to 
a vacuum pump. After the flask was three times evacuated and refilled with nitrogen, to 
remove all oxygen, a solution of BLDI-OMe (2.0 g, 4.6mmol) and 1- octanol 
(2.4g,18.4mmol) in  dry DMF (10 mL) was added and heated up to 125 
oC with or 
without 50µl DBTDL (dibutyl tin dilaurate), while stirred for 72 hours. The solvent and 
excess 1-octanol were removed by evaporation and then the residue was dissolved in 38 
 
20mL mixture of ethyl acetate and hexane (2:1, v:v). The resultant solution was washed 
with 100mL 5% (m/m) CaCl2 (aq), thereafter with 100mL aqueous solution of Na2CO3 
(1mol/l) and subsequently with 100mL distilled water. The organic solutions were died 
over anhydrous magnesium sulfate. After removal of MgSO4 by filtration, the solvent 
was removed by evaporation to yield a light yellow wax like product (3). 
1H-NMR (d6-DMSO): δ = 0.81 (6H, m, CH2CH3), 1.23 to 1.62 (30H, m, alkane chain), 
2.94 (2H, m, NHCH2), 3.60 (3H, s, OCH3), 3.88 to 3.93 (5H, m, CH+CH2CO), 6.96 (1H, 
t, CH2NH), 7.42 (1H, d, CHNH). 
 
2.2.5. Hydrolysis of BLDI-OMe to caprolactam blocked 1-lysine diisocyanate acid 
(BLDI-OH) (4) 
 
BLDI-OMe (10g, 22.8mmol) was suspended in 30mL THF and 70mL H2O. The pH of 
this solution was adjust to 13 and maintained at this value for 5 hours at room 
temperature by the continuous addition of an aqueous KOH solution (2mol/l). The 
reaction mixture was then acidified to around pH 4 with 4M HCl, forming a milk like 
suspension. The acid containing BLDI-OH solution was extracted by diethyl ether until 
there was no suspension formed when a new charge of acid was added. The resultant 
diethyl ether solution was dried over anhydrous MgSO4. After removal of MgSO4, the 
solvent was evaporated and the residue was dissolved in a mixture of chloroform and 
methanol (60:1). After flash chromatography with chloroform and methanol with ratio of 
60:1, the elute was evaporated and the solid was died at 100
oC for 7days in the vacuum 
oven, giving 8g (80%) free acid BLDI-OH. 
1H-NMR (CDCl3): δ = 1.34 to 1.87 (18H, m, CH2CH2CH2ring + CHCH2CH2CH2), 2.62 
(4H, m, CH2CO), 3.18 (2H, m, NHCH2), 3.88 (4H, m, NCH2), 4.39 (1H, q, CH), 9.21 
(1H, t, CH2NH), 9.62 (1H, d, CHNH), 10.25 (1H, s, COOH). 
13C-NMR (CDCl3): δ = 179.9 (NCOCH2, ring), 174.5 (CHCOOH), 154.5 (NHCON) 
ESI-MS m/z: (M+1)
+ 425.24, (M+Na)
+ 447.22  
 EA:  Cal: N, 13.20%; C, 56.59%; H, 7.60%; Exp: N, 13.10%; C, 56.02%; H, 7.69% 
 
2.2.6. Synthesis of BLDI-NHS (active ester (5)) 39 
 
 
BLDI-OH (10g, 23.6mmol) was dissolved in 100 methylene chloride. To this solution 
dry and finely powdered N-hydroxysuccinimide (NHS, 2.74g, 23.8 mmol, molar ratio 
1.01 times of BLDI-OH) was added. The flask was cooled in an ice-water bath, after 
which dicyclohexyl carbodiimide (DCC, 4.88g, 23.7mmol) was added in a molar ratio of 
1.005 times of BLDI-OH. The reaction mixture was stirred vigorously at 0
 oC for 1 hour 
and at room temperature for 24 hours. After the removal of precipitated dicyclohexyl urea 
by filtration, the crude product was extracted with distilled water. The resultant was dried 
over anhydrous MgSO4. After removal of MgSO4 by filtration, the product was further 
purified by flash chromatography with chloroform and methanol with ratio of 60:1. The 
pure product was collected to give 8.5g (85%) BLDI-NHS. 
1H-NMR (CDCl3): δ = 1.42 to 2.04 (18H, m, CH2CH2CH2ring + CHCH2CH2CH2), 2.67 
to 2.82 (8H, m, CH2CO), 3.30 (2H, m, NHCH2), 3.98 (4H, m, NCH2), 4.80 (1H, q, CH), 
9.26 (1H, t, CH2NH), 9.81 (1H, d, CHNH). 
ESI-MS m/z: (M+1)
+ 522.25, (M+Na)
+ 544. 24. 
 EA:  Cal : N, 13.43%; C, 55.27%; H, 6.76%; Exp: N, 13.21%; C, 55.54%; H, 6.82%. 
 
2.2.7. Synthesis of BLDI-HA (6)  
 
BLDI-NHS (10g, 19.2mmol) was dissolved in 100 mL methylene chloride. A large 
excess of hexylamine (6.4mL, 48mmol) was added. The reaction mixture was stirred at 
room temperature overnight. After removal of precipitated NHS salt by filtration, the 
solution was washed with 300mL 5% NaHCO3 aqueous solution and with 300mL brine 
(saturated NaCl aqueous solution). The resultant solution was dried over anhydrous 
MgSO4. After removal of MgSO4 by filtration and solvent by evaporation, the crude 
product was collected. Then after flash chromatography with chloroform and methanol 
with ratio of 60:1, the pure product was collected to give 9g (90%) BLDI-HA. 
1H-NMR (CDCl3): δ = 0.83 (3H, m, CH3), 1.06 to 1.92 (26H, m, CH2CH2CH2ring + 
chains), 2.68 (4H, t, CH2CO), 3.22 (4H, m, NHCH2), 3.94 (4H, m, NCH2), 4.23 (1H, q, 
CH), 6.24 (1H, t, NHC5H10), 9.24 (1H, t, CH2NH), 9.52 (1H, d, CHNH). 
ESI-MS m/z: (M+1)
+ 508.35, (M+Na)
+ 530.33.  40 
 
 EA: Cal : N, 13.80%; C, 61.51%; H, 8.93%; Exp: N, 13.54%; C, 62.04%; H, 9.16%. 
 
2.3. Results and discussion  
 
2.3.1. Synthesis of blocked lysine diisocyanates 
 
Polyurethanes are prepared from diisocyanates and polymeric diols. (Blocked) 
diisocyanates are synthesized from the corresponding diamines and phosgene. In cases 
where the polymers are used for implants, it is preferred to use a natural diamine, such as 
diamino butane, lysine or ornithine. The term “natural” is in particular used herein as 
being naturally present in a human body. Lysine is a natural diamine that has additionally 
an acid side group that could be very useful to incorporate bio-active moieties. Loontjens 
et al. showed that primary amines react quantitatively with carbonyl biscaprolactam 
(CBC), forming blocked isocyanates.
26 This route allows making blocked isocyanates 
without the need for making first the corresponding isocyanate. The reaction of CBC with 
the amino group of lysine, in which the acid group is on the α-position with respect to an 
amino group, was not studied yet. The steric and electronic influences of the acid (or 
ester) group nearby the amino group could hamper the reactivity severely. For making 
blocked diisocyanate this acid group had to be protected temporarily, as it could interfere 
during the synthesis. The protection group, however, should be removable in order to be 
able to couple later on bio-active molecules onto the acid side group. As shown in 
Scheme 2.4 a methyl ester was chosen for that purpose. It was expected that during the 
synthesis of the methyl ester with thionyl chloride the HCl-salt of lysine would be 
formed, which could prevent the reaction between the amino groups and the methyl ester. 
 
 
 Scheme 2.4 Preparation of the methyl ester of lysine as temporarily protection moiety of 
the acid group.  
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When lysine mono-HCl salt was mixed at 0
oC in methanol with thionyl chloride, lysine 
acid chloride was formed. Subsequently, the acid chloride reacted with methanol under 
reflux to form methyl ester of lysine. After the clear solution was cooled to room 
temperature within 4 hours, the lysine methylester dihydrochloride crystals were isolated 
by filtration and washed with acetone. The white powder product was collected giving a 
yield of 96.8%. The purity of the crystals is over 99%, according to HPLC measurement. 
Figure 2.1 shows the 
1H-NMR spectrum of lysine methyl ester dihydrochloride (1). All 
signals in the spectra are in agreement with the expected product.  
 
 
1 2 3 4 5 6 7 8 9 10  
Figure 2.1 
1H-NMR spectrum of lysine methylester dihydrochloride  
 
After the protection step the caprolactam blocked lysine methylester diisocyanate (BLDI-
OMe) was prepared according to the procedure as depicted in Scheme 2.5.  
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Scheme 2.5 Synthesis of caprolactam blocked lysine methyl ester diisocyanate  
 
In a typical experiment a suspension of lysine methylester dihydrochloride in dry 
chloroform was added to a solution of CBC in chloroform. Triethyl amine (TEA) was 
added to scavenge HCl and to de-protonate the amino groups of lysine. During heating 
the formation of TEA-HCl salt can free the primary amine groups. The resulting mixture 
was refluxed at 76
 oC for 60 hours in a nitrogen atmosphere. In contrast to the reaction 
with common primary amines, reaction times were now much longer. The primary amino 
group nearby the ester is indeed much less reactive (60h) than common aliphatic primary 
amines (8h). A slight excess of CBC with respect to the amino groups was used. It was 
found that the reaction of both primary amines with CBC went to completion when small 
excess CBC was used. Although the second caprolactam ring of CBC, i.e. the one of the 
blocked isocyanate, is substitutable as well, no such a reaction takes place below 100
 oC. 
It was argued that the intermediate product is stabilized by intra-molecular hydrogen 
bonding of the –NH of the blocked isocyanate and the carbonyl group of caprolactam 
(Scheme 2.5), as evidenced by 
1H-NMR spectroscopy (NH at 9.21 and 9.66 respectively).  
Besides the desired blocked isocyanate, caprolactam and triethylamine hydrochloride 
crystals were formed. Most of the TEA-salt was removed by filtration. Caprolactam and 
residual TEA·HCl salt were readily water soluble, while the product was not. In that case 
a simple aqueous extraction was sufficient to separate caprolactam and TEA·HCl from 
reaction product. The addition of CaCl2, NaCl and HCl increases the solubility of 
caprolactam in water and decrease the solubility of blocked diisocyanate at same time, 
thereby improving the purification procedure. Hence, this method is very suitable to 
make lysine blocked isocyanates in high yield. Although the purity of the compound was 
already quite high, the monomer was still purified by column chromatography to be on 
the safe side for the consecutive polymerizations.   
Figure 2.2 shows the 
1H-NMR spectrum of blocked lysine diisocyanate methyl ester 
(BLDI-OMe) (2) before and after the column chromatography purification step. All 43 
 
signals in the spectra were in agreement with the expected product, whereas only small 
traces of impurities are visible. The signals of CBC (e.g. at 3.86ppm), and of the amines 
have completely disappeared, whereas the signals of released caprolactam (e.g. at 2.4ppm) 
is almost absent.  
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Figure 2.2 
1H-NMR spectra of caprolactam blocked lysine diisocyanate methyl ester; top: 
before column chromatography; below: after column chromatography.    
 
For sake of completeness, the 
13C-NMR spectrum of the purified monomer is given as 
well (Figure 2.3), although they cannot be used for quantitative analysis. The signals in 
the 
13C-NMR spectra were in agreement with the expected products. The signals of CBC 
(e.g. at 176 ppm and 157 ppm) and of the amines have completely disappeared, whereas 
the signal of the released caprolactam (e.g. at 178 ppm) is almost invisible.  
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Figure 2.3 
13C-NMR spectrum of caprolactam blocked lysine diisocyanate methylester 
(2). 
 
Besides NMR techniques, the product was also analyzed by ESI-MS and elemental 
analysis, as well as by high performance liquid chromatography (HPLC). Based on all 
these techniques the purity of product appeared to be over 99%. Furthermore, because of 
strong hydrogen bonding, the product is very stable. After storage for three years no 
change was noticed by 
1H-NMR. Compound (2) comprised two blocked isocyanates and 
one methyl ester functional groups. The ester group was intended to be used as an anchor 
group for further modifications, whereas the blocked isocyanates were meant to make 
polyurethanes. Hence, it was essential for this work that both active groups could be 
activated separately. 
 
2.3.2 Model reaction of the blocked diisocyanate with 1-octanol  
 
The polyaddition reaction of polyols onto diisocyanates is the common route to make 
polyurethanes. Yet, it is also possible to react blocked diisocyanates with polydiols, 45 
 
forming the same polyurethanes. However, blocked isocyanates are less reactive and 
higher temperatures are needed for the polymerization. The pendant ester functionality is 
in principle accessible for transesterification reaction, which would result in branched or 
even crosslinked products. Hence, it was important to find the conditions to substitute 
selectively caprolactam by a hydroxyl comprising compound, without attacking the 
methyl ester side group. To study this reaction in detail 1-octanol was chosen as model 
compound. The obtained low molecular weight products were better analyzable and the 
excess of octanol could easily be removed under vacuum. The model reaction was 
studied with and without dibutyltin dilaurate (DBTDL), a common catalyst for the 
preparation of polyurethanes. The reactions were followed by 
1H-NMR. The deblocking 
temperature of caprolactam blocked diisocyanate in the presence of hydroxyl functional 
compounds starts at about 125 
oC. In order to try to suppress or even prevent the 
participation of the methyl ester group, a reaction temperature of 125
oC was applied. The 
reaction is depicted in Scheme 2.6.  
 
 
 
Scheme 2.6 Modeling reaction of BLDI-OMe and 1-octanol 
 
During the reaction the caprolactam rings were substituted by 1-octanol forming urethane 
linkages. The formed caprolactam was easily removed by the aqueous washing steps.   
We found that, in the presence of dibutyl tin dilaurate (DBTDL), not only the blocked 
isocyanates, but also the ester reacted to a large extend with octanol, i.e. yielding 
branched products. In Figure 2.4 it can be seen that the sharp singlet of the methyl ester 
(3) 
(2) 46 
 
peak at 3.6ppm (orange square) is strongly reduced. As a result the reaction of BLDI-
OMe with diols in the presence of DBTDL would lead to crosslinked products. 
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Figure 2.4 
1H-NMR spectrum of modeling reaction of BLDI-OMe and Octanol with 
catalyst DBTDL.  
 
Fortunately, the desired product was obtained in high yields when the reaction was 
performed without the tin catalyst (DBTDL). In Figure 2.5 the 
1H-NMR spectrum is 
given of resulting product obtained from the reaction of BLDI-OMe with an excess of 1-
octanol without catalyst. 47 
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Figure 2.5 
1H-NMR spectra of caprolactam blocked lysine diisocyanate (BLID-OMe) and 
the reaction product of BLDI-OMe and octanol, without using a catalyst. 
 
The NH signals of the caprolactam blocked isocyanate moieties with their characteristic 
absorption at 9.66 and 9.21 ppm were absent after the reaction. Instead two new NH 
signals appeared at 7.42 and 6.92 ppm, which were assigned to the urethane protons. 
These NH signals shift to higher field is due to the absence of intramolecular-hydrogen 
bonding which was induced by caprolactam ring. More importantly, the signal of methyl 
ester COOCH3 (orange square) was still there and was even completely maintained. This 
means that the methyl ester anchor group survived 72 hours at 125
oC heating in the 
presence of an excess of octanol, which is very important for preparing polyurethanes 
with pendant ester groups, needed for further modification of polymers. 
13C-NMR 
showed the absence of carbonyl group (179.9 ppm) of caprolactam ring, further 
supporting the complete progress of the reaction.  
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2.3.3  Hydrolysis of BLDI-OMe yielding caprolactam blocked lysine diisocyanate 
acid (BLDI-OH) (4) 
 
To enable the necessary derivatization reactions, reaction conditions had to be found to 
hydrolyze the methyl ester side chains without hydrolyzing the blocked isocyanate 
groups. Hydrolysis of the ester had to be done before the polymerization, since the ester 
linkages of the polyester diols in the polyurethane backbone are susceptible to cleavage 
as well. We found finally conditions under which the ester of BLDI-OMe (2) can be 
hydrolyzed without hydrolyzing the blocked diisocyanate groups. The reaction was 
performed at room temperature at pH 13 (Scheme 2.7).  
 
 
 Scheme 2.7 Hydrolysis of the methyl ester of BLDI-OMe 
 
The reaction was followed by monitoring in the 
1H-NMR spectrum the disappearance of 
CH3 signal of methyl ester side chain and the appearance of the free carboxylic acid 
signal at 3.60 ppm and 10.25 ppm respectively (Figure 2.6). The reaction was complete 
after about 5 h. All signals in the spectrum can be assigned to the expected products. ESI-
MS and elemental analysis were supporting evidence that the desired product was 
obtained.  49 
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Figure 2.6  
1H-NMR spectrum of hydrolyzed blocked diisocyanate BLDI-OH. 
   
2.3.4. Synthesis of BLDI-NHS (5) (active ester) 
 
The pendant carboxylic acids can used to tether functional groups. However, harsh 
reaction conditions to modify carboxylic acids were not preferred. A more general 
method is to use activated esters,
28-30  which react under ambient conditions. There were 
several options to convert the free acid of blocked diisocyanate into the active ester. One 
option was to react free acid with the N-hydroxysuccinimide (NHS) to form NHS 
activated ester. This activated ester can easily react with all kind of nucleophiles, such as 
the N-terminus of the peptide or proteins, forming a stable covalent amide bond.  
To facilitate the reaction with N-hydroxy succinimide dicyclohexyl-carbodiimide (DCC) 
was used to activate carboxylic acid group (Scheme 2.8).  
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Scheme 2.8 Synthesis of NHS active ester caprolactam blocked lysine diisocyanate BLDI-
NHS 
 
The reaction was performed at room temperature and monitored, by 
1H-NMR, the 
disappearance of COOH signal and appearance of NHS signal at 10.25 ppm and 2.82 
ppm respectively (Figure 2.7). The reaction completed in high yields after about 24 h. All 
signals in the spectrum could be assigned to the expected products.  
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Figure 2.7   
1H-NMR spectrum of NHS active ester caprolactam blocked lysine 
diisocyanats BLDI-NHS 
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ESI-MS and elemental analysis were supporting evidence that the desired product was 
obtained. Although NHS active esters are reactive, they appeared to be stable enough to 
be stored under dry conditions for several months without any sign of deterioration.
31,32  
 
2.3.5. Synthesis of BLDI-HA (6) for biomaterials modeling reaction 
 
A final prove of the feasibility of our route to make lysine blocked diisocyanate with 
pendant functional groups was to substitute the NHS group by a simple amine, for which 
hexyl amine was used. To prevent hydrolysis of NHS by traces of water
29 anhydrous 
methylene chloride was used as solvent.  Hexylamine substituted indeed the NHS group, 
without affecting the blocked isocyanate groups. While being coupled onto the blocked 
diisocyanate BLDI-HA (6) was formed and the precipitation of the NHS-amine salt was 
noticed at same time (Scheme 2.8).  
 
 
 
Scheme 2.8 Synthesis of hexylamine caprolactam blocked lysine diisocyanate BLDI-HA 
 
The reaction was performed at room temperature and monitored by 1H-NMR via the 
disappearance of NHS signal and appearance of amide and CH3 of hexylamine signals at 
2.82, 6.38 and 0.8 ppm respectively (Figure 2.8). The reaction was complete after about 
24 h. All other signals in the spectrum could be assigned to the expected products. ESI-
MS and elemental analysis supported furthermore that the desired product was obtained. 
The coupling reaction, which was successfully performed in high yields, could be seen as 
a model reaction for coupling of the N-terminus of peptides, proteins or other bio-active 
compounds. 
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Figure 2.8   
1H-NMR spectrum of hexylamine caprolactam blocked lysine diisocyanate 
BLDI-HA 
 
2.4. Conclusion  
 
The lysine blocked diisocyanate methyl ester was successfully synthesized in high yield 
by reacting the methyl ester of lysine HCl-salt, in the presence of a base, with carbonyl 
biscaprolactam (CBC).  In a highly selective step only one of the two caprolactam rings 
of CBC was substituted by the primary amines, yielding the methyl ester of caprolactam 
blocked lysine diisocyanate. The caprolactam blocked lysine diisocyanate groups reacted 
exclusively with 1-octanol in high conversions without modifying the methyl ester, but 
only when no metal catalyst was used. This offered probably enabling conditions to make 
linear polyurethanes with pendant ester groups.  
In order being able to introduce pendant bio-functional side groups we found the 
condition at which we could hydrolyze the ester group without affecting the blocked 
isocyanate groups. This is the major advantage of blocked diisocyanate over the methyl 
ester of lysine diisocyanate.  53 
 
The free acid group was converted into the N-hydroxysuccinimide activated ester. The 
activated ester allows modification with various nucleophiles. In a model reaction the 
substitution of the NHS-group by hexyl amine was successfully performed.  
The various modified caprolactam blocked lysine diisocyanates can be used to make very 
well defined polymer structures, which will be discussed in the following chapters.   
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Chapter 3  
 
Linear polyurethanes based on caprolactam blocked lysine diisocyanate 
methyl ester  
 
Abstract 
 
The aim of this chapter was to make linear polyurethanes by using the difference in 
reactivity of the blocked isocyanate groups and the methyl ester of caprolactam blocked 
lysine diisocyanate methyl ester (BLDI-OMe) in the reaction with polydiols. For that 
poly(ε-caprolactone) (PCL) and poly(ethyleneglycol) (PEG) were selected as 
representative examples for the two classes of polyurethanes (PUs). Poly(ester-urethanes) 
were successfully synthesized by reacting PCL with BLDI-OMe, in solution as well as in 
bulk. In bulk the polymerizations were much faster than in solution. Above 180
 oC, in 
bulk, branching of the polyurethanes happened. As a result, depending on the conditions, 
either linear or branched polymers or even polymer networks could be made with the 
same monomer mixtures.  
Polyethylene glycol was selected to study the polymerization performance of polyethers 
with BLDI-OMe in bulk. In contrast to PCL, linear poly(ether-urethane) could not be 
obtained in this case. Even at 125
oC (deblocking temperature of caprolactam blocked 
isocyanate group), the reactivity of hydroxyl groups of PEG towards the ester group was 
already too high. As a result, poly (ether-urethane) networks were formed after prolonged 
heating. This offered a convenient way to make polyurethane networks, which will be 
discussed in chapter 4.      58 
 
3.1. Introduction 
 
As described in Chapter 1, polyurethanes (PUs) have been widely used in biomedical 
devises. PUs are highly biocompatible and have widely tunable properties. Commonly 
they are prepared from diisocyanates and polymeric diols. However, the same polymers 
can be prepared by using blocked diisocyanates instead of unprotected isocyanates. The 
only difference is that the polymerization rate is slower due to the protective group. 
Above a certain threshold temperature hydroxyl groups are able to substitute the blocking 
group, yielding polyurethanes. The advantage of blocked isocyanates is that they are 
stable below 100 
oC, allowing chemical modifications, which are impossible with 
unprotected isocyanates.  
Numerous groups, including ours, have investigated biodegradable linear polyurethanes 
comprising degradable polyester as soft segments, and various diisocyanates and chain 
extenders as hard segments.
1-12 Varying the chain extender to diisocyanate ratio in the 
hard block, or altering the molecular weight or composition of the polyester in the soft 
block will dictate the ultimate physical properties of the polymers and the ultimate 
degradation rate.
3-8  
During degradation of polyurethanes formations of carcinogenic and mutagenic aromatic 
diamines have been reported, originating from the aromatic diisocyanates. Whether the 
concentration of these harmful degradation products attain a physiologically relevant 
level is still unresolved and in debate.
13,14 An alternative for aromatic isocyanates, in 
order to eliminate the concern of aromatic amines, is the utilization of diisocyanates 
based on amino acids, such as lysine.
15-17 These compounds provide a route to 
synthesizing biodegradable polyurethanes that are expected to yield only non-toxic 
degradation products. Bruin et al. reported that if the diisocyanates were liberated by 
hydrolysis of the urethane bonds of the polymer during degradation, the isocyanate 
functionalities would react with water to regenerate the diamine. If lysine diisocyanate 
ethyl ester was used , an essentially nontoxic diamine would be formed.
18 Subcutaneous 
implantations in guinea pigs elicited what the authors described as ‘‘no adverse tissue 
reactions”.
19 Other researchers have utilized lysine diisocyanate (LDI) and butane 
diisocyanate (BDI) to develop both crosslinked and linear biodegradable polyurethane 59 
 
elastomers for biomedical applications and have not described any significant toxic or 
tumorigenic responses of these materials upon implantation.
20–25 Also, BDI- and LDI-
based polyurethanes have been reported to be both tissue and cell biocompatible
 .
22-27 
So far, only the non-blocked lysine diisocyanate was used in biomedical polyurethanes.
 
The use of free isocyanates has some serious drawbacks.
 Remnant traces of the high 
reactive and highly toxic isocyanates in the human body are not acceptable. More 
importantly, the presence of the isocyanate group did not tolerate any chemical 
modification of the ester side group of lysine. Hence, introduction of relevant bio-active 
functional groups via this ester function was not feasible.  
As described in Chapter 2, the caprolactam blocked lysine diisocyanate methyl ester 
(BLDI-OMe) reacted exclusively with 1-octanol in high conversions via the blocked 
isocyanate groups without affecting the ester. It appeared to be essential that no catalyst 
was used. This offered perhaps the possibility to react functionalized blocked lysine 
diisocyanate with diols, affording catalyst-free linear polyurethanes with functional side 
groups.
 
In this chapter, the synthesis is reported of polyurethanes (PUs) that were obtained from 
blocked lysine diisocyanate (prepared according to the method as described in Chapter 2) 
and polycaprolactone and poly(ethylene glycol) diols. The synthesis, characterizations 
and properties of the PUs are described in detail.  
 
3.2. Materials and Methods  
 
3.2.1. Materials 
 
CBC (carbonyl biscaprolactam) was obtained from DSM Innovation Center, ALLINCO®, 
(> 99 % pure according to HPLC) and used without purification. 
  L-Lysine monohydrochloride, thionylchloride, calciumchloride dihydrate, anhydrous 
magnesium sulfate, poly(ethyleneglycol)600 (PEG600), poly(ε-caprolactone)530 
(PCL530), chloroform-d (CDCl3-D, 99.8 atom % D) and dimethyl sulfoxide-d6 (DMSO-
d6, 99.5 atom % D) were purchased from Sigma-Aldrich.  60 
 
Ethyl acetate and anhydrous N,N-dimethylformamide (DMF), were purchased from 
Acros Organics.  
Methanol, acetone, chloroform, triethylamine (TEA), n-hexane, hydrochloric acid fuming  
37%, tetrahydrofuran (THF), were purchased from Lab-Scan Analytical Science. 
Caprolactam blocked lysine diisocyanate methyl ester (BLDI-OMe) was synthesized 
according to the method as described previously (chapter 2).  
 
3.2.2. Analysis   
 
Column chromatography was performed on silica gel (Silica-P flash silica gel from 
Silicycle, size 40-63 μm). TLC was performed on silica gel 60/Kieselguhr F254. 
Components were visualized by UV and staining with a solution of a mixture of KMnO4 
(5g) and K2CO3 (20 g) in H2O (500 mL). 
Size exclusion chromatography (SEC) measurements were performed in 
dimethylformamide with 0.01M LiBr on a Viscotek GPC max equipped with model 302 
TDA detectors, using 2 columns (Pl-gel 5µ 30 cm mixed-C from Polymer Laboratories). 
The data analysis was done using conventional calibration with polystyrene standards 
accompanied by in-house software. 
1H-NMR spectra were recorded on a Varian AMX400, using CDCl3 as solvent. 
ATR-FTIR was done using broker IFS88 spectrometer equipped with a Golden Gate 
(Graseby specac) single reflection ATR accessory. Spectra resolution was 4 cm
-1 and 32 
scans were taken per spectrum  
Differential Scanning Calorimetry (DSC) measurements were performed on a Perkin 
Elmer DSC 7 instrument. The samples with masses varying between 7-10 mg were 
heated from -60 
oC to +90 
oC with a rate of 10 
oC / min.  
 
3.2.3. Solution polymerization of BLDI-OMe and PCL530 
 
3.2.3.1 Optimizing the ratios between PCL530 and BLDI-OMe  
A 100 mL glass flask was fitted with a nitrogen inlet and an outlet to a vacuum pump. 
After the flask was evacuated and refilled with nitrogen for three times, to remove all 61 
 
oxygen, a solution of BLDI-OMe (2.0 g, 4.6mmol) and various amounts of PCL530 in 
the anhydrous DMF (10 mL) was added and heated to 125 
oC while stirring. After 72 
hours, samples were taken and the polymer solutions were poured into the diethyl ether. 
The precipitate was separated by centrifugation and, after the supernatant was removed, 
the polymers were dried in a vacuum oven at 50 
oC for 48 h.  
 
3.2.3.2. Polymerization kinetics 
A 100 mL glass flask was fitted with a nitrogen inlet and an outlet to a vacuum pump. 
After the flask was three times evacuated and refilled with nitrogen, to remove all oxygen, 
a solution of BLDI-OMe (2.0g, 4.6mmol) and PCL530 (2.38g, 4.5mmol) in the 
anhydrous DMF (10 mL) was added and heated up to 125 
oC while stirring, for several 
days. During the polymerization, after various time intervals, samples were taken and 
poured into the diethyl ether. The precipitate was separated by centrifugation and after 
the supernatant was removed the polymers were dried in a vacuum oven at 50 
oC for 48 h. 
The molecular weights were determined by size exclusion chromatography (SEC).  
 
3.2.4. Bulk polymerization of BLDI-OMe and PCL530 
 
3.2.4.1 Polymerization kinetics 
A 100 mL glass flask was fitted with a nitrogen inlet and an outlet to a vacuum pump. 
After the flask was three times evacuated and refilled with nitrogen, to remove all oxygen, 
dry BLDI-OMe and PCL530 were added in a molar ratio of 1.025. The mixture was 
heated up to 125 
oC while stirring under vacuum, for several days. Samples were taken at 
several time intervals and analyzed by SEC measurement directly, without purification by 
precipitation.  
 
3.2.4.2. Polymerization at higher temperatures in bulk  
A 100 mL glass flask was fitted with a nitrogen inlet and an outlet to a vacuum pump. 
After the flask was three times evacuated and refilled with nitrogen, to remove all oxygen, 
dry BLDI-OMe and PCL530 were added in a molar ratio of 1.025. The mixture was 
subsequently heated up to 145 
oC, 160
 oC, 180
 oC respectively, while stirring under 62 
 
vacuum, for various time till 24 hours. Samples were taken and analyzed by SEC 
measurement directly, without purification by precipitation. 
 
3.2.5. Bulk polymerization of BLDI-OMe and PEG600 
 
A 100 mL glass flask was fitted with a nitrogen inlet and an outlet to a vacuum pump. 
After the flask was three times evacuated and refilled with nitrogen, to remove all oxygen, 
dry BLDI-OMe and PEG600 were added in a 1:1 molar ratio. The mixture was heated up 
to 125 
oC while stirring under vacuum for 72hours. Samples were taken and analyzed by 
SEC measurement directly, without purification by precipitation. 
 
3.3. Results and discussion  
 
3.3.1. Solution polymerization of BLDI-OMe and PCL530 
 
As described in Chapter 2, 1-octanol reacted exclusively and in high conversions with the 
blocked isocyanate groups of caprolactam blocked lysine diisocyanate methyl ester 
(BLDI-OMe) and not with the ester moiety, but only when no catalyst was used. Hence, 
linear polyurethanes could be expected to be obtained when polydiols were used instead 
of 1-ocatanol. The most commonly used polydiols for synthesizing polyurethanes are 
polyester and polyether diols. Here, poly(ε-caprolactone)530 (PCL530) and 
poly(ethylene glycol)600 (PEG600) were used to represent polyester and polyether diols.  
Poly (ε-caprolactone) is commonly used as soft segment polyester in polyurethanes. It is 
known to be biocompatible, slowly hydrolysable and enzymatically degradable. The 
molar weight of linear polyurethanes has to be relatively high, having a sufficient 
quantity of the crystalline hard phase to increase physical crosslinking, in order to 
achieve good mechanical properties. However, residues of the crystalline fraction caused 
inflammatory reactions in vivo.
28, 29 Here we chose therefore a low molecular weight 
PCL530 as soft segment to react with blocked lysine diisocyanate, forming amorphous 
polyurethanes. Due to the asymmetrical structure of lysine diisocyanate it is difficult, 
maybe even impossible to obtain crystalline hard segments. Moreover, the pendant ester 63 
 
side group offered the possibility to form chemical instead of physical crosslinks, which 
enables to tune the mechanical properties of these amorphous polymers.    
Initially, the polymerizations were done by heating a solution of BLDI-OMe and PCL530 
in various ratios in anhydrous DMF in a nitrogen atmosphere at 125 
oC, which is above 
the deblocking temperature of caprolactam blocked isocyanates.
30,31 The polymerization 
scheme is depicted in Scheme 3.1. During the polymerization the caprolactam rings were 
substituted by PCL530, forming the corresponding polyurethanes. Samples were taken 
after 72 hours and were precipitated in diethyl ether to remove caprolactam and low 
molecular compounds. The polymers were collected by centrifugation and, after the 
supernatant was removed by decantation, the samples were dried in an oven before 
performing the molecular weights analysis by SEC.  
 
 
 
Scheme 3.1 Synthesis of polyurethanes from the blocked lysine diisocyanate (BLDI-OMe) 
and poly(ε-caprolactone) (PCL), polymerized without catalyst . 
 
 
Synthesis of PUs is a typical condensation polymerization. The stoichiometry of 
polymerization reactants is very important for getting high molecular weights.
32 
Therefore, polymerizations with various ratios between the amounts of blocked 
diisocyanate and PCL530 were performed to equalize the molar ratio of the functional 
groups. The molecular weight of the commercial PCL530 may be different from exactly 64 
 
530 Da. Hence, the optimal weight ratios have to found by trial and error, near the 
stoichiometric point. All the PUs prepared in DMF at 125 
oC were well soluble in DMF, 
even at room temperature, without any sign of gel formation. Since the polymers 
dissolved well in DMF the SEC analyses were therefore performed in the same solvent. 
Table 3.1 gives the molecular weights of PUs, which were obtained by varying the ratio 
between BLDI-OMe and PCl530. From the table, it can be seen at a molar ratio of 1.025 
between blocked diisocyanate and PCL530, thus with a small excess of the BLDI-OMe, 
the highest molecular weight was obtained. This means that the molecular weight of 
PCL530 was very close to its theoretical value, assuming that the purity of BLDI-OMe 
was high. The PDI of all polymers was below 2, meaning that no branching took place 
under those conditions. So, the molar ratio as found in this series of experiments was also 
chosen in the next series of polymerizations.  
 
Table 3.1 Molecular weights of PUs depending on the theoretical molar ratio between 
BLDI-OMe and PCl530 (72h, 125 
oC). 
Ratio of 
BLDI-OMe :  PCl530  Mn (Da)  Mw (Da)  P.D.I 
1.200 : 1  5,100  6,600  1.3 
1.102: 1  5,700  7,500  1.3 
1.074 : 1  5,800  8,200  1.4 
1.050 : 1  6,400  7,400  1.2 
1.025 : 1  7,500  13,900  1.8 
1.003 : 1  6,800  11,700  1.7 
 
The molecular weight of polymers obtained from condensation polymerizations, also 
named step-growth polymerizations, increases step by step till one kind of functional 
groups is totally consumed.
32 Therefore, the optimization of the stoichiometry was 
important. 
After having established the optimal molar ratio, the polymerization kinetics of PUs from 
BLDI-OMe and PCL530 were studied. During the polymerization at 125 
oC in DMF, 
every 12 hours samples were taken, until 192 hours and the molecular weights were 
measured by SEC. From table 3.2 and figure 3.1 it can be seen that during the 65 
 
polymerization until 192 hours, the number average molecular weight (Mn) increased in 
time to about 10,000 Da. The polydispersity was low (< 2.0) until a polymerization time 
of 108h (Mn = 7,300 Da) and became somewhat larger (2.6) at the end of the 
polymerization (192h), but the PDI was still narrow for condensation polymerizations 
that could potentially give branched polymers. The PDI value shows that, at least until a 
Mn of 7,300 Da, linear polymers were obtained. If prolonged reaction times were applied 
higher molecular weight polymers were obtained, and it appeared that some branching 
might have occurred.  
 
Table 3.2 SEC results of polyurethane molecular weights depend on polymerization time, 
in DMF as solvent 
Time(h)  12  24 36 48 60 72 84 96  108  192 
Mn  (Da)  2,200  2,700 3,300 4,100 4,700 5,400 6,200 6,800 7,300 9,700 
Mw (Da)  2,600  3,600 5,000 6,500 8,000 9,700  11,500  13,100  14,600  25,100 
PDI 1.19  1.34 1.49 1.60 1.69 1.81 1.85 1.93 2.00 2.58 
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Figure 3.1 The relationship between molecular weights and reaction time of solution 
polymerization of PCL and BLDI-OMe in DMF at 125
oC: (a) Mn vs time, (b) Mw vs time.    
 
In Figure 3.2 the 
1H-NMR spectrum is given of the polyurethane with a Mn of 9,700 Da 
and a DPI of 2.58. All signals in the spectrum were in agreement with the expected 
products, originating from lysine diisocyanate and PCL530. Importantly, the sharp singlet 66 
 
signal of methyl ester COOCH3 (3.5ppm) is still there and is even completely maintained, 
according to NMR. It means that the pendant methyl ester group did not react at all with 
hydroxyl groups at 125 
oC, which confirms the model reaction in chapter 2 (scheme 2.6). 
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Figure 3.2  
1H-NMR spectrum (CDCl3) of resulting product obtained from the solution 
reaction from BLDI-OMe and PCl530 which Mn and DPI are 9,700 and 2.58 respectively. 
 
It was obvious that the polymerization rate was very slow at 125
 oC. After 8 days (192 
hours), the Mn was around ten thousand Da. The polymerization rate was of course very 
low because of the low reactivity of blocked isocyanate groups. Moreover, a (tin) catalyst, 
which is normally used to increase the reaction rate, was omitted to prevent (successfully) 
branching. But, too long reaction times could result in side reactions, such as oxidation, 
which is not acceptable.  
 
3.3.2. Bulk polymerization of BLDI-OMe and PCL530 
 67 
 
The polymerization was performed without any solvent at 125
 oC. The polymerization 
was continued until 132h, while taking every 12h a sample. The caprolactam formed 
during the reaction evaporated because of the high temperature and vacuum conditions 
applied during the polymerization. As a result, a pure polymer was finally obtained. The 
resulting 
1H-NMR spectra were very similar to those in figure 3.3, while the caprolactam 
signals at 7.0 and 3.3 ppm were absent. The molecular weights increased in time, 
similarly as found with the solution polymerization (table 3.3 and figure 3.3), but now 
much faster.  
 
Table 3.3 Molecular weights obtained by SEC of polyurethanes after various 
polymerization times, in bulk condition (T = 125 
oC), using polystyrene standards 
Time  (h)  12  24  36  48  60 72 84  96  108 120  132 
Mn  (Da) 2,300  4,500 5,300 5,900 8,000 10,200  13,900  16,900 18,300 18,600  19,400 
Mw  (Da)  2,600 5,300  6,900  8,700 12,800 17,200  26,200  32,400 36,600 39,000  42,800 
PDI  1.17  1.19 1.31 1.47 1.60  1.70  1.88  1.92 2.00 2.10  2.20 
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Figure 3.3 The relationship between molecular weights and reaction time of the bulk 
polymerization of PCL and BLDI-OMe at 125
oC: (a) Mn vs time (b) Mw vs time.    
 
After 108 hours reaction, the Mn was already 18,000 Da in bulk conditions, while it was 
only 7,000 Da in solution. Notice that the PDI is still only 2.1, which is very close to 2.0, 
as it should be for polycondensations, without branching reactions. After a 68 
 
polymerization time of about 100 hours the increase of the molecular weights slowed 
down, because of the high viscosity of system and of the low concentration of functional 
groups left. But, the molecular weights still increased slowly, but significantly. To reduce 
the length of the polymerization and to increase the molecular weights further, higher 
reaction temperature were investigated, although branching could take place. 
In table 3.4 the results of the bulk polymerization (industry favored) at higher 
temperatures are compiled. 
 
Table 3.4 The molecular weights determined by SEC of polyurethanes prepared from 
PCL and BLDI-OMe in bulk at various temperatures 
T (
o
C)  Time (h)  Mn (Da)  Mw (Da)  PDI 
145 6  17,400  33,000  1.91 
145 22  35,400  80,100  2.26 
160 4  13,000  22,400  1.73 
160 24  56,300  165,000  2.93 
180 4  36,800  333,500  9.06 
 
As shown in table 3.4, a number average molecular weight of 17,000 Da and PDI of 1.9 
was obtained at 145 
oC after 6 hours reaction, which is equal to reaction at 125 
oC for 96 
hours. Notice that the PDI is still 1.9, indicating that no branching took place. 
Polymerization time of 6 hours is convenient and very common, also in industrial 
processes.  The number average molecular weight increased till 35,400 Da with PDI of 
2.2 after 22 hours at 145
oC. The polydispersity of these polymers is still remarkably 
narrow, which means that the methyl ester group did not significantly react with the 
hydroxyl group of PCL530.  
The 
1H-NMR results gave further evidence for the formation of only linear polymers. 
From figure 3.4(a), it can be seen that the sharp singlet signal of methyl ester COOCH3 
(3.6 ppm) is still there and is even completely maintained. The methyl ester groups are 
amazingly stable even when heated to 160
 oC in a bulk polymerization. 69 
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Figure 3.4 Spectra of a polyurethane with a Mn of 35,400 Da and PDI of 2.26, obtained 
from a bulk polymerization at 145
 oC for 22 hours, starting from BLDI-OMe and PCl530 
(a): 
1H-NMR spectrum (CDCl3); (b):ATR-FTIR spectra.  
 
The conversion of PCL530 into PU was further supported by the ATR-FTIR analysis. 
From the ATR-FTIR measurement (Figure 3.4(b)), two distinctive vibration bands have 
been detected in the PU sample that was not present in the PCL530 spectrum: 1672cm
-1 
(shoulder of peak 1720cm
-1) and 1525cm
-1, originating from urethane carbonyl stretching 
vibration (amide I) and NH deformation vibration (amide II). The peak arranges from 
3100cm
-1 to 3450cm
-1 and from 2814cm
-1 to 3050cm
-1 are related to the NH stretching 
vibration and CH2, CH3 stretching vibration respectively. The highest sharp peak at 
1720cm
-1 consists of ester carbonyl stretching vibration from both PCL530 ester and 
methylester side group of blocked diisocyanate. The absorption intensity is big because 
the urethane carbonyl stretching vibration peak is partly overlapped by the ester carbonyl 
peaks.
33  
When heated to 180 
oC, branching occured, demonstrating that the methyl ester group 
reacted with the hydroxyl group of PCL530. This was evidenced by a broad 
polydispersity index of 9.06.  
These results revealed an unexpected, but very interesting discovery that the bulk 
polymerization conditions of PCL and BLDI-OMe showed a high selective reactivity of 70 
 
the hydroxyl groups of PCL for caprolactam blocked isocyanates and the pendant methyl 
ester. Only the caprolactam blocked isocyanate groups reacted with hydroxyl groups of 
PCL, whereas the ester group remained intact up to 160
 oC. Nevertheless, BLDI-OMe 
behaved in bulk polymerizations as a trifunctional monomer above 180
 oC, which could 
be used to synthesize polyurethane networks. Hence, the degree of polymerization and 
branching was tunable by varying the polymerization temperature and time. 
 
3.3.3. Glass Transition temperature (Tg) of PUs depend on BLDI-OMe and PCL530 
 
All our PU samples were transparent sticky wax like polymers without any indication 
that crystallization took place. The lack of crystallinity was considered as an important 
advantage to prevent inflammation reactions, when the polymer degrades in the body, 
due to remnant crystal moieties. Hence, it was expected that our PUs would not have 
detectable melting temperatures. Possible melting temperatures and glass transition 
temperatures (Tgs) were determined by DSC. The samples were heated from -60
oC to 
90
oC, at heating rate of 10
oC/min. Table 3.5 give the glass transition temperatures (Tgs) 
of PUs with different molecular weights. 
 
Table 3.5 Glass transition temperatures (Tg) of polyurethanes from PCL and BLDI-OMe, 
with various molecular weights which were prepared in bulk reaction. 
Sample(P#) Mn (Da)  Mw (Da)  PDI  Tg  (
oC)   
1 PUOMe-PCL530  4,300  6,500  1.5  -32.8 
2 PUOMe-PCL530  9,900  19,200  1.9  -28.1 
3 PUOMe-PCL530  23,900  48,500  2.0  -26.0 
4 PUOMe-PCL530  36,900  90,100  2.44  -35.4 
5 PUOMe-PCL530  52,500  169,800  3.24  -26.3 
 
None of the samples showed any indication of meting transitions. All the samples show 
low Tg values in a range of -33
 oC to -26
 oC, because of the flexible polyester spacer 
segment (PCL530). All PUs had the same soft segment (same chain mobility) which 
resulted in the similar Tgs. The Tg did not increase with increasing molecular weights of 
the PUs, and even not in branched polymers or in PU networks (chapter 4).    71 
 
 
3.3.4. Bulk polymerization of BLDI-OMe and PEG600 
 
PEG600 was selected as a representative example of polyether diols to synthesize PUs 
with the caprolactam blocked lysine diisocyanate methyl ester. As discussed before, we 
found that the bulk polymerization of a blocked diisocyanate with PCL530 was faster, as 
compared with solution polymerization in DMF. Accordingly, the polymerizations of 
PEG600 and BLDI-OMe were performed at 125
oC in bulk as well. However, after a 
polymerization time of 72h, an unexpected gelation took place, which was not found with 
PCL530. The hydroxyl groups of PEG have apparently a higher reactivity towards the 
ester group than those of PCL’s (figure 3.5).  One can speculate that hydroxyl groups of 
PEG are more acidic than the one of PCL. The hydroxyl group in PEG is two methylene 
groups apart from the electron withdrawing β-oxygen atom. The hydroxyl group in PCL 
is five methylene groups away from the ε-carbonyl group, resulting in a less acidic 
hydroxyl group.  
The pKa  value of hydroxyl functional compounds is a measure for the degree of 
dissociation of compound in a proton and an anion and is a measure of the acid strength. 
Numerous pKa prediction models have been developed, based on various approaches. M. 
Meloun and S. Bordovska
34 compared the predicted values obtained with four software 
packages (PALLAS, MARVIN, ACD/pKa DB, and SPARC) to experimental results of 
three sets of compounds. They concluded that the ACD/pKa DB model provided the most 
accurate predicted values, showing the best results in six different statistical 
characteristics. By using the online available ACD/pKa DB software we calculated that  
pKa values of PEG and PCL were 14.6 and 15.5 respectively. Although the differences 
were not large, it still meant that the hydroxyl group of PEG was more acidic than the one 
of PCL’s, resulting apparently in more active species towards the methyl ester.  
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Figure 3.5 Structures of PEG and PCL 
 
3.3.4. Conclusion 
 
The poly(ester-urethanes) were successfully synthesized from our homemade 
caprolactam blocked lysine diisocyanate methyl ester and either polycaprolactone530 or 
PEG600.  
In solution as well as in bulk a typical step-growth polymerization with PCL was 
observed. Molecular weights (Mn) up to 10,000 Da were obtained in the solution 
polymerization. As expected the bulk polymerization was much faster than the 
polymerization in DMF. In bulk molecular weights (Mn) up till 35,000 Da were obtained, 
with still a rather narrow molecular weight distribution of 2.26. Remarkably, the 
hydroxyl groups of PCL reacted in bulk nearly exclusively with the blocked isocyanate 
groups and not with the methylester group. Linear polyurethanes were obtained in the 
bulk polymerization, when the reaction temperature was below 160
oC. Bulk poly(ester-
urethanes) networks can be obtained at temperatures above 180
oC. By varying the 
polycaprolactone molecular weights and the crosslink density the mechanical properties 
can be tailored. 
Next to the polyester diol (PCL), a commonly used polyether diol, PEG, was heated with 
BLDI-OMe to make another series of non-crosslinked polyurethanes. In contrast to PCL, 
the hydroxyl groups of PEG600 reacted already at 125
oC (deblocking temperature of 
caprolactam blocked isocyanate group) with the pendant ester group, resulting directly in 
poly(ether-urethane) networks with useful mechanical properties (Chapter 4).  73 
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Chapter 4  
 
Polyurethane networks based on caprolactam blocked lysine 
diisocyanate  
 
Abstract 
 
In this chapter the synthesis of amorphous polyurethane networks is described, based on 
polydiols and on a homemade caprolactam blocked lysine diisocyanate methyl ester 
(BLDI-OMe). Poly(ε-caprolacton) and poly(ethyleneglycol) were selected as 
representative examples for the two classes of polyurethanes (PUs). The polyurethane 
networks were prepared in a single-stage process. After mixing the monomers, the curing 
was performed by heating the samples for 48 hours at 160
oC under vacuum. The PU 
network films, based on both PEG600 and PCL530, were flexible and totally transparent 
solids, which indicated that no crystalline phases were present. This was supported by 
DSC measurement. The polymer films swelled but did not dissolved in chloroform, 
demonstrating the crosslinked topology. The PU-PEG600 network was more hydrophilic 
than PU-PCL530 network, which resulted in a higher absorption of water. In vitro 
degradation test showed that the PU-PEG600 network degraded completely in 35 days, 
whereas PU-PCL530 lost about 3.5wt% of weight during this period. Mechanical 
measurements revealed that both polymers displayed rubber-like behavior. The lack of 
yield points in stress-stain curves demonstrated the amorphous character.  76 
 
4.1. Introduction 
  
Biodegradable polymers are receiving more and more attention due to their wide use in 
biomedical application.
1,2 They may act as temporary scaffolds to facilitate tissue 
regeneration or replacement and may also be used for temporary therapeutic purposes, 
eliminating the need for subsequent removal.
3,4  The majority of the biodegradable 
polymers developed in the last two decades were aimed at either drug delivery systems
2 
or fracture fixation devices and are typically hard, rigid materials
5. An important aspect 
of tissue engineering is the design of scaffolding materials which mimic the properties of 
extracellular matrices. Moreover, due to the temporarily character in this application, a 
tunable degradation behavior is mandatory. In this respect, the physical-, chemical- and 
biological properties and the biodegradation behavior of the materials are decisive for 
their suitability.  
A variety of hydrolytically degradable polymers have been developed for tissue 
engineering scaffold applications. However, the majority of these polymers consisted of 
high molecular weight linear aliphatic (co)polyester. These materials often possess 
mechanical properties best suited for hard tissue engineering because of their relatively 
higher glass transition temperature and high modulus.
6-10 For engineering of soft tissues, 
elastic scaffolds are desirable since they are amenable to mechanical conditioning 
regimens that might be desirable during tissue development.
11 For example, the elastic 
moduli are ranging from approximately 400 MPa for poly(ε-caprolacton) to 3000 to 3500 
MPa for poly(glycolide) and poly(lactide),  while soft tissue, such as myocardium, have 
elastic moduli below 1 MPa.12-14 
Polyurethane elastomers have been used as biomaterials for several decades in the 
fabrication of medical implants such as cardiac pace makers and vascular grafts because 
of their unique physical properties and relatively good biocompatibility as well as their 
biodegradability.
15,16 In order to achieve good mechanical properties, the molar weight of 
linear polyurethanes has to be relatively high, to have a sufficient quantity of a crystalline 77 
 
hard phase to display an appropriate physical crosslinking. However, crystalline residues 
that stay behind after degradation caused inflammatory reactions in vivo.
17,18  
It has been reported that polyurethanes, based on lysine diisocyanate, degrade by 
hydrolysis of urethane linkages yielding lysine,
19,20 while others have reported that 
urethane and urea linkages are enzymatically degraded.
21,22 Hence, polyurethanes and 
polyurea based on lysine are apparently (bio) degradable, and are therefore suitable for 
temporarily scaffolds. 
As described in Chapter 3, transparent non-crystalline linear polyurethanes were 
successfully synthesized from our homemade caprolactam blocked lysine diisocyanate 
methyl ester and PCL530. Interestingly, it was noticed that poly(ether-urethane) formed 
already networks at 125
oC (without catalysts), which is the minimum temperature at 
which deblocking of caprolactam blocked isocyanate groups starts. In contrast, 
poly(ester-urethane) needed at least a temperature of 200
 oC to form crosslinked materials, 
which may result in  side reactions, such as transesterifications.  However, we have 
showed earlier (chapter 2) that the methyl ester group of caprolactam blocked lysine 
diisocyanates reacted with 1-octanol at 125
oC in the presence of a tin catalyst. This 
offered the possibility to synthesize also poly(ester-urethane) networks at lower 
temperature.   
In this chapter, the synthesis is reported of non-crystalline polyurethane networks that 
were obtained from caprolactam blocked lysine diisocyanate methyl ester (prepared 
according to the method as described in Chapter 2) and polycaprolactone or 
poly(ethylene glycol) diols. The synthesis, characterizations and properties of the PUs are 
described in detail.  
 
4.2. Materials and Methods  
 
4.2.1. Materials 
 
CBC (carbonyl biscaprolactam)  was kindly obtained from DSM Innovation Center, 
ALLINCO®, (> 99 % pure according to HPLC) and used without purification. 78 
 
  L-Lysine monohydrochloride, thionylchloride, calciumchloride dihydrate, anhydrous 
magnesium sulfate, tin(II)2-ethylhexanoate, poly(ethyleneglycol)600 (PEG600), 
poly(ethyleneglycol)1000 (PEG1000), and poly(ε-caprolacton)530  (PCL530) were 
purchased from Sigma-Aldrich.  
Poly (ε-caprolacton) 1250 (PCL1250) was purchased from Polysciences Inc.  
Ethyl acetate and propylene glycol, were purchased from Acros Organics.  
Methanol, acetone, chloroform, triethylamine (TEA), n-hexane, hydrochloric acid fuming  
37% and tetrahydrofuran (THF) were purchased from Lab-Scan Analytical Science.  
Phosphate buffered saline (PBS, pH=7.4) was obtained from Apotheek (Pharmacy) 
UMCG (University Medical Center of Groningen, the Netherlands). All purchased 
compounds were used as obtained. 
Caprolactam blocked lysine diisocyanate methyl ester (BLDI-OMe) was synthesized 
according to the method which have been described in chapter 2.  
 
4.2.2 Synthesis of polymer networks 
 
Polyurethane networks were prepared by using a single-stage process.  A mixture of 
appropriate amounts of BLDI-OMe and a polydiol (in a molar ratio of 1:1.1) were heated 
at 100
oC to reduce the viscosity. Only when PCL was used as polydiol 2.5wt% of 
tin(II)2-ethylhexanoate was added as a catalyst. The mixture was subsequently poured 
into a preheated open mold (Figure 1) and cured for 48 hours at 160
oC under vacuum. 
The size of the strip shaped PU networks was 40x3.0x0.8mm 
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Figure 4.1. The teflon mold for preparing polyurethane networks. The dimension of the 
strip space of mold was 40x3.0x0.8mm. 
 
4.2.3 Characterizations of polymer networks  
 
Differential Scanning Calorimetry (DSC) measurements were performed on a Perkin 
Elmer DSC 7 instrument. About 10 mg of the samples were heated from -80 
oC to +90
oC 
with a rate of 10
oC/min.  
ATR-FTIR measurements were performed on a broker IFS88 spectrometer equipped with 
a Golden Gate (Graseby specac) single reflection ATR accessory. Spectra resolution was 
4 cm
-1 and 32 scans were taken per spectrum. 
Gel contents (in wt%) were determined by extraction of the networks with chloroform. 
The extracted networks were first carefully air-dried and then dried in vacuum at 40 
oC 
until a constant weight was reached. The gel content (%) was defined as: [Wd/Wo]*100%, 
where Wd represents the weight of the sample after drying and Wo represents the weight 
before immersing in chloroform.  
Swelling measurements were carried out on non-extracted polymer networks in 
chloroform at room temperature. After immersing the films for 24h in chloroform they 
were dried with a tissue and weighted immediately. The degree of swelling was 80 
 
calculated from the weight increase after swelling using the following equation: the 
degree of swelling (%) = [(Ws−Wo) /Wo]*100%, where Ws represents the weight of the 
sample swollen in chloroform and Wo  represents the weight before immersing in 
chloroform. 
The equilibrium water uptake of non-extracted thin film was determined after 
conditioning at 37
oC in distilled water for three days.
23 Water uptake was defined as the 
mass increase of the thin film: water uptake (wt %) = [(Ww−Wo)/Wo]*100%, where Ww 
represents the weight of the wet sample after immersing and Wo represents the weight 
before immersing in water. 
The contact angle measurements were carried out at room temperature by using a custom 
built microscope-goniometer system. A 1.00 μL drop of the deionized water was placed 
on a prepared PU network film using a Hamilton micro-syringe and the contact angle was 
measured after 60 s. The measurements involve the fitting of a drop picture with home-
built software. Four measurements were carried out in different regions on the surface. 
Mechanical properties were determined at room temperature using an Intron (5565) 
tensile tester equipped with a 100N load-cell at a cross-head speed of 10 mm/min. 
Specimens (40x3.0x0.8mm) were prepared in the open mold (Figure 1).  
In vitro degradations were performed in phosphate buffered saline (PBS, pH=7.4). Non-
extracted, strip like specimens (10x3.0x0.8mm, cut from origin samples) (n=3/time point) 
were placed in vials containing 20 mL of PBS at 37
oC in the dark oven. PBS was 
changed after each analysis point. At predetermined times, the mass was determined after 
drying the specimens to constant weight in vacuum at 40
oC. The weight loss was defined 
as follows: weight loss (%) = [(Wo−Wt)/Wo]*100%, where Wo represents the weight of the 
dry sample before degradation and Wt represents the weight of the dry sample after 
degradation at various time intervals.  
 
4.3. Results and discussion  
 
4.3.1. Synthesis 
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One of the most widely used techniques to obtain polyurethanes is accomplished in a 
very efficient and fast way by mixing, in a one-step procedure, polyols, isocyanates and 
chain extenders .
23  
The polyurethane networks described in this chapter were prepared from the novel 
caprolactam blocked lysine diisocyanate methyl ester (BLDI-OMe, synthesized as 
described in chapter 2) and various polyols, by using a one-step processing technology. 
As the aim of this project was to make amorphous PUs, low molecular polydiols, such as 
PEG600, PEG1000, PCL530 and PCL1250, were used as soft segments to suppress 
crystallization. As described earlier (chapter 3), it was not necessary to use catalysts for 
synthesis of poly(ether-urethane) networks, but it was indispensable for poly(ester-
urethane). Commonly used catalysts, such as amines or organometallic compounds, may 
be toxic. Among them, tin(II)2-ethylhexanoate (commonly referred as stannous octoate) 
is a good choice, as this catalyst is accepted by the Food and Drug Administration (FDA) 
in coatings  in food contact applications .
24  
By varying the molar ratio of raw materials, the reaction temperatures and the 
polymerization times, PUs with different properties can be obtained, depending on the 
intended applications. In this study, the molar ratio between polydiols and BLDI-OMe 
was fixed to 1.1:1. 2.5wt% tin(II)2-ethylhexanoate used when PCL was the polyol of 
choice. The reactants were stirred at 100
oC for 5min to form a homogenous mixture and 
were then cured in a mold for 48 hours at 160
oC under vacuum. Under the applied 
conditions, the blocked diisocyanate as well as the methyl ester group of BLDI-OMe 
were able to react with hydroxyl groups, forming PU networks. The liberated 
caprolactam and methanol evaporated during the curing process, due to the high 
temperature and vacuum condition.  
The linear polyurethanes, based on BLDI-OMe and short soft segments polydiols, were 
sticky at room temperature and were free flowing viscous liquids when heated. In 
contrast, the crosslinked polyurethanes were not sticky at all and could not flow any more, 
even not at 220
oC. The PU network films, based on PEG600 as well as on PCL530, were 
flexible and totally transparent solids, which indicated that no crystalline phases were 
formed. The films based on the higher molecular polydiols, PEG1000 and PCL1250, 82 
 
appear to be stiff and had a white appearance, which indicated that crystalline phases 
were formed.  
 
4.3.2. DSC measurements 
 
The absence of crystallinity was supported by DSC measurement. For that, the samples 
were heated from -80
oC to +90
oC, at heating rate of 10
oC/min. Figure 4.2 shows the 
second heating thermogram of various polyurethanes. The thermal transitions are listed in 
Table 4.1. For PU-PEG600 and PU-PCL530 networks, there was no sign of 
crystallization (no Tm) visible, but they were clearly visible in PU-PEG1000 and PU-
PCL1250 samples. Obviously, longer soft segments allowed polymer chains to align, 
resulting in crystalline phases in these samples. The crystallinity of PU-PCL1250 was 
more pronounced than of PU-PEG1000. As the aim of this study was to prepare 
amorphous polyurethanes, we focused on non-crystalline PU-PEG600 and PU-PCL530 
networks for further investigations. 
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Figure 4.2 DSC thermograms (10
oC/min) of PU networks:(a) PU-PEG600, (b) PU-
PCL530, (c) PU-PEG1000, (d) PU-PCL1250 83 
 
 
Table 4.1 Glass transition temperature (Tg) and melting temperatures (Tm) of PU 
networks  
Samples Tg  (
oC) Tm  (
oC) 
PU-PEG600 -40.5  none 
PU-PEG1000 -48.5  21.1 
PU-PCL530 -30.7  none 
PU-PCL1250 -53.8  28.4 
 
 
4.3.3. ATR-FTIR analysis 
 
The PU-PEG600 and PU-PCL530 networks were further investigated by the ATR-FTIR 
analysis (Figure 4.3). The peaks ranging from 3200 cm
-1 to 3450 cm
-1 and from 2814 cm
-
1 to 3000 cm
-1 were related to the N-H stretching vibrations and C-H (CH, CH2 and CH3) 
stretching vibration respectively. In PU-PCL530 spectrum, the band at 1710 cm
-1 was due 
to the urethane and the ester carbonyl (from PCL530 and methyl ester of BLDI-OMe) 
stretching vibration. Consequently, the absorption intensity of that peak of the PU-
PCL530 network was bigger than that of PU-PEG600 network.  The strong peak at 1100 
cm
-1 of PU-PEG600
  was attributed to the C-O-C stretching from polyether PEG600 
segment.    84 
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Figure 4.3 FTIR spectra of PU-PCL530 and PU-PEG600 networks 
 
4.3.4. Swelling tests 
 
Next, the PU networks were characterized by performing swelling tests using chloroform 
as swelling medium. Water uptake and water contact angles were also measured to 
determine the polyurethane bulk and surface polarity. The gel contents, degrees of 
swelling, water uptake and water contact angle of the networks are summarized in Table 
4.2.  
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Table 4.2 The swelling, water uptake and contact angles of PU-PEG600 and PU-PCL530 
networks 
Samples Degree  of 
swelling in 
chloroform (%) 
 
Gel content  
in chloroform 
(%) 
Water uptake 
(%) 
Water contact 
angle (
o) 
PU-PEG600 730  94.9  189  68.5±  3 
 PU-PCL530  1100  85.7  102  88.5± 3 
 
In contrast to the linear polymers, all the crosslinked samples did not dissolve in 
chloroform,, but swelling occurred. The weight increase in chloroform was seven fold 
and eleven fold for PU-PEG600 and PU-PCL530 networks, respectively.  The polymer 
with the highest gel content (94.9) had the lowest chloroform swelling degree. However, 
we cannot conclude here that there is relation between the lower gel content and the 
amount absorbed chloroform, because the difference in polarity of the polyester and 
polyether diols is much more important. Water uptake was measured to determine 
hydrophilicity of the polymer networks. It was expected that this would have a substantial 
impact on hydrolytic degradation rate. The PU-PEG600 network can absorb more water 
(89wt%) than PU-PCL530 networks (2wt%), because of the hydrophilic nature of 
PEG600.  
The water contact angle is a measure for the surface polarity. The PU-PEG600 network 
(68.5
o) was, as expected, more hydrophilic than PU-PCL530 (88.5
o).  
 
4.3.5. Mechanical properties 
 
The mechanical properties of polyurethane networks are shown in Figure 4.4 and in 
Table 4.3. The properties showed a rubber-like behavior. The lack of yield points in the 
whole stress-strain curves of PU-PEG600 and PU-PCL530 demonstrated that the 
amorphous character retained even under stress, (Figure 4.4). No signs of strain-
hardening were observed. As shown in Table 4.3, the rubber like behavior of PU-PEG600 
and PU-PCL530 was also apparent from the elastic modulus, elongation at break and 86 
 
stress at break, which were 1.64MPa and 0.65MPa, 101% and 164%, 0.88MPa and 
0.57MPa, respectively.  In this case, the PU-PEG600 had higher modulus and stress at 
break but lower elasticity than PU-PCL530. By varying the synthesis parameters, it is 
possible to obtain different mechanical properties, which can be utilized to fulfill the 
requirements of numerous biomedical applications. The PU-PEG600 and PU-PCL530 
networks in this study were designed to be in the range of scaffolds for soft tissue.
12-14  
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Figure 4.4 Stress and strain curves of PU-PEG600 and PU-PCL530 networks 
 
Table 4.3 Mechanical properties of PU-PEG600 and PU-PCL530 networks 
Samples Modulus  (MPa)  Elongation   
at break (%) 
Stress at break 
(MPa) 
PU-PEG600 1.64±0.2  101±10  0.88±0.04 
 PU-PCL530  0.65±0.1  164±15  0.57±0.04 
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4.3.6. Hydrolytic degradation 
 
The in vitro degradation experiments of the polyurethane networks were carried out by 
immersing samples in PBS (pH 7.4) at 37
oC, while following the weight losses in time. 
The results are plotted in Figure 4.5. Please note the difference is scale of the Y-axis of 
both compounds. The PU-PCL530 network showed a very low mass loss, of about 3.5% 
after 110 days. However, this is probably due to extractables, and not to hydrolysis. This 
might explain why the weight loss leveled off after the first few days. A slow degradation 
was expected from PCL-based polyurethanes, which are commonly used in long lasting 
biomedical applications.
25,26 It is generally believed that in vitro and in vivo degradation 
of polyester urethanes proceeds via autocatalytic hydrolytic chain scission of the ester 
bond of the polyester soft segment.
27 
 In contrast, the PU-PEG600 network exhibited 
progressive mass loss over 35 days ranging finally up to 100%. The higher hydrophilicity 
of the PU-PEG networks (corresponding to water uptake results) resulted in much faster 
degradation rate.
28,29 The PU-PEG600 network could be used as short term materials. 
Depending on the applications, the polyester and polyether diols co-polyurethanes could 
be prepared to form soft segments with intermediate degradation times.  
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(a)                                                                  (b) 
Figure 4.5 In vitro degradation (PBS, pH 7.4, 37
oC) of polyurethane networks: (a) PU-
PEG600, (b) PU-PCL530.  
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4.4. Conclusion 
 
The polyurethane networks were successfully synthesized based on polydiols and our 
homemade caprolactam blocked lysine diisocyanate methyl ester (BLDI-OMe) by using a 
one-step processing technology. PEG600, PEG1000, PCL530 and PCL1250 were used as 
polydiols to study the synthesis of non-crystalline PU networks. Only the PU network 
films based on PEG600 and PCL530 gave non-crystalline materials, as evidenced by 
their transparency, by DSC measurement and by the lack of yield points in stress-strain 
curves. These networks swelled, but did not dissolve in chloroform, demonstrating the 
crosslinked structure. In the mechanical tests, both networks showed rubber-like behavior.  
The PU-PEG600 network was more hydrophilic than PU-PCL530 network, and could, as 
a consequence, absorb more water. In in vitro degradation tests, the PU-PEG600 network 
degraded much fast than the PU-PCL530 networks. PU-PEG600 needed only 35 days to 
degrade 100%, while the PU-PCL530 network lost about 3.5% of weight (extractables) in 
the same period. The PU-PEG600 and PU-PCL530 networks in this study are potentially 
suited for scaffolds for soft tissue.  89 
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Chapter 5 
 
Polyurethanes provided with pendant covalently grafted GRGDG 
peptide moieties 
 
 
 
 
Abstract  
 
Poly(ester-urethanes), comprising pendant activated N-hydroxysuccinimide (NHS) esters, 
were prepared from the NHS-activated ester of caprolactam blocked lysine diisocyanate 
and polycaprolactone. The NHS-activated ester offered an enabled technology to prepare 
bio-active polyurethanes. First, hexyl amine was used, as model compound, to substitute 
the NHS-group, demonstrating the ability of the concept. Along the same line, an amino-
functional, cell-adhesion promoting peptide, GRGDG, was coupled onto polyurethane 
backbones. NMR, IR and elemental analysis proved the successful tethering of both, 
hexyl amine and the GRGDG peptide, on the polyurethane backbone. XPS and water 
contact angle measurement of spin-coated polyurethanes on glass slides confirmed the 
presence of the grafted peptides, showing a strong change of the surface property of 
polymer. The water contact angle went down from about 85
o to 20
o, demonstrating the 
highly hydrophilic character due to the GRGDG moiety. In vitro cell adhesion 
experiments with human dermal fibroblast (HDF) cells showed that, with and without the 
presence of serum in culture medium, the GRGDG-grafted polyurethanes impressively 
enhanced cell attachment compared with the starting polyurethanes. In serum-free 
circumstance, the GRGDG-grafted polyurethane showed even a better cell survival and 
spreading than on tissue culture polystyrene (TCPS). 
                                             .                          92 
 
5.1. Introduction 
 
For decades a large number of synthetic polymeric materials with a variety of properties 
are available for biomedical applications,
1 like in prostheses, implants and tissue 
engineering matrices. Most of the materials have sufficient mechanical properties, as well 
as desired stability towards degradation or display a controlled degradation behavior.
1 
They are biocompatible and produce during degradation only non-toxic substances. An 
important problem still is the inadequate interaction between the polymers and human 
cells, leading in vivo to foreign body reactions, such as inflammation, aseptic loosening, 
local tissue waste, and implant encapsulation as well as thrombosis and embolization.
2 
Approaches to improve biomaterials include reduction of unspecific protein adsorption, 
known as non-fouling properties, enhancement of specific protein adsorption and 
material modification by immobilization of cell recognition motives to obtain controlled 
interaction between cells and synthetic substrates. 
3-12 
Since RGD peptides (R: arginine; G: glycine; D: aspartic acid) have been found to 
promote cell adhesion in 1984 (Cell attachment activity of fibronectin can be duplicated 
by small synthetic fragments of the molecule, Nature 309 (1984) 30), numerous materials 
have been RGD-functionalized in academic studies for medical applications. The RGD 
sequence is also proved by far to be the most effective and most often employed peptide 
sequence for stimulated cell adhesion on synthetic surfaces. The RGD tripeptide 
sequence has been found in vitronectin, fibronectin, von Willebrand factor, fibrinogen, 
and collagens. This tripeptide has been shown to play a crucial role in mediating cell 
attachment and subsequent spreading.
13,14 When immobilized onto a surface, RGD-
containing synthetic peptides promote cell attachment in a manner similar to that of 
fibronectin, whereas in solution the same peptides inhibit the attachment of cells to 
surfaces coated with fibronectin or with the peptides,
13 due to the blocking of the 
integrins. It has been shown that some cell receptors (i.e., integrins) bind to the RGD 
sequence of a single protein only, whereas other receptors recognize RGD sequences in 
various proteins.
15  
The process of integrin mediated cell adhesion comprises a cascade of four different 
partly overlapping events
5: cell attachment, cell spreading, organization of actin 93 
 
cytoskeleton, and formation of focal adhesions. Firstly, in the initial attachment step the 
cell contacts the surface and some ligand binding occurs that allows the cell to withstand 
gentle shear forces. Secondly, the cell body begins to flatten and its plasma membrane 
spreads over the substratum. Thirdly, this leads to actin organization into microfilament 
bundles, referred to as stress fibers. In the fourth step the formation of focal adhesions 
occurs, which link the ECM (extracellular matrix) to molecules of the actin cytoskeleton. 
Progress in understanding the interactions of RGD-containing peptides and cell receptors 
has stimulated a great deal of interest in the development of novel biomaterials that may 
improve long-term cell attachment and growth. Synthetic RGD-containing peptides 
immobilized on poly(tetrafluoroethylene), poly(ethy1eneterephthalate),
16,17 poly(viny1 
alcohol),
18 polyacrylamide,
19 and poly(carbonate urethane)
20 surfaces have been shown to 
support cell attachment and spreading.  
Polyurethanes (PUs) are widely used as cardiovascular biomaterials due to their good 
blood compatibility,
21-23 biodegradability and mechanical properties. However, cellular 
adhesion on PU materials is relatively poor. Various methods have been developed to 
promote the cell adhesion property. These include bulk modification of the chemical 
structure of PU,
24,25  surface modification such as ion beam irradiation
26  or plasma 
treatment
27, and coating with or grafting of adhesive proteins
28-30.  
Previously, we successfully synthesized poly(ester-urethanes) (linear and networks) 
starting from our homemade caprolactam blocked lysine diisocyanate methyl ester 
(BLDI-OMe) and polycaprolacton530 (chapter 3 and 4). To utilize the methylester side 
group of BLDI-OMe, for the incorporation of RGD groups, the methylester had to be 
hydrolyzed.  However, hydrolyzing the methylester without affecting the ester linkages 
of the polyester diols in the polymer backbone is impossible. For this, we took the 
advantage of the stability of blocked diisocyanate (BLDI-OMe). As we showed earlier 
(chapter 2), the methylester could be hydrolyzed under well-defined conditions without 
affecting the blocked isocyanate group.  
Here we studied if the pendant acid group, that offered the possibility to make activated 
esters (chapter 2), could be used as a possible route to introduce RGD-peptide side-
groups. If successful, the next challenge would be to demonstrate that these immobilized 94 
 
peptides preserved their ability to improve the cell adhesion property of our 
polyurethanes.  
 
5.2. Materials and Methods  
 
5.2.1. Materials 
 
CBC (carbonyl biscaprolactam)  was kindly obtained from DSM Innovation Center, 
ALLINCO®, (> 99 % pure according to HPLC) and used without purification. 
 L-Lysine monohydrochloride, thionylchloride, calcium chloride dihydrate, hexyl amine, 
dibutyltin dilaurate (DBTDL, 95 %), 1-octanol, anhydrous magnesium sulfate, 
dicyclohexyl-carbodiimide (DCC), N-hydroxysuccinimide (NHS), α-naphthol, urea, 
poly(ε-caprolacton)530 (PCL530), chloroform-d (CDCl3-D, 99.8 atom % D) and 
dimethyl sulfoxide-d6 (DMSO-d6, 99.5 atom % D) were purchased from Sigma-Aldrich.  
Ethyl acetate, potassium hydroxide and anhydrous N,N-dimethylformamide (DMF), were 
purchased from Acros Organics.  
Methanol, acetone, ethanol, chloroform, triethylamine (TEA), n-hexane, hydrochloric 
acid fuming 37%, tetrahydrofuran (THF), dichloromethane (DCM), were purchased from 
Lab-Scan Analytical Science. 
Phosphate buffered saline (PBS, pH=7.4) was obtained from Apotheek UMCG 
(University Medical Center of Groningen, the Netherlands). All compounds and solvents 
were used as obtained, unless stated otherwise. 
GRGDG was kindly obtained from by Dr. D. Löwik from the Radboud University of 
Nijmegen (the Netherlands). 
Caprolactam blocked lysine diisocyanate methyl ester (BLDI-OMe) and  BLDI-NHS 
were synthesized according to the methods as described previously (chapter 2).  
The linear PCL530 based polyurethanes were synthesized according to the method as 
described in chapter 3.  
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5.2.2. Analysis  
 
Column chromatography was performed on silica gel (Silica-P flash silica gel from 
Silicycle, size 40-63 μm). TLC was performed on silica gel 60/Kieselguhr F254. 
Components were visualized by UV and staining with a solution of a mixture of KMnO4 
(5g) and K2CO3 (20 g) in H2O (500 mL). 
Size exclusion chromatography (SEC) measurements were performed in 
dimethylformamide (DMF) with 0.01M LiBr on a Viscotek GPC max equipped with 
model 302 TDA detectors, using 2 columns (Pl-gel 5µ 30 cm mixed-C from Polymer 
Laboratories). The data analysis was done using conventional calibration with 
polystyrene standards accompanied by in-house software. 
1H-NMR was recorded on a Varian AMX400 using CDCl3 or DMSO-d6 as solvent.  
Element analysis (EA) was performed on a HEKAtech Gmbh Euro-EA CHNanalyzer.  
ATR-FTIR was done using a Broker IFS88 spectrometer equipped with a Golden Gate 
(Graseby specac) single reflection ATR accessory. Spectra resolution was 4 cm
-1 and 32 
scans were taken per spectrum. 
Sakakgushi assay
20 was used for the detection of arginine in the samples. 0.5 mL of α-
naphthol (0.01wt% in 95wt% ethanol +5wt% urea) and three pellets of NaOH were added 
to a glass tube containing approximately 5 mg of sample. After 5 min, 0.5 mL bromine 
solution (2wt% in 100 ml of 8wt% NaOH) was added to the tube. An orange-red solution 
appears in the tube as an indication of the presence of arginine. 
Differential Scanning Calorimetry (DSC) measurements were performed on a Perkin 
Elmer DSC 7 instrument. The samples, with masses varying between 7-10 mg, were 
heated from -60 
oC to +90 
oC with a rate of 10 
oC / min.  
 
Surface property 
 
Surface property characterization was performed on polymer-coated glass slides (1x1cm
2) 
and silica wafers (1x1cm
2). The glass slides and silica wafers were cleaned with chromic 
acid, washed with deionized water and dried. Subsequently, a 5% (w/v) polymer solution 96 
 
in DMF was spin-coated (2,000rpm) on the substrates. The polymer-coated samples were 
dried under vacuum for 24h at 40
oC before characterization    
The water contact angle measurements were carried out at room temperature by using a 
custom built microscope-goniometer system. A 1.00 μL drop of the deionized water was 
placed on a prepared polymer-coated glass slide using a Hamilton micro-syringe and the 
contact angle was measured after 30s. The measurements involve fitting of a droplet 
picture with home-built software. Three measurements were carried out in different 
regions on the surface. 
The XPS (X-ray photoelectron spectroscopy) measurements were performed with a 
monochromatic small-spot X-ray Photoelectron Spectrometer System (Thermo Scientific 
K-Alpha) with an Al Kα monochromator X-ray Source (1486.6eV).  The base pressure in 
the spectrometer during the measurement was 10
-8 mbar.  
 
Cell adhesion 
 
Human dermal fibroblast cells (HDF; Sciencell, USA) were generously provided by Dr. 
Marco C. Harmsen (University Medical Center of Groningen, the Netherlands). Cells 
were harvested for the experiments by incubating them in accutase (enzyme cell 
detachment medium) for 3 min at 37°C. Half number of the cells was collected by 
centrifugation and re-suspended in EMEM (Eagle’s minimum essential medium), 
additional with L-glutamine (2mM), sodium pyruvate (1mM)) and 10wt% bovine fetal 
calf serum (FCS). The other cells were re-suspended in same medium without FCS. 
Polymer-coated glass slides were placed in 24-well tissue culture plates (Corning) and 
sterilized for 15 min under ultraviolet light. Next, 1x10
5cells/mL were seeded on each 
polymer substrate and allowed to attach for a desired time. The wells were subsequently 
rinsed with PBS to remove non-adherent cells, and the adherent cells were fixed with a 
solution of 2wt% paraformaldehyde for 10min. Cells were stained with 0.5wt% DAPI 
(4',6-diamidino-2-phenylindole) in PBS for 1h. The cell number was determined by 
fluorescence microscopy utilizing a Leica DC 300F microscopy (Wetzlar, Germany). 
Adherent cells were counted in twelve or thirteen randomly chosen areas in the central 97 
 
and peripheral regions of each polymer substrate. The morphology of attached cells was 
examined using microscope with bright field mode.  
 
5.2.3. Synthesis of N-hydroxysuccinimide functional polyurethanes (PU-NHS)  
 
A 100 mL glass flask was fitted with a nitrogen inlet and an outlet to a vacuum pump. 
After the flask was three times evacuated and refilled with nitrogen, to remove all oxygen, 
dry N-hydroxysuccinimide activated ester of caprolactam blocked lysine diisocyanate 
(BLDI-NHS) was added in a molar ratio of 1.025 with respect to PCL530. BLDI-NHS 
was synthesized according to the method as described previously (chapter 2). The 
mixture was subsequently heated up to 130, 135, 140 and 145
oC, respectively, while 
stirring under vacuum for 12 hours, and taking meanwhile samples.   
 
5.2.4. Modification of PU-NHS with hexyl amine  
 
PU-NHS was dissolved in 100 mL methylene chloride. A threefold excess of hexyl amine 
was added. The reaction mixture was stirred at room temperature overnight. After 
removal of precipitated NHS-amine salt by filtration, the solution was washed with a 
5wt% NaHCO3 aqueous solution and with brine (saturated NaCl aqueous solution). The 
resultant solution was dried over anhydrous MgSO4.  After removal of MgSO4  by 
filtration the polymer solutions were poured into diethyl ether. The precipitate was 
separated by centrifugation and after the supernatant was removed the polymers were 
dried in the vacuum oven in 50 
oC for 48 h.  
 
5.2.5. Modification of PU-NHS with GRGDG  
 
The GRGDR peptide and triethylamine (TEA) were added to a solution of PU-NHS 
(10% w/v) in DMF. The coupling reaction was performed at 50
oC under dry nitrogen 
during 48 hours. The peptide and TEA was added in a slight excess with respect to 
stoichiometric amounts of NHS groups of the polymer. After removal of precipitated 
NHS-amine salt by filtration, the peptide grafted polymer (PU-GRGDG) was precipitated 98 
 
in deionized water. The polymer was collected by centrifugation and, after the 
supernatant was removed by decantation. The polymer was subsequently dissolved in 
DMF and further purified by pouring this solution into diethyl ether. The product was 
separated by centrifugation and after the supernatant was removed the polymers were 
dried in the vacuum oven in 50
oC for 48 h.  
   
5.3. Results and discussion  
 
5.3.1. Synthesis of PU-NHS, PU-HA and PU-GRGDG 
 
Poly(ester-urethanes) are the workhorses of biomedical polyurethanes. They offer 
excellent mechanical properties and a can be tuned to give controlled hydrolytic 
degradation rates. As described in Chapter 3, linear poly(ester-urethanes) were 
successfully synthesized by our homemade caprolactam blocked lysine diisocyanate 
methyl ester (BLDI-OMe) and polycaprolactone 530. When no catalyst was used the 
pendant ester group of BLDI-OMe remained during the polymerization totally unaffected, 
which offered a very important tool for modification of polymers. However, to enable 
derivatization reactions, hydrolysis of the pendant ester group had to be done without 
cleaving the ester linkages of the polyester diols in the polyurethane backbone, which is 
difficult, maybe even impossible. 
A successful methodology to hydrolyze the ester group of the caprolactam blocked lysine 
diisocyanate methyl ester was found, without destroying the blocked isocyanate function, 
which enabled the preparation of functionalized caprolactam blocked lysine diisocyanate. 
The esterification of the acid group with N-hydroxysuccinimide (NHS), yielding BLDI-
NHS activated ester (chapter 2), offered a possible route to decorate poly(ester urethanes) 
with various functional groups. This could be done either in the monomer, before the 
polycondensation, or afterwards in the polymers, after the polycondensation. In the latter 
case the NHS activated ester had to survive the polymerization conditions. This was 
investigated first, as it would offer a convenient route to prepare functional PUs. The 
synthesis of BLDI-NHS has been reported previously in detail (Chapter 2). PCL530 was 
used here in this chapter as a representative example for polyesters. The reaction scheme 99 
 
is depicted in Scheme 5.1. The polymerization was performed in bulk (Chapter 3) at 
temperature of 125
oC and higher, and during various residence times. The only side 
product would be caprolactam, provided that NHS was not substituted. Caprolactam 
formed during the reaction, evaporated because of the high temperatures and vacuum 
conditions. As a result, a pure polymer could finally be obtained. The polymers dissolved 
well in DMF, proving that no crosslinking had taken place. Although, the NHS-ester is 
much more reactive than the methyl ester, it still survived the polymerization conditions, 
at least to a substantial extent. Since the polymers dissolved well in DMF the SEC 
analyses were therefore performed in the same solvent. Table 5.1 gives the molecular 
weights of PU-NHS based on BLDI-NHS and PCL530, which were obtained by varying 
the polymerization temperature and time. 
 
 
 
Scheme 5.1 Synthesis of PU-NHS from blocked lysine diisocyanate (BLDI-NHS) and 
poly(ε-caprolacton) (PCL), polymerized without catalyst. 
 
From Table 5.1 it can be seen that the PDIs of polymers with number average molecular 
weights up till about 8,000 Da were still quite narrow. This indicated that branching, i.e. 
reactions of PCL with the activated ester, did not take place or only in a very limited 
extent. It demonstrated that the NHS-activated ester survived the applied polymerization 
conditions. However, after a heating time of 12 hours the NHS group participated in the 
reaction. The blocked isocyanate groups were apparently more reactive than the NHS-
ester. When the concentration of the blocked isocyanates group decreased during the 100 
 
polymerization the NHS-ester became involved, resulting finally in a crosslinked 
polymer network. Since we were aiming for amorphous polyurethane networks, this 
crosslink reaction offered an important tool for preparing polyurethane networks.  
 
Table 5.1 Molecular weights of PU-NHS, based on BLDI-NHS and PCL530, at various 
polycondesation temperatures and times  
T(
oC) Time(h)  Mn (Da)  Mw (Da)  PDI 
130 
4 4,850 7,650  1.57 
8 8,230  43,130  5.24 
12 Crosslinked 
135 
4 6,370  14,780  2.32 
8 12,000  323,480  26.94 
12 Crosslinked 
140 
4 6,920 7,340  1.49 
8 9,180  49,480  5.34 
12 Crosslinked 
145 4  8,780  21,070  2.40 
 
The polymer obtained from the bulk polymerization of BLDI-NHS and PCL530 at 145
 oC 
for 4 hours (with a Mn of 8,780 and a DPI 2.40) was chosen to be characterized in more 
detail and was used for further modifications. The structure was confirmed by 
1H-NMR 
spectroscopy, as depicted in Figure 5.1. It is important to stress that the signals of the 
NHS-group still were present (2.8 ppm; Chapter 2, Figure 2.6), confirming that the 
activated ester remained unaffected. Activated NHS ester groups can in principle react 
with all kind of nucleophiles, which would be useful to attach for instance the N-terminus 
of peptides or proteins, forming a stable covalent amide bond. As described in Chapter 2, 
in a model reaction the substitution of the NHS-group by particularly amines (hexyl 
amine) was successfully performed with the monomer.  
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Figure 5.1 
1H-NMR spectrum (CDCl3) of the product obtained from the bulk 
polymerization of BLDI-NHS and PCL530 at 145
 oC for 4 hours with a Mn of 8,780 Da 
and a DPI of 2.40. 
 
First the substitution of the NHS group of the pedant ester in the polymers by hexylamine, 
as a model compound, was studied to examine the possibility for introducing other 
functionalities. As our aim was to promote cell adhesion, the next step was to introduce a 
GRGDG peptide.    
 
5.3.2. Modification of PU-NHS with hexyl amine and GRGDR  
 
The polymer modification reaction is depicted in scheme 5.2. To prevent hydrolysis of 
NHS by traces of water anhydrous methylene chloride and DMF were used as solvent.
31 
Hexylamine was indeed able to substitute the NHS group, thereby being coupled onto the 
polyurethane backbone, forming PU-HA, while a precipitate of NHS-amine salt was 
formed at same time. The reaction was performed at room temperature and monitored by 
5 
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1H-NMR via the disappearance of NHS signal and appearance of CH3 of hexylamine 
signals at 2.8 and 0.8 ppm respectively (Figure 5.2). The reaction was complete after 
about 24 h. This indicates that the NHS groups of PU-NHS were able to be substituted by 
amino groups at room temperature, without affecting the ester bonds in the polymer 
backbone. This demonstrated a remarkable difference in sensitivity of the NHS-ester 
bond for amines and hydroxyl groups. While the hydroxyl groups of PCL hardly reacted 
with the NHS-ester at 145 
oC, the amino group of hexyl amine reacted even at room 
temperature. These mild conditions were very important to prevent chain scission of the 
polyester backbone by amines. 
Although the amino groups of GRGDG were less nucleophile that the primary amine of 
hexyl amine, we found that the substitution reaction proceeded as well. The reaction was 
performed at 50
oC in anhydrous DMF because of limited solvability of the peptide in 
DMF at room temperature. The GRGDG peptide substituted the NHS groups, while 
being coupled onto the polyurethane backbone forming PU-GRGDG and a precipitate of 
NHS-amine (TEA) salt at same time. The reaction was monitored by 
1H-NMR via the 
disappearance of NHS signal at 2.8 ppm.  
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Scheme 5.2 Synthesis of PU-HA and PU-GRGDG from PU-NHS 
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Figure 5.2 
1H-NMR spectrum (CDCl3) of PU-NHS, which was obtained from the bulk 
reaction at 145
 oC for 4 hours from BLDI-NHS and PCl530 (Mn = 8,780 and DPI = 2.40) 
and the hexyl amine and GRGDG modified PUs.  
 
The 
1H-NMR spectra indicated that a reaction with GRGDG took place, by the 
disappearance of the NHS moiety. However, the presence of the peptide was less well 
detectable with 
1H-NMR in CDCl3. To gather more evidence, the modified polyurethanes 
were characterized by IR spectroscopy. Figure 5.3(a) shows the FTIR spectra of GRGDG 
and NHS in the region between 1900 and 1450 cm
-1. The spectra of PU-NHS, PU-
GRGDG and PU-HA are depicted in Figure 5.3 (b). Strong absorbance bands were 
observed at 1715 cm
-1 in the amide I (1630-1690 cm
-1) and amide II (1475-1585 cm
-1) 
regions of the GRGDG spectrum. In the NHS spectrum, the absorbance at 1783 cm
-1 and 
1815 cm
-1 were assigned to carbonyl stretching of the N-hydroxysuccinimide (NHS) 
ring,
32 which were totally absent in PU-HA and PU-GRGDG spectra, as shown in Figure 
5.3 (b). For all polymers, the bands at 1695 cm
-1 and 1730 cm
-1 were attributed to the 
urethane carbonyl and ester absorbance
23, respectively. The amide I bands partially 
PU-HA 
PU-NHS 
PU-GRGDG 104 
 
overlapped with the carbonyl stretching (1715 cm
-1) of polyurethanes. The important 
difference in these spectra is the increase of the intensity at approximately 1655 cm
-1 for 
the PU-GRGDG sample. Since the spectrum of GRGDG showed strong bands in the 
same region, the increased intensity in the spectrum of modified polyurethane was 
attributed to the grafted peptide.
18 The differences between the spectra of PU-NHS, PU-
HA and PU-GRGDG indicated that the NHS groups were successfully substituted by 
hexyl amine and GRGDG peptide, but further evidence was desired.  
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Figure 5.3 ATR-FTIR spectra of (a):NHS and GRGDG; (b): PU-NHS, PU-HA and PU-
GRGDG 
 
5.3.2. Sakaguchi assay and Elemental analysis  
 
To support the spectroscopic results, a chemical assay (Sakaguchi assay) and elemental 
analysis were performed. The Sakaguchi assay was used to verify the substitution 
reaction of the NHS group by the GRGDG peptide. In the Sakaguchi assay a solution will 
color orange on adding α-naphthol if arginine comprising peptides are present. Indeed, 
for the PU-GRGDG sample, an orange coloration (i.e. positive response) was observed, 
whereas the PU-NHS and PU-HA samples showed a negative response (Figure 5.4). 
Since arginine was detectable by the Sakaguchi reaction,
33 the results confirmed the 
coupling of peptide to the polyurethane.  105 
 
 
 
 
Figure 5.4 Results of Sakaguchi assay, from left: PU-GRGDG, PU-NHS, PU-HA 
 
The success of the synthesis of the RGD-containing peptide grafted polyurethane was 
further investigated by elemental analysis. Table 5.2 summarizes the theoretical and 
experiment results of the nitrogen elemental analysis for polymers and GRGDG peptide. 
 
Table 5.2 Elemental analysis: especially nitrogen content of PUs and GRGDG 
PU 
N (wt%) 
Calculation value  Experimental value 
PU-NHS 5.28  5.45 
PU-HA 5.35  5.45 
PU-GRGDG 7.32  7.21 
GRGDG 24.34  23.47 
 
When PU-NHS was modified by hexyl amine, there was only a slightly change of 
nitrogen content of the polymer, both in theoretical and experiment results. If every NHS 
group was substituted by GRGDG peptide, the nitrogen content should increase 106 
 
substantially, from 5.28wt% to 7.32wt%, because the high nitrogen content of GRGDG 
peptides (24wt% N). The experimental PU-GRGDG sample contained 7.21% nitrogen 
which was very close to the theoretical value (7.32%). Based on the elemental analysis, it 
was calculated that modified polymer contained approximately 350mg of peptide per 
gram of PU-GRGDG. This quantitative analysis suggests that the substitution of the NHS 
groups on the polyurethane by the GRGDG peptide was nearly 100%.  
 
5.3.3. Glass Transition temperature (Tg) of PU-NHS and modified PUs 
 
Both the starting polymer and modified polymers are transparent sticky wax-like, slightly 
yellow transparent products. This matched with our targets, as we were aiming for low 
molecular, non-crystalline, potentially crosslinkable polymers. PU-GRGDG is a little 
stiffer than the others because of the high amount of hydrogen bonding moieties, 
introduced by the grafted peptide. The fully transparency indicated the absence of 
crystallization. Consequently, it was expected that our PUs would not have detectable 
melting temperatures. To verify this and to measure the glass transition temperatures (Tgs) 
of our PUs, DSC measurements were performed. The samples were heated from -60
oC to 
90
oC at heating rate of 10
oC/min. In the DCS diagram, indeed, no sign of any 
crystallization peak was visible. Table 5.3 gives the glass transition temperatures (Tgs) of 
PU-NHS, PU-HA and PU-GRGDG.  
 
Table 5.3 Glass transition temperature (Tg) of polyurethanes 
PU Tg
oC 
PU-NHS -30.2 
PU-HA -31.3 
PUGRGDG -22.9 
 
All the samples showed the expected low Tg values because of the flexible long alkyl 
aliphatic polyester spacer segment (PCL530). All PUs had same soft segment, having the 
same chain mobility, which resulted in similar Tgs. It is worthy to note that the Tg of PU-107 
 
GRGDG was around 8
oC higher than other samples. It can be attributed to the introdution 
of extra hydrogen bonding moieties by grafted peptide on the polyurethane.   
 
5.3.4. Surface properties (XPS & water contact angle)  
 
To determine contact angles and to analyze the materials by XPS the polymers were 
applied as coatings on glass slides. The polymers were dissolved in DMF (5% w/v), spin 
coated (2,000rpm) on glass substrates and subsequently dried under vacuum for 24h at 
40
oC.  
The water contact angle measurement results are listed in Table 5.4. The glass slide and 
PU-OMe (sample as described in chapter 3) were chosen as the blank for comparison, 
since the NHS group of PU-NHS was suspected to be sensitive for hydrolysis in water.
31 
The glass slide (α = 80
o) and PU-OMe surface (α = 89
o) appeared to be hydrophobic. In 
spite of the presence of the hydrophobic hexyl chain, the water contact angle of PU-HA 
was lower (α = 65
o) than the blank samples. This can be attributed to the high content of 
amides, resulting in hydrogen bonding between polymer and water. Incorporation of the 
peptide onto the polymer backbone strongly decreased the contact angle to below 20
o 
(Figure 5.5), and made the surface highly hydrophilic. This was obviously due to the high 
density of grafted water soluble GRGDG peptide on the surface.
25  This was further 
proved by the XPS measurement.   
 
Table 5.4 Water Contact angles of various PUs 
Sample  Water contact angle(
o) 
Glass slide 
PU-OMe 
79.5 ± 3 
88.5 ± 3 
PU-HA  64.6 ± 3 
PU-GRGDG  17.7 ± 3 
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Figure 5.5 Pictures of a water droplet deposited on the surface of left: PU-HA;  
right: PU-GRGDG 
 
The XPS analysis was used to determine the chemical composition of the surface layer, 
quantified by the N, C and O atomic percentages of PU-NHS and PU-GRGDG. In Figure 
5.6 the XPS spectra of the PU-NHS and PU-GRGDG are shown. From these XPS spectra 
the elemental compositions of the surface layers were calculated. XPS measures about a 
5-10 nm thick top layer of a surface. After modification of the polymer with the GRGDG 
peptide, the nitrogen content increased from 4.94 to 7.34wt%, which is quite similar as 
the bulk elemental analysis results, as shown in Figure 5.6 (a) and (c). It indicated that the 
density of GRGDG peptide on the surface was also around 350mg/g polymer, just the 
same as in the bulk. The C1s peaks (Figure 5.6 (b) and (d)) were composed of the C-C 
component at 284.5eV due to aliphatic hydrocarbons, the C-N component at 285.64eV, 
the C-O component at 286.18eV, the O=C-N component at 286.68eV and O=C-O 
component at 288.6eV from urethane, amide and ester groups respectively.
34 Table 5.5 
summarises the various chemical compositions and the atomic percentages for PU-NHS 
and PU-GRGDG. The peaks for carbon next to nitrogen in the form of C-N and O=C-N 
showed an increase from 12.73% and 3.21% to 14.52% and 5.72% respectively, after 
substitution of the NHS by the peptide.
35 This again strongly confirmed the successful 
attachment of nitrogen-rich peptides moieties to the polymer and it showed that the 
peptides were present on the surface in almost the same density as in the bulk of the 
polymer.  
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Figure 5.6 XPS spectra of (a) PU-NHS wide scan (b) PU-NHS C1s core level region (c) 
PU-GRGDG wide scan (d) PU-GRGDG C1s core level region  
 
Table 5.5 Carbon 1s chemical state quantification by XPS of PU-NHS and PU-GRGDG 
(atomic percentages and the corresponding binding energies in eV) 
Sample C-C 
284.5eV 
C-N 
285.64eV 
C-O 
286.18eV 
O=C-N 
286.68eV 
O=C-O 
288.6eV 
PU-NHS  53.87% 12.73% 14.65%  3.21%  15.54% 
PU-GRGDG  51.60% 14.52% 13.74%  5.72%  14.41% 
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The water contact angle data, supported by the XPS data, showed that the grafted 
peptides significantly increased the hydrophilicity of the coated surface, influencing 
strongly the surface properties of the polymers. This might improve the biocompatibility, 
which was studied by cell adhesion experiment.  
 
5.3.5. Cell adhesion 
 
Cell adhesion experiments on the polymer surface were an important test for evaluation 
of biocompatibility of polymers. Here we examined whether the peptides incorporated 
into polymer backbone could enhance Human dermal fibroblast cells (HDF) adhesion.  
PU-OMe was used as a blank, instead of PU-NHS, because of the water sensitivity of the 
latter. Figure 5.7 show the cell attachment profiles of the polyurethanes and, for control, 
the tissue culture polystyrene (TCPS) substrates in a serum (Figure 5.7 (a)) and a serum-
free (Figure 5.7 (b)) medium.   
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Figure 5.7 Human dermal fibroblast cell attachment profiles of TCPS, PU-GRGDG, PU-
HA and PU-OMe: (a) EMEM containing 10% FCS; (b) EMEM without 10% FCS   
 
After 2 hours of incubation, relatively small number of cells (about 10,000 cells/cm
2) 
were attached to all the substrates in the serum containing medium. The number of 
attached cells on PU-GRGDG was slightly higher (around 15,000 cells/cm
2) than on the 111 
 
other polymers. Cell adhesion increased in a time-dependent fashion in the serum-
supplemented media (Fig. 5.7(a)). After six hours, the adhesion on PU-GRGDG was a 
threefold (around 45,000 cells/cm
2) higher than on the other polymers (around 
15,000cells/cm
2). After 24 hours, there were more cells attached on all substrates in the 
serum mediated growth experiments. Still the number of attached cells (around 55,000 
cells/cm
2) was the highest on PU-GRGDG substrate. Adhesion of HDF onto PU-OMe 
and PU-HA was substantially lower (around 25,000 cells/cm
2). The adhesion properties 
of these two substrates did not differ significantly from each other. Apparently, GRGDG 
peptide modified polyurethane was more favorable to attached human cells, particularly 
in short times.
25,31 Other RGD comprising polymer systems that are well described in the 
literature, show similar performances.
31,32,34,35  
Without serum the cells survive for several hours until maximally several days, 
depending on the type of cells. We also performed cell adhesion experiments using a 
serum-free medium, since serum could influence the cell adhesion. Because serum 
contains fibronectin, which rapidly binds to almost any surface, rendering almost any 
surface adhesive to cells, but in a non-covalent fashion. Without serum, we could study 
the neat biomaterials properties much better, without the interference of other RGD-
containing molecules (e.g. fibronectin). From Figure 5.7 (b) it can be seen that the 
number of all attached cells increased when the incubation time was raised from 2 hours 
to 6 hours. PU-GRGDG still attracted approximately two times more cells (around 
50,000 cells/cm
2) than PU-HA and PU-OMe, and 1.5 times more than TCPS, after 6 
hours incubation time. The adhesion had significantly decreased on all surfaces (in 0% 
FCS) except PU-GRGDG which still adhered around 46,000cells/cm
2 on the surface. 
This number is almost a fourfold of that of the other substrates. Obviously, a lot of cells 
died without serum after several hours, and, as a result, they were not able any more to 
attach to the surface of substrates. But, the adhesive peptides of PU-GRGDG maybe 
perform as the nutrition for cells, keeping them still live when attached on the polymer 
surface. It means GRGDG peptide modified polyurethane can attract not only more cells 
than unmodified polyurethanes in the serum-free circumstance, but keep them in addition 
longer alive.  112 
 
The results suggested that the grafted GRGDG peptide of PU-GRGDG promoted Human 
dermal fibroblast cells (HDF) adhesion on the surface of polyurethane. It means that 
GRGDG peptides were assessable for bio-active interactions after coupling onto PU-NHS. 
Considering that NHS group can easily substituted by amino functional nucleophiles, PU-
NHS can give numerous possibilities to synthesize a library of functional polyurethanes.  
 
5.4. Conclusion 
 
 NHS-activated ester containing polyurethanes were successfully synthesized from NHS-
functional caprolactam blocked lysine diisocyanate (BLDI-NHS) and PCL. During the 
polymerization the pendant NHS groups were not substituted by the hydroxyl groups of 
polycaprolactone (PCL), under well selected conditions, while they were easily 
substituted by amino functional compounds. Hexyl amines, as a model compound, as 
well as a bio-active amino-functional GRGDG peptide, were coupled onto the polymer 
backbone via the same route. 
1H-NMR, IR, XPS and elemental analysis showed almost 
100% substitutions of the NHS-group by hexyl amine and the peptide, forming PU-HA 
and PU-GRGDG. XPS and elemental analysis of PU-HA- and PU-GRGDG proved that 
there was about 350mg peptide per gram polymer. According to XPS, the concentration 
of peptides on spin-coated surfaces was the same as in the bulk of the polymer. The low 
contact angle (α = 20
o), due to the presence of GRGDG, was a further prove for the 
presence of the peptides on the surface. The GRGDG peptides promoted adhesion of 
HDF cells, even in the serum-free conditions. Since these polyurethanes could also be 
applied by a (spin) coating technique, they may also be used as functional coatings on the 
implantable devices to promote cell adhesion. Hence, PU-NHS can offer a platform to 
prepare a library of bio-functional polyurethanes. 
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Chapter 6 
 
Polyurethanes based on caprolactam blocked lysine diisocyanates 
decorated with biotin moieties 
 
Abstract 
 
The aim of this chapter was to explore the possibility for introducing a biotin moiety, 
with and without a long nontoxic spacer, onto our homemade blocked lysine diisocyanate  
and to synthesize corresponding polyurethanes.  The presence of biotin on polymers 
would allow immobilization of various biomolecules, like peptides or protein, through 
biotin-avidin interactions. In a first step the pendant ester group of blocked lysine 
diisocyanate was converted into a primary amino or hydroxyl group. The pendant amino 
group was used to couple biotin and, as a result, biotinylated blocked lysine diisocyanate 
(BLDI-C6-biotin) was obtained. The pendant hydroxyl group was nosylated by 4-
nitrobenzenesulfonyl chloride, forming BLDI-C6-ONs. This compound was used as an 
initiator for the ring opening polymerization of oxazolines. A primary amino group at the 
end of BLDI-C6-PMOX was obtained by end-capping the living polymer with 
hexamethylene tetramine. Next, biotin was coupled onto the BLDI-PMOX, to form a 
BLDI-PMOX-biotin. The polymerization of the biotinylated blocked lysine diisocyantes 
with PCL530 yielded the corresponding polyurethanes.  116 
 
6.1. Introduction 
A number of polymers have proven their value as biomaterials because of the versatility 
in chemistry, which gives rise to materials with great diversity of physical and 
mechanical properties.
1 Depending on the application either long-lasting or temporarily 
properties are needed. Degradable polymers are of utmost interest for temporarily 
applications, such as in tissue engineering, as they are able to degrade and to resorb and 
excrete without surgical intervention. In this class of polymers, polyurethanes (PU) 
represent a major class of synthetic elastomers that have been evaluated for a variety of 
medical implants, particularly for long-term implants.
2,3 They have excellent mechanical 
properties and good biocompatibility. They are used in the fabrication of medical 
implants such as cardiac pace makers and vascular grafts. The main challenge is currently 
the inadequate interaction between these polymers and human cells, leading in vivo to 
foreign body reactions, such as inflammation, infections, aseptic loosening, local tissue 
waste, and implant encapsulation as well as thrombosis and embolization.
4,5 So far, 
modification of polymers with various biomolecules was chosen to solve this problem.  
An attractive alternative to the biomolecule entrapment involves the covalent binding of 
the biomolecule to polymer films bearing adequate functional groups. Covalent bonds are 
mostly formed between side-chain-exposed functional groups or proteins with suitable 
modified supports. However, tissue engineering requires degradable polymers and the 
number of degradable polymers decorated with side groups are rare. Another handicap of 
the existing polymers is that often an irreversible binding is used to fix bio-active groups 
onto polymer backbones. Biochemical affinity (i.e avidin-biotin) reactions offer a gentle 
method for oriented immobilization of biomolecules, providing an important advantage 
over other immobilization techniques. Moreover, not only oriented and homogeneous 
attachment can be obtained but it is also possible to detach biomolecules and to make 
repeated use of the same surface.    
The use of avidin-biotin technology in generating biocompatible surfaces has been 
reviewed in great detail.
6 The approach exploits one of the strongest non-covalent bonds 
(Kd = 10
15 M
-1) ever observed, preventing the use of harsh conditions during covalent 
binding biomaterials. An excellent overview of the binding couple avidin-biotin can be 
found in the book “Avidin-Biotin Chemistry: A Handbook”.
7 Avidin is a tetrameric 117 
 
glycoprotein soluble in aqueous solutions and stable over wide pH and temperature 
ranges. It can bind up to four molecules of biotin. The bond formation is very rapid and 
unaffected by pH, temperature, organic solvents, enzymatic proteolysis, and other 
denaturing agents. Streptavidin is a closely related tetrameric protein, with similar 
affinity to biotin, but differing in other aspects, such as molecular weight, amino acid 
composition and so on. The properties of avidin and streptavidin have been improved 
using chemical and recombinant methods providing enhanced stability and/or controlled 
biotin binding. For example, NeutrAvidin displays highly specific binding to biotin, 
whereas NitrAvidin gives a pH-dependent biotin binding with strong interaction at acidic 
conditions (pH 4-5) and dissociation at a higher pH.  
Biotin or vitamin H is a naturally occurring vitamin found in all living cells. Only the 
bicyclic ring is required to be intact for the interaction with avidin; the carboxyl group on 
the valeric acid side chain is not involved and can be modified to generate biotinylation 
reagents used for conjugation with proteins. Since biotin is a small molecule, its 
conjugation to macromolecules does not affect their conformation, size, or functionality. 
Biotinylation reagents can be classified depending on their reactivity toward diverse 
functional groups. The NHS ester of biotin is the most commonly used biotinylation 
reagent to target amine groups,
8 whereas biotin hydrazide can be used to target either 
carbohydrates or carboxyl groups.
9 A typical biotin/avidin/biotin multilayer is composed 
by biotin directly immobilized and avidin creating a secondary layer for binding 
biotinylated molecules (Scheme 6.1).  
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Scheme 6.1 Immobilization of biotinylated biomolecules to the substrate via avidin-biotin 
mediated systems.  
This approach is generally preferred due to the higher organization obtained in 
comparison to that of the direct immobilization of avidin. For instance, the biotin layer 
promotes an ordered avidin over-structure with two biotin-binding sites facing the surface 
and the other two facing outward. A glycopolymer-derivatized surface over the biotin-
streptavidin-biotin layer has been used for surface glycoengineering.
10  
  Coupling of biotin groups to our polyurethanes would allow immobilizing of 
biomolecules, like peptides or protein, through biotin-avidin interactions. As described 
earlier (Chapter 2), the caprolactam blocked lysine diisocyanate methyl ester (BLDI-
OMe) was successfully synthesized in high yields and the methylester could be 
hydrolyzed under well-defined conditions without affecting the blocked isocyanate group. 
The pendant acid groups was available to be converted into activated esters (chapter 2), 
which could offer the possibility to introduce biotin moieties. In this chapter, the 
synthesis of the biotinylated blocked lysine diisocyanate with and without space are 
reported. After that these functionalized blocked lysine diisocyanate were used to 
synthesize the corresponding functional polyurethanes.  
6.2. Materials and Methods  
 
6.2.1. Materials 
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CBC (carbonyl biscaprolactam) was obtained from DSM Innovation Center, ALLINCO®, 
(> 99 % pure according to HPLC) and used without purification. 
 L-Lysine  monohydrochloride,  thionylchloride, calciumchloride dihydrate, 1,6 
hexanediol,  hexamethylenediamine, 6-aminohexanol, 4-nitrobenzenesulfonyl chloride 
(NsCl), hexamethylenetetramine (HMTA), ninhydrin, 2-methyl-2-oxazoline (MOX) 
anhydrous magnesium sulfate, dicyclohexyl-carbodiimide (DCC), N-hydroxysuccinimide 
(NHS), biotin, chloroform-d (CDCl3-D, 99.8 atom % D) and dimethyl sulfoxide-d6 
(DMSO-d6, 99.5 atom % D)  were purchased from Sigma-Aldrich and used as obtained.  
Ethyl acetate, potassium hydroxide (KOH), sodium hydroxide (NaOH), anhydrous 
acetonitrile and anhydrous N,N-dimethylformamide (DMF),  were purchased from Acros 
Organics and used as obtained.  
Methanol, acetone, chloroform, triethylamine (TEA), n-hexane, hydrochloric acid fuming 
37%, sulfuric acid, tetrahydrofuran (THF), dichloromethane (DCM), diethyl ether, were 
purchased from Lab-Scan Analytical Science and used as obtained. 
Caprolactam blocked lysine diisocyanate methyl ester (BLDI-OMe), the corresponding 
acid (BLDI-OH) and NHS modified acid (BLDI-NHS) were synthesized according to the 
method as described previously (chapter 2).  
 
6.2.2. Analysis 
 
Column chromatography was performed on silica gel (Silica-P flash silica gel from 
Silicycle, size 40-63 μm). TLC was performed on silica gel 60/Kieselguhr F254. 
Components were visualized by UV and staining with a solution of a mixture of KMnO4 
(5g) and K2CO3 (20 g) in H2O (500 mL). The presence of primary amines in NH2-
containing compounds were detected by using ninhydrin. 
1H-NMR was recorded on a Varian AMX400 using CDCl3 or DMSO-d6 as solvent. 
Chemical shift values are reported in ppm with the solvent resonance as the internal 
standard (CHCl3:  7.26 for 
1H; d6-DMSO:  3.3 and 2.5 for 
1H). Data are reported as 
follows: chemical shifts, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = 
broad, m = multiplet). 
Mass spectra were recorded on a LTQ Orbitrap XL (ESI+). 120 
 
Size exclusion chromatography (SEC) measurements were performed in 
dimethylformamide with 0.01M LiBr on a Viscotek GPC max equipped with model 302 
TDA detectors, using 2 columns (Pl-gel 5µ 30 cm mixed-C from Polymer Laboratories). 
The data analysis was done using conventional calibration with polystyrene standards 
accompanied by in-house software. 
ATR-FTIR spectra were recorded on a Broker IFS88 spectrometer equipped with a 
Golden Gate (Graseby specac) single reflection ATR accessory. Spectra resolution was 4 
cm
-1 and 32 scans were taken per spectrum. 
The water contact angle measurements were carried out at room temperature by using a 
custom built microscope-goniometer system. A 1.00 μL drop of the deionized water was 
placed on a prepared polymer-coated glass slide using a Hamilton micro-syringe and the 
contact angle was measured immediately. The measurements involve fitting of a drop 
picture with home-built software. Three measurements were carried out in different 
regions on the surface. 
 
6.2.3. Synthesis of BLDI-NH-C6-biotin  
 
BLDI-NH-C6-NH2 (2). BLDI-NHS (1) (5g, 9.6mmol, from chapter 2) was dissolved in 
100 methylene chloride in a glass flask of 250 mL in a nitrogen atmosphere. A 10 times 
molar excess of hexamethylene diamine (11.2g, 96mmol) was added. The reaction 
mixture was stirred at room temperature overnight. After removal of precipitated NHS 
salt by filtration, the crude product was washed with 500mL 5% NaHCO3 aqueous 
solution and subsequently with 300mL brine (saturated NaCl aqueous solution). The 
resultant solution was dried over anhydrous MgSO4. After filtering off MgSO4 the solvent 
was evaporated in a rotavapor and further died at 45
oC for 48h in the vacuum oven.  
1H-NMR (CDCl3): δ= 9.52 (1H, d, CHNH), 9.22 (1H, t, CH2NH), 6.45 (1H, t, NHC6H12), 
4.21 (1H, q, CH), 3.95 (4H, m, caprolactam ring NCH2), 3.24 (4H, m, NHCH2), 2.68 (4H, 
m, caprolactam ring CH2CO), 1.95-1.25 (28H, m, caprolactam ring 6CH2 + alkyl chain 
8CH2). 
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BLDI-NH-C6-biotin (3). N-hydroxysuccimide (1.32g, 11.3mmol) and 
dicyclohexylcarbodiimide (2.35g, 11.4mmol), were added to biotin (2.35g, 9.6mmol) 
dissolved in anhydrous 80 mL dimethylformammide (DMF) in a glass flask under 
nitrogen atmosphere. The reaction mixture was stirred for 24h at room temperature.
72 
After dicyclohexyl urea was filtered off, BLDI-C6-NH2 (2) in DMF (5.15g, 9.5mmol in 
20mL DMF) and triethylamine were added. After 4h, the NHS salt was filtered off. The 
solution was concentrated by rotary evaporator and precipitated in diethyl ether. After 
flash chromatography with chloroform and methanol with ratio of 4:1, the elute solvent 
was evaporated and the solid was dried at 50
oC for 2days in the vacuum oven, giving 3g 
(60%) biotinylated blocked lysine diisocyanate BLDI-NH-C6-biotin.
 
1H-NMR (DMSO-d6): δ = 9.46 (1H, d, OCCHNHCO), 9.10 (1H, t, CH2NHCO), 8.06 (1H, 
t, CH2NHCOCH), 7.74 (1H, t, CH2NHCOCH2), 6.40 (1H, d, biotin ring: CONHCHCH), 
6.34 (1H, d, biotin ring: CONHCHCH2), 4.30 (1H, t, biotin ring: NHCHCH2), 4.28 (1H, 
q, OCCHNHCO), 4.12 (1H, q, biotin ring: CONHCHCH), 3.86 (4H, m, NCH2), 3.12-
2.95 (7H, m, 3NHCH2 + SCH), 2.78 and 2.56 (2H, m, biotin ring SCH2), 2.65 (4H, m, 
CH2CON), 2.18 and 2.02 (2H, NHCOCH2), 1.87-1.21 (32H, m, caprolactam ring 6CH2 + 
alkyl chain 10CH2). 
ESI-MS m/z: (M+1)
+ 751.06 (M+Na)
+ 773.04 
 
6.2.4. Synthesis of Nosylate initiator (imide linkage) 
 
BLDI-NH-C6-OH (4). BLDI-NHS (1) (5g, 9.6mmol) was dissolved in 50 mL methylene 
chloride. An excess of 6-aminohexanol (2.3g, 19.6mmol) was added. The reaction 
mixture was stirred at room temperature overnight. After removal of precipitated NHS 
salt by filtration, the solution was washed with 300mL 5% NaHCO3 aqueous solution and 
with 300mL brine (saturated NaCl aqueous solution). The resultant solution was dried 
over anhydrous MgSO4. After removal of MgSO4 by filtration and solvent by evaporation, 
the crude product was collected give around 4.5g (90%) BLDI-NH-C6-OH.  
1H-NMR (CDCl3):  δ= 9.50 (1H, d, CHNH), 9.19 (1H, t, CH2NH), 6.50 (1H, t, 
NHC6H12OH), 4.18 (1H, q, CH), 3.88 (4H, m, caprolactam ring NCH2), 3.52 (2H, m, 122 
 
CH2OH),  3.18 (4H, m, NHCH2), 2.64 (4H, t, caprolactam ring CH2CO), 1.95-1.22 (26H, 
m, caprolactam ring 6CH2 + alkyl chain 7CH2). 
 
BLDI-NH-C6-ONs (5). BLDI-NH-C6-OH (4) (5g, 9.5mmol) was dissolved in 40mL of 
chloroform. 4-nitrobenzenesulfonyl chloride (NsCl) (2.53 g, 11.6mmol) was added drop 
wise to a solution of BLDI-NH-C6-OH at 0 
oC, followed by drop wise addition of TEA to 
the mixture solution.  Reaction was carried out at 0 
oC for 2 hours and another 4 hours at 
room temperature under nitrogen atmosphere.  The obtained product was washed with 
200mL 5% citric acid, 200mL 5% NaHCO3 aqueous solution and with 300mL brine. The 
resultant solution was dried over anhydrous MgSO4.  After removal of MgSO4  by 
filtration and solvent by evaporation, the crude product was collected. After flash 
chromatography with chloroform, the pure product was collected by evaporating the 
solvent by using the rotavapor to give around 4g (60%) BLDI-NH-C6-ONs. 
1H-NMR (CDCl3): δ= 9.51 (1H, d, CHNH), 9.22 (1H, t, CH2NH), 8.39 (2H, d, benzyl 
ring CHCNO2), 8.19 (2H, d, benzyl ring CHCSO3), 6.25 (1H, t, NHC6H12O), 4.20 (1H, q, 
CH), 4.12 (2H, m, CH2O),  3.94 (4H, m, caprolactam ring NCH2), 3.24 (4H, m, NHCH2), 
2.68 (4H, t, caprolactam ring CH2CO), 1.95-1.25 (26H, m, caprolactam ring 6CH2 + alkyl 
chain 7CH2). 
ESI-MS m/z: (M+1)
+ 709.32, (M+Na)
+ 731.30. 
 
6.2.5. Synthesis of poly(2-methyl-2-oxazolines) (BLDI-NH-PMOX-ONs) (6) and 
kinetic study  
 
2-methyl-2-oxazoline (MOX) (3.7 mL, 43mmol) was mixed with 37 mL anhydrous 
acetonitrile in a nitrogen atmosphere and cooled to 0
oC. The initiator BLDI-NH-C6-ONs 
(5) (3.04 g, 4.3mmol, amount calculated according to [Mo]/[I] =10) was added to this 
mixture and left at 0
 oC for 1 hour. The solution was then quickly heated to reflux and 
stirred for several hours till all MOX was consumed. The living polymer was collected 
after precipitating in diethyl ether and, after isolation by filtration, dried in vacuum oven 
at 40
 oC for 48 hour. During the polymerization, samples were taken, once per hour to do 
the kinetic study, which were followed by 
1H-NMR measurement. 123 
 
1H-NMR (CDCl3): δ= 9.52 (1H, d, CHNH), 9.24 (1H, t, CH2NH), 8.24 (2H, d, aromatic 
ring CHCNO2), 8.01(2H, d, aromatic ring CHCSO3), 6.37 (1H, broad, NHC6H12O), 4.36 
(1H, d, ring NCHCH3), 4.24 (1H, q, CH), 3.95 (4H, m, caprolactam ring NCH2), 3.72-
3.28 (repeating unit of PMOX NCH2-CH2N), 3.24 (4H, m, NHCH2), 2.68 (4H, t, 
caprolactam ring CH2CO), 2.29-2.00 (repeat unit of PMOX CH3), 1.95-1.25 (26H, m, 
caprolactam ring 6CH2 + alkyl chain 7CH2). 
 
 
6.2.6. Synthesis BLDI-NH-PMOX-biotin 
 
BLDI-NH-PMOX-NH2. (7) The living polymer from 6.2.5 (3.6g, 2.4mmol) was 
terminated before precipitation by adding hexamethylenetetramine (HMTA, 0.84g, 
6mmol) dissolved in 10mL chloroform. After 1 hour stirring at room temperature the 
solvent was evaporated. The residue was dissolved in 10 mL of toluene, 15mL methanol 
and 1.9g of concentrated sulfuric acid and solution was refluxed for 4 hours. The mixture 
was neutralized by adding a 50wt% NaOH/water solution, the salts were filtered off and 
the filtrate was stripped to dryness on a rotary evaporator. The residue was dissolved in 
chloroform and precipitated in diethyl ether. The white powder was further dried by 
vacuum oven at 40
oC for 48hour leaving around 2.2g (60%) of BLDI-NH-PMOX-NH2.  
1H-NMR (CDCl3):  δ= 9.52 (1H, d, CHNH), 9.24 (1H, t, CH2NH), 6.37 (1H, broad, 
NHC6H12O), 4.24 (1H, q, CH), 3.95 (4H, m, caprolactam ring NCH2), 3.72-3.28 
(repeating unit of PMOX NCH2-CH2N), 3.24 (4H, m, NHCH2), 2.68 (4H, t, caprolactam 
ring CH2CO), 2.29-2.00 (repeat unit of PMOX CH3), 1.95-1.25 (26H, m, caprolactam 
ring 6CH2 + alkyl chain 7CH2). 
 
BLDI-NH-PMOX-biotin. (8) N-hydroxysuccimide (NHS, 0.16g, 1.4mmol) and 
dicyclohexylcarbodiimide (DCC, 0.31g, 1.5mmol), were added to biotin that was 
dissolved in anhydrous dimethylformamide (0.32g, 1.3mmol in 20mL DMF) under N2. 
The reaction mixture was stirred for 24h at room temperature.
72 The precipitated 
dicyclohexyl urea was filtered off. Subsequently, BLDI-NH-PMOX-NH2 (7) in DMF 
(2.02g, 1.3mmol in 10mL DMF) and triethylamine (0.3g, 3.0mmol) were added. After 124 
 
12h stirring at room temperature the solvent was evaporated. The residue was dissolved 
in 10mL chloroform, the salts were filtered off and the filtrate was precipitated in diethyl 
ether. The product was isolated by filtration and further dried in vacuum oven 40
oC for 
48hour leaving around 1.5g (75%) of BLDI-NH-PMOX-biotin.  
1H-NMR (DMSO-d6): δ= 9.52 (1H, d, CHNH), 9.24 (1H, t, CH2NH), 6.40 (1H, d, biotin 
ring: CONHCHCH), 6.34 (1H, d, biotin ring: CONHCHCH2), 4.21 (1H, t, biotin ring: 
NHCHCH2), 4.06 (1H, q, OCCHNHCO), 3.96 (1H, q, biotin ring: CONHCHCH), 3.80 
(4H, m, caprolactam ring NCH2), 3.45-3.19 (repeating unit of PMOX NCH2-CH2N), 3.03 
(4H, m, NHCH2), 2.69-2.56 (7H, m, 3NHCH2 + SCH), 2.71 and 2.51 (2H, m, biotin ring 
SCH2), 2.45 (4H, m, caprolactam ring CH2CO), 2.0-1.84 (repeat unit of PMOX CH3), 
1.64-1.16 (32H, m, caprolactam ring 6CH2 + alkyl chain 10CH2). 
 
6.2.7. Synthesis BLDI-O-PMOX-biotin 
 
BLDI-O-C6-OH (10). BLDI-OH (9) (5g, 11.8mmol, from chapter 2) was dissolved in 
50mL chloroform, whilst being cooled at 0
oC by using an ice bath. Thionyl chloride 
(1mL, 13.7mmol) was added drop wise whilst maintaining the temperature below 20
oC. 
A ten-fold excess of 1, 6-hexanediol (14g, 118mmol) was added. The reaction mixture 
was stirred at room temperature for another 48 hours. The solution was washed with 
300mL 5% NaHCO3 aqueous solution and with 300mL brine (saturated NaCl aqueous 
solution). The resultant solution was dried over anhydrous MgSO4. After removal of 
MgSO4 by filtration and solvent by evaporation, the crude product was collected. Then 
after flash chromatography with chloroform and methanol with ratio of 60:1, the pure 
product was collected to give around 6g (65%) BLDI-O-C6-OH.  
1H-NMR (CDCl3): δ= 9.66 (1H, d, CHNH), 9.21 (1H, t, CH2NH), 4.40 (1H, q, CH), 4.09 
(2H, m, COOCH2) 3.92 (4H, m, caprolactam ring NCH2), 3.48 (2H, m,CH2OH), 3.22 (2H, 
m, NHCH2), 2.68 (4H, t, caprolactam ring CH2CO), 1.94-1.22 (26H, m, caprolactam ring 
6CH2 + alkyl chain 7CH2). 
  
BLDI-O-C6-ONs (11). BLDI-O-C6-OH (10) (5g, 9.5mmol) was dissolved in 40mL of 
chloroform. 4-nitrobenzenesulfonyl chloride (NsCl) (2.53 g, 11.6mmol) was added drop 125 
 
wise to solution of BLDI-O-C6-OH at 0 
oC followed by addition of TEA drop wise to the 
mixture.  Reaction was carried out at 0 
oC for 2 hours and another 4 hours at room 
temperature.  The obtained product was washed with 200mL 5% citric acid, 200mL 5% 
NaHCO3 aqueous solution and with 300mL brine. The resultant solution was dried over 
anhydrous MgSO4. After removal of MgSO4 by filtration and solvent by evaporation, the 
crude product was collected. Then after flash chromatography with chloroform, the pure 
product was collected to give around 4g (60%) BLDI-O-C6-ONs. 
1H-NMR (CDCl3): δ= 9.69 (1H, d, CHNH), 9.25 (1H, t, CH2NH), 8.39 (2H, d, aromatic 
ring CHCNO2), 8.12 (2H, d, aromatic ring CHCSO3), 4.38 (1H, q, CH), 4.15 (2H, m, 
CH2O), 4.09 (2H, m, COOCH2), 3.94 (4H, m, caprolactam ring NCH2), 3.24 (2H, m, 
NHCH2), 2.68 (4H, t, caprolactam ring CH2CO), 1.95-1.25 (26H, m, caprolactam ring 
6CH2 + alkyl chain 7CH2). 
ESI-MS m/z: (M+1)
+ 724.29,  (M+Na)
+ 747.15. 
 
 BLDI-O-PMOX-ONs (12) and kinetic study. 2-methyl-2-oxazoline (MOX) (3.7 mL, 
43mmol) was mixed with 37 mL anhydrous acetonitrile in a nitrogen atmosphere and 
cooled to 0
oC. The initiator BLDI-O-C6-ONs (11) (3.04 g, 4.3mmol, amount calculated 
according to [M0]/[I] = 10) was added to this mixture and the latter was left at 0
 oC for 1 
hour. The solution was then quickly heated to reflux and stirred for several hours till all 
the MOX was consumed. The living polymer was collected after precipitating in diethyl 
ether and after isolation by filtration dried in vacuum oven at 40
 oC for 48 hour. During 
the polymerization, samples were taken after each hour, to do the kinetic study. The 
molecular weights were based on 
1H-NMR measurement. 
1H-NMR (CDCl3): δ= 9.52 (1H, d, CHNH), 9.24 (1H, t, CH2NH), 8.24 (2H, d, aromatic 
ring CHCNO2), 8.01(2H, d, aromatic ring CHCSO3), 4.36 (1H, d, ring N
+CHCH3), 4.24 
(1H, q, CH), 4.09 (2H, m, COOCH2), 3.95 (4H, m, caprolactam ring NCH2), 3.72-3.28 
(repeating unit of PMOX NCH2-CH2N), 3.24 (2H, m, NHCH2), 2.68 (4H, t, caprolactam 
ring CH2CO), 2.29-2.00 (repeat unit of PMOX CH3), 1.95-1.25 (26H, m, caprolactam 
ring 6CH2 + alkyl chain 7CH2). 
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BLDI-O-PMOX-NH2 (13). The living polymer (3.6g, 2.4mmol) was terminated by 
adding a hexamethylenetetramine (HMTA, 0.84g, 6mmol) solution (in 10mL chloroform). 
After 1 hour stirring at room temperature in nitrogen the solvent was evaporated. The 
residue was dissolved in 10 mL of toluene, 15mL methanol and 1.9g of concentrated 
sulfuric acid and the solution was reflux for 4 hours. The mixture was neutralized by 
adding 50wt% NaOH in water solution, the salts were filtered off and the filtrate was 
stripped to dryness on a rotary evaporator. The residue was dissolved in chloroform and 
precipitated in diethyl ether. The white powder was further dried by vacuum oven at 40
oC 
for 48hour leaving 2.2g (60%) of BLDI-O-PMOX-NH2.  
1H-NMR (CDCl3): δ= 9.52 (1H, d, CHNH), 9.24 (1H, t, CH2NH), 4.24 (1H, q, CH), 4.09 
(2H, m, COOCH2), 3.95 (4H, m, caprolactam ring NCH2), 3.72-3.28 (repeating unit of 
PMOX NCH2-CH2N), 3.24 (4H, m, NHCH2), 2.68 (2H, t, caprolactam ring CH2CO), 
2.29-2.00 (repeat unit of PMOX CH3), 1.95-1.25 (26H, m, caprolactam ring 6CH2 + alkyl 
chain 7CH2). 
. 
 
BLDI-O-PMOX-biotin(14).  N-hydroxysuccimide (NHS, 0.16g, 1.4mmol) and 
dicyclohexylcarbodiimide (DCC, 0.31g, 1.5mmol), were added to biotin dissolved in 
anhydrous dimethylformamide (0.32g, 1.3mmol in 20mL DMF). The reaction was stirred 
for 24h at room temperature under nitrogen. Dicyclohexyl urea was filtered off, and 
BLDI-O-PMOX-NH2 (13) in DMF (2.02g, 1.3mmol in 10mL DMF) and triethylamine 
were added. After 12h stirring at room temperature the solvent was evaporated. The 
residue was dissolved in 10mL chloroform, the salts were filtered off and the filtrate was 
precipitated in diethyl ether. After isolation by filtration the product was further dried in 
vacuum oven 40
oC for 48hour leaving 1.5g (75%) of BLDI-O-PMOX-biotin.  
1H-NMR (DMSO-d6): δ= 9.47 (1H, d, CHNH), 9.07 (1H, t, CH2NH), 6.34 (1H, d, biotin 
ring: CONHCHCH), 6.27 (1H, d, biotin ring: CONHCHCH2), 4.20 (2H, m, COOCH2), 
4.07 (1H, t, biotin ring: NHCHCH2), 3.96 (1H, m, OCCHNHCO), 3.96 (1H, q, biotin ring: 
CONHCHCH), 3.80 (4H, m, caprolactam ring NCH2), 3.45-3.19 (repeating unit of 
PMOX NCH2-CH2N), 3.03 (4H, m, NHCH2), 2.69-2.56 (7H, m, 3NHCH2 + SCH), 2.71 
and 2.51 (2H, m, biotin ring SCH2), 2.45 (4H, m, caprolactam ring CH2CO), 2.0-1.84 127 
 
(repeat unit of PMOX CH3), 1.64-1.12 (32H, m, caprolactam ring 6CH2 + alkyl chain 
10CH2). 
 
6.2.8. Synthesis of biotinylated polyurethanes 
 
A 10 mL glass flask was fitted with a nitrogen inlet and an outlet to a vacuum pump. 
After the flask was three times evacuated and refilled with nitrogen, to remove all oxygen, 
dry biotinylated monomers BLDI-NH-C6-biotin (3) or BLDI-NH-PMOX-biotin (8) or 
BLDI-O-PMOX-biotin (14) were added in an roughly equal molar with respect to 
PCL530, respectively. The mixture was heated up to 160 
oC while stirring under vacuum 
for 24hours.  
 
6.3. Results and discussion  
 
6.3.1. Synthesis of BLDI-NH-C6-biotin  
 
There are various options to incorporate biotin in polyurethanes. In one option the 
carboxylic acid group of biotin was converted with N-hydroxysuccimimide (NHS) into 
the corresponding reactive NHS-ester, according to the method described in the literature 
(Scheme 6.2).
11 The activated ester can easily react with primary amino groups.  
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Scheme 6.2 Synthesis of biotin-NHS
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The synthesis of BLDI-NHS has been reported in detail in chapter 2. It was shown that a 
model compound, hexylamine, was able to substitute the NHS group, thereby being 
coupled onto the ester group of blocked lysine diisocyanate, forming BLDI-HA. A 
precipitate of NHS-amine salt was formed at same time.  128 
 
In order to prepare an amino functional BLDI (BLDI-NH-C6-NH2 (2)) a large excess of 
hexamethylene diamine was used (ten folds to blocked diisocyanate) to reduce the 
possibility that both amino groups would react with BLDI-NHS. The reaction was 
performed at room temperature and the disappearance of NHS signal and appearance of 
amide signals were monitored by 
1H-NMR at 2.82 and 6.45 ppm, respectively. The 
reaction was complete after about 12 h. After removing the excess of hexamethylene 
diamine and by subsequently adding biotin-NHS, biotin was coupled onto BLDI-NH-C6-
NH2. After stirring for 12 hours at room temperature, the crude product was isolated by 
precipitating in diethyl ether and further purified using column chromatography. Scheme 
6.3 shows the structure and the synthetic route to prepare the biotinylated blocked lysine 
diisocyanate (BLDI-NH-C6-biotin). 
 
NN
H
O O
N
H
O NH
O
N
O
NH2
NN
H
O
O
N
H
OO
O
N
O
N H2N
NH2
O
NH
O
H
HN
H S
O
N
O
O
TEA
NN
H
O O
N
H
O NH
O
N
O
NH
NH
O
H
HN
H S
O
O O
(1) (2)
(3)  
 
Scheme 6.3 Synthesis of BLDI-NH-C6-NH2 and BLDI-NH-C6-biotin 
 
The reaction was monitored by 
1H-NMR and in figure 6.1 the 
1H-NMR spectrum of 
BLDI-NH-C6-biotin is shown. The peaks at δ 6.40 and 6.34 ppm are belonging to the NH 129 
 
from biotin ring which is very characteristic in 
1H-NMR spectrum of biotin.
12 All other 
signals in the spectrum were in agreement with the expected products. ESI-MS results 
supported that the desired product was obtained.  
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Figure 6.1 
1H-NMR spectrum of BLDI-C6-biotin 
 
6.3.2. Synthesis BLDI-NH-PMOX-biotin 
 
With a C6 spacer between a polymer backbone and a bio active compound the 
accessibility may be insufficient. Therefore, longer spacers between the bio group and 
backbone may be crucial for binding or function performances.
13,14 Similarly as required 
for biomaterials, the spacer should be nontoxic. Water soluble spacers are desired to 
improve the accessibility of the bio-active groups in the aqueous environment of the body. 
There are two kinds of polymers, poly(ethylene glycol) (PEG) and poly(2-alkyl-1,3-
oxazolins) (POX), that meet these requirements. PEG, prepared by means of anionic 130 
 
polymerization, is one of the best investigated biomedical polymers. In this study we 
chose the other polymer poly(oxazoline) as our spacer polymer, which has been prepared 
by a living cationic polymerization leading to narrowly distributed macromolecules.
15 An 
advantage of polyoxazolines is that various functional groups, such as double bonds, 
epoxy-groups, siloxanes, hydroxyl groups and amines, can conveniently be introduced as 
end-groups.
16 It was established that, for instance, the living cationic polymerization of 2-
alkyl-1,3-oxazolines started with bifunctional initiators and terminated with various 
nucleophiles led to well-defined macromolecules functionalized at both terminal ends.
17  
 
6.3.2.1. Synthesis of derivatives of BLDI-OMe  
 
Here, we explored the option to couple biotin via a spacer onto polyurethane backbones. 
The caprolactam blocked lysine diisocyanate methyl ester was used as starting material to 
prepare an initiator for the polymerization of 2-methyl-1,3-oxazoline (MOX). The living 
polymer was terminated with hexamethyleneteramid, to introduce an amine end group. 
The NH2 end group was needed for coupling biotin-NHS onto the blocked diisocyanate 
functional PMOX. The synthesis of initiator for PMOX is depicted in scheme 6.4.  
 
 
Scheme 6.4 Synthesis of BLDI-NH-C6-OH and of the initiator BLDI-NH-C6-ONs(5) for 
the preparation of  polyoxazolines 131 
 
 
By reacting 6-aminohexanol, with BLDI-NHS a hydroxyl functional blocked isocyanate 
(BLDI-NH-C6-OH (4)) was obtained. This intermediate compound was easily nosylated 
by 4-nitrobenzenesulfonyl chloride (NsCl) at room temperature, forming BLDI-NH-C6-
ONs (5). After isolation and purification steps, the structure of initiator was validated by 
1H-NMR in CDCl3. The peaks at 8.39 and 8.19 ppm were assigned to the aromatic 
protons (Figure 6.2) and the peak at 4.12 ppm was related with CH2 next the nosylate 
group. All other signals in the spectrum were in agreement with the expected product. 
ESI-MS also supported that the desired product was obtained. 
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Figure 6.2 
1H-NMR spectrum of initiator (BLDI-NH-C6-ONs(5)) for preparing 
polyoxazolines 
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6.3.2.2. Polyoxazolines comprising a BLDI end group 
 
The initiator was used to polymerize 2-methyl-1,3-oxazoline (MOX)  cationically via a 
ring-opening polymerization mechanism. To study the kinetics, polymerizations were 
performed in a monomer/BLDI-NH-C6-ONs ratio of 10.  
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Figure 6.3 
1H-NMR spectrum of the living polymer BLD-INH-PMOX-ONs  
 
Polymerization of 2-oxazoline monomers, using a nosylate initiator, has been shown to 
have a 100% efficiency.
18 In our case, the blocked lysine diisocyanate nosylate initiator 
gave indeed a complete initiation during the polymerizations. This was proven by the 
shifts of aromatic signals of initiator in proton NMR from 8.39 and 8.19 ppm to 8.24 and 
8.01 respectively (Figure 6.3). The high intensity peaks at 3.72-3.28 and 2.29-2.00 ppm 
are related to the repeating unit of PMOX. All other signals in the spectrum were in 133 
 
agreement with the expected products. This meant that the blocked isocyanate groups 
survived the polymerization conditions.  
Kinetics of 2-methyl-1,3-oxazolines (MOX) polymerizations, using the nosylate initiator, 
were followed by 
1H-NMR measurements (Figure 6.4).  Samples of the acetonitrile 
solutions were taken within selected time intervals during the polymerization and 
dissolved in CDCl3 for analysis.  
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Figure 6.4 
1H-NMR spectra of PMOX samples at various time intervals during the 
polymerization of MOX, initiated by BLDI-C6-ONs (Calculated DP=10, concentration 
10%w/V, monomer/ solvent).  
 
The big peaks at around 2 ppm were assigned to acetonitrile. The peaks at 9.47, 9.16, 
3.86 and 2.59 ppm were preserved during the reaction, and were related to the blocked 
diisocyanate groups. The peaks centered at 4.13 and 3.69 ppm represented unreacted 
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5h 134 
 
MOX, which intensity decreased with increasing of reaction time with respect to the 
aromatic signals (8.13 and 7.94 ppm). At same time, the intensity of peak centered at 3.34 
ppm (repeating unit of PMOX) increased with increasing of time. The 
1H-NMR signals 
were used to calculate the degree of polymerization (DP) (Figure 6.5).  
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Figure 6.5 Degree of the polymerization of MOX, initiated by BLDI-NH-C6-ONs 
(Calculated DP=10, concentration 10%w/V, monomer/ solvent). 
 
This graph shows that the polymerization was quite rapid. It can be seen that after 4h the 
polymerization rate leveled off and the DP of polymer became constant. The highest DP 
obtained was 7, which was lower than the calculated value based on the 
[monomer]/[initiator] ratio of 10. A possible explanation for this discrepancy could be the 
presence of moisture. Traces of water in a cationic polymerization can give proton 
initiating, resulting in more polymer chains with lower molecular weights.   
The molecular weights and polydispersities of BLDI-NH-PMOX-ONs were determined 
by using size exclusion chromatography (SEC). The molecular weights were in 
agreement with the 
1H-NMR results, as shown in Table 6.1. The polydispersities as 
obtained by SEC were around 1.4. This value is quite high for living cationic 
polymerization. However, this is not unusual for low molecular weight polymers (DP=10) 135 
 
and if the initiation step is not much faster than the propagations steps. Depending on the 
applications, various lengths of spacers can be chosen.  
Introduction of an amino functional group at the chain end is, according to the literature
19, 
possible by end-capping the living polymer with ammonia. However, we found that the 
yield of this reaction was very low. End-capping of the living polymer by hexamethylene 
tetramine (HMTA), resulted in a convenient method to introduce primary amino 
functional end group, after acid hydrolysis of the HMTA moiety of the HMTA functional 
polymers.
20 By subsequently reacting the amino functional PMOX with biotin-NHS, a 
PMOX-spacer comprising biotinylated blocked lysine diisocyanate was successfully 
obtained (Scheme 6.5). 
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Scheme 6.5 Polymerization of MOX with BLDI-functional initiator, termination of the 
living PMOX with hexamethylene tetramine, followed by hydrolysis to obtain BLDI-C6-
NH-PMOX-NH2  and the modification thereof with biotin. 
 
The successful end-capping of the living polymers with HMTA and the subsequently 
formations of polymers with NH2 end group were first demonstrated by the ninhydrin 
staining method on the TLC plate (Figure 6.6).
11  Ninhydrin gives selectively a 
discoloration in the presence of primary amines. The appearance of a violet color on the 
TLC plate showed the presence of primary amine group.  
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Figure 6.6 Detection of primary amines on TLC slide with ninhydrin: 1=hexylamine; 
2=BLDI-PMOX-NH2; 3=BLDI-PMOX-ONs.  
 
The efficiency of the termination reaction with HMTA and the subsequent biotin 
coupling reactions were determined by 
1H-NMR. Figure 6.7 displays the 
1H-NMR 
spectra of BLDI-NH-PMOX-NH2 and BLDI-NH-PMOX-biotin. The absence of aromatic 
signals (8.13 and 7.94 ppm) is a further evidence of the successful termination reaction in 
high yields with HMTA. This can be seen by comparing Figure 6.7 (a) with Figure 6.3. 
The  peaks at 6.40 and 6.34 ppm belong to the NH from biotin ring which is very 
characteristic in 
1H-NMR spectrum of biotin, as discussed previously.  
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Figure 6.7 
1H-NMR spectra of a: BLDI-NH-PMOX-NH2 in CDCl3 and b: BLDI-PMOX-
biotin in DMSO-d6.   
 
All the other signals in the spectra were as well in agreement with the expected products. 
Although strong bases and acids were used during the reaction, no hydrolysis of the 
PMOX spacer happened. This was further supported by SEC measurement as shown in 
Table 6.1. The molecular weights of the polymers did not change significantly during the 
modification reaction. Importantly, the blocked diisocyanate groups were still available to 
make new biotinylated polyurethanes.  
 
Table 6.1 Molecular weight of BLDI-NH-PMOX  
Sample 
DP 
calculated 
NMR GPC 
DP Mn(Da) DP Mn(Da)   PDI 
BLDI-NH-PMOX-ONs 10  9  1,501  11  1,658 1.4 
BLDI-NH-PMOX-NH2 10 10  1,390  13  1,639 1.3 
BLDI-NH-PMOX-biotin 10  10  1,615  13  1,796  1.3 
 
During the purification step in this series of experiments (precipitate in diethyl ether), low 
molecular weight products were removed.  This could explain why the DP of PMOX in 139 
 
SEC measurements in this series was higher (DP = 10) than in the aforementioned kinetic 
study  (DP = 7). The molecular weights obtained from 
1H-NMR measurements are in the 
same range as those obtained by SEC. 
 
6.3.3. Synthesis BLDI-O-PMOX-biotin 
 
In BLDI-NH-PMOX-biotin we selected an amide linkage between the spacer and the 
caprolactam blocked lysine diisocyanate, because of the high stability of amides. But the 
electron withdraw ability of amide group, which is located close to one of blocked 
diisocyanate groups (Scheme 6.3 and 6.4), might influence the reactivity of that blocked 
isocyanate with the hydroxyl groups of polyols during the polyurethane synthesis.  
When a side group was coupled via an ester linkage, we showed earlier (chapter 3) that 
the hydroxyl groups of PCL reacted well with the blocked isocyanate groups. By this 
route poly(ester-urethanes) were successfully synthesized from caprolactam blocked 
lysine diisocyanate methyl ester (BLDI-OMe) and polycaprolactone530. In order to get 
decent polymerization rates, the PMOX-spacer was coupled onto the blocked lysine 
diisocyanate via an ester linkage. In Scheme 6.6, the preparation of a blocked lysine 
diisocyanate functional initiator with such an ester linkage, the polymerization of MOX, 
the termination with hexamethylene tetramine, the hydrolysis of the HMTA and the 
attachment of biotin are depicted.  
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Scheme 6.6 Reaction scheme of the preparation of blocked lysine diisocyanate functional 
initiator, the polymerization of MOX, the termination with hexamethylene tetramine, the 
hydrolysis of the HMTA and the attachment of biotin.   
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By reacting an excess of 1,6-hexanediol with BLDI-OH (9) a hydroxyl functional 
blocked isocyanate (BLDI-O-C6-OH (10)) was obtained. Similarly as with BLDI-NH-C6-
OH (4), this intermediate compound was easily nosylated by 4-nitrobenzenesulfonyl 
chloride (NsCl) at room temperature, forming BLDI-O-C6-ONs (11). As with BLDI-NH-
C6-ONs, BLDI-O-C6-ONs also gave complete initiation during the polymerizations. The 
same procedures were used, as with the amide-linkage comprising initiator, to introduce 
amino, as well as biotin end groups. The 
1H-NMR results are summarized in Figure 6.8, 
in which the spectra are given of BLDI-O-C6-ONs, BLDI-O-PMOX-ONs, BLDI-O-
PMOX-NH2 and BLDI-O-PMOX-biotin. Except for the presence of an ester linkage, 
these polymers were the same as with the amide comprising polymers, which we 
described earlier in this chapter. All the signals in the spectra were in agreement with the 
expected products.  
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Figure 6.8 
1H-NMR spectra of a: BLDI-O-C6-ONs; b: BLDI-O-PMOX-ONs; c: BLDI-O-
PMOX-NH2; d: BLDI-O-PMOX-biotin. 142 
 
 
In summary, the compounds BLDI-NH-C6-biotin, BLDI-NH-PMOX-biotin and BLDI-O-
PMOX-biotin were successfully synthesized, while the blocked diisocyanate groups were 
still available to make new biotinylated polyurethanes.   
 
6.3.4. Synthesis of biotinylated polyurethanes 
 
Our homemade caprolactam blocked lysine diisocyanate methyl ester reacted with 
polydiols to form polyurethanes, as has been described in former chapters. In an attempt 
to synthesize biotinylated polyurethanes, the biotinylated blocked lysine diisocyanate 
BLDI-NH-C6-biotin, BLDI-NH-PMOX-biotin and BLDI-O-PMOX-biotin were heated at 
160 
oC for 24h in bulk with PCL530, as a representative polyester diol. The 
polymerization, as evidenced by an increase of the viscosity, proceeded in a similar way 
as with the non-functional blocked lysine diisocyanate. The corresponding polymers were 
characterized by NMR (Figure 6.9) and SEC (table 6.2) analysis. In the 
1H-NMR spectra, 
the peaks at 6.40 and 6.34 ppm (pink square) were observed in all biotinylated polymers. 
These peaks belong to the NH from biotin ring which are very characteristic in the 
1H-
NMR spectrum of biotin comprising compounds. It means after polymerization biotin 
was still there. This was expected considering the stability of the amide linkage between 
biotin and PMOX, and because of our experience that the methyl ester group of the 
blocked lysine diisocyanate survived in the polymerization with PCL. The peak centered 
at 2.25 ppm, originating from PCL530, was also present in spectra of the polyurethanes, 
but was not present in the spectra of the biotinylated monomers/oligomers.   143 
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Figure 6.9 
1H-NMR spectra of a: PCL530 in CDCl3 and b: PU-NH-C6-biotin, c: PU-NH-
PMOX-biotin and d: PU-O-PMOX-biotin in DMSO-d6. 
 
Biotinylated polyurethanes with and without spacer were prepared, but the molecular 
weights were rather low (table 6.2). However, the final aim of this work was to make 
crosslinked materials and for that molecular weights of about 3 to 5,000 Da were desired. 
Moreover, it is not needed that every monomer is provided with biotin groups. 
Copolymers with non-functional diisocyanates are a possible route to obtain higher 
molecular weights, if necessary. Here we limited ourselves to demonstrate the concept on 
how to synthesize biotinylated monomers, followed by a polycondensation to obtain 
biotinylated polyurethanes. Future work will be focused on specific applications of these 
novel polymers.  
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Table 6.2 Molecular weight of PU-C6-biotin, PU-NH-PMOX-biotin and PU-O-PMOX-
biotin 
sample Mn(Da) Mw(Da) PDI 
PU-C6-biotin 3,421  8,155  2.4 
PU-NH-PMOX-biotin 4,778  13,349  2.8 
PU-O-PMOX-biotin 5,684  16,  732  2.9 
 
6.4. Conclusion 
 
The NHS activated ester group of our homemade caprolactam blocked lysine 
diisocyanates (BLDI) was used to provide BLDI with primary amino or hydroxyl groups. 
The pendant amino group was used to couple biotin, yielding biotinylated blocked lysine 
diiocyanate (BLDI-NH-C6-biotin). Longer spacers between the bio-active group and 
polyurethane polymer backbone were prepared by nosylation of the hydroxyl pedant 
group of blocked lysine diisocyanate with 4-nitrobenzenesulfonyl chloride, forming 
BLDI-NH-C6-ONs. This compound was used as initiator for the ring opening 
polymerization of 2-methyl-1,3-oxazolines (MOX). With this highly efficient initiator 
blocked lysine diisocyanates with living poly(methyl oxazoline) side chains were 
obtained (BLDI-NH-PMOX). End-capping of the living polymer by hexamethylene 
tetramine (HMTA), resulted in a convenient method to introduce in a nearly quantitative 
yield primary amino functional end group. Next, biotin was coupled onto BLDI-NH-
PMOX-NH2 to form BLDI-NH-PMOX-biotin. The amide linkage between the BLDI and 
the spacer is located next to the blocked isocyanate and had an influence of the reactivity 
of the neighboring blocked isocyanate group. Therefore, also a biotin functional polymer 
with ester group between the blocked isocyanate and the polyoxazoline (BLDI-O-
PMOX-Biotin) was successfully synthesized. 
All three synthesized biotinylated blocked lysine diisocyanates were polymerized with 
PCL530 to prepare the corresponding polyurethanes. Coupling of biotin groups to our 
polyurethanes would allow immobilizing biomolecules, like peptides or protein, through 
biotin-avidin interactions. It gives a huge amount of possibilities to diversify the 
applications, which need to be studied in the future.  145 
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Summary 
 
Due to a wide range of physical and chemical properties, polyurethanes (PUs) are used in 
numerous applications like coatings, foams, fibers, engineering plastics and biomaterials. 
The use of biomaterials for medical implants is rapidly growing due to the aging of the 
world population and because it is not accepted anymore to live with loss of function due 
to trauma or wear. There are generally two classes of materials in use. For long lasting 
applications, like for tubes, the polymers should be stable under physiological conditions. 
In contrast, for tissue engineering the polymers should be biodegradable in a controlled 
way. Depending on the composition, polyurethanes can fulfill all these requirements and 
have to be selected accordingly. 
It is convenient to synthesize polyurethanes from diisocyanates (DIs) since the DIs are 
reactive towards alcohols at low temperature, when catalyzed, and with amines without 
catalysts. However, there are several major drawbacks. The high reactivity and toxicity of 
isocyanates do not allow contamination of the body by traces of remnants .  
More importantly, due to the high reactivity, it is not possible to have or to introduce 
moieties with active hydrogens, like hydroxyl groups, amine of acids, while keeping the 
isocyanate groups intact. Temporarily blocking the isocyanate groups could be an 
attractive alternative, while still affording the same polyurethanes with polyols. They are 
less reactive and therefore possibly suitable to introduce bio-active moieties. The only 
difference is that the polymerization rate is slower due to the protective group. Above a 
certain threshold temperature hydroxyl groups are able to substitute the blocking group, 
yielding polyurethanes. The advantage of blocked isocyanates is that they are stable 
below 100 
oC, allowing chemical modifications, which are impossible with unprotected 
isocyanates. 
This thesis studies the synthesis of linear or crosslinked polyurethanes from caprolactam 
blocked lysine diisocyanate (BLDI), which were provided with functional side groups. A 
novel synthetic methodology to prepare BLDI was developed. By making use of the 
expected stability of BLDI and the presence of a pendant ester group, the introduction 
bio-functional side groups like GRGDG and biotin via that pendant ester group was 148 
 
studied. Amorphous polymer networks were studied to avoid the presence of remnant 
polymer crystals after degradation. Some preliminary experiments with human cells were 
employed to demonstrate the biocompatibility of the resulting polyurethanes. 
Chapter 2 present an efficient route for the synthesis of caprolactam blocked lysine 
diisocyanate methyl ester (BLDI-OMe) and the derivatization and a detailed 
characterization thereof.  The synthesis of BLDI-OMe was based on the highly selective 
reaction between compounds comprising primary amines and carbonyl biscaprolactam 
(CBC). In a highly selective reaction step only one of the two caprolactam rings of CBC 
was substituted by the amino groups of lysine, yielding BDLI-OMe. The structure and 
the purity of BLDI-OMe were determined by 
1H-NMR, 
13C-NMR, elemental analysis 
and HPLC. The accordingly determined purity was higher than 99%. A successful model 
reaction showed that octanol substituted selectively only the caprolactam blocking group, 
while leaving the methyl ester unaffected, demonstrating the possibility to make linear 
polyurethanes with pendant ester groups. It was essential to omit the commonly used tin 
catalyst, as the ester reacted with octanol in the presence of this catalyst. Crucial for the 
aim of this work was that conditions were found to hydrolyze the ester group of BLDI-
OMe without affecting the blocked isocyanate groups. So, depending on the reaction 
conditions either the blocked isocyanate group or the ester was reactive. The free acid 
group could be converted into the N-hydroxysuccinimide (NHS) activated ester. The 
activated ester allowed further modification with various nucleophiles, as was 
demonstrated by the substitution of the NHS-group with hexyl amine, as a model 
reaction. 
Chapter 3 demonstrates the difference in selectivity of the blocked isocyanate groups 
and the methyl ester of caprolactam blocked lysine diisocyanate methyl ester (BLDI-
OMe) in the reaction with polydiols during the polyurethane synthesis. For that poly(ε-
caprolactone) (PCL) and poly(ethyleneglycol) (PEG) were selected as representative 
examples for the two classes of polyurethanes (PUs). Linear poly(ester-urethanes) were 
successfully synthesized by reacting PCL with BLDI-OMe, in solution as well as in bulk. 
In bulk the polymerizations were much faster than in solution. Above 180 
oC, in bulk, 
branching of the polyurethanes happened. As a result, depending on the conditions, either 149 
 
linear or branched polymers or even polymer networks could be made with the same 
monomer mixtures.  
Polyethylene glycol was selected to study the polymerization performance of polyethers 
with BLDI-OMe in bulk. In contrast to PCL, linear poly(ether-urethane) could not be 
obtained in this case. Even at 125
oC (deblocking temperature of caprolactam blocked 
isocyanate group), the reactivity of hydroxyl groups of PEG towards the ester group was 
already too high. As a result, poly (ether-urethane) networks were formed on heating. 
This offered a convenient way to make polyurethane networks, which will be discussed 
in chapter 4. 
Chapter 4 describes the synthesis of amorphous polyurethane networks based on 
polydiols and our homemade caprolactam blocked lysine diisocyanate methyl ester 
(BLDI-OMe) by using a one-step processing technology. After mixing the monomers, the 
curing was performed by heating the samples for 48 hours at 160
oC under vacuum. 
PEG600, PEG1000, PCL530 and PCL1250 were used as polydiols to study the synthesis 
of non-crystalline PU networks. Only the PU network films based on PEG600 and 
PCL530 gave non-crystalline materials, as evidenced by their transparency and by DSC 
measurement. The polymer films swelled but did not dissolved in chloroform, 
demonstrating the crosslinked topology.  
The PU-PEG600 network was more hydrophilic than PU-PCL530 network, which 
resulted in a higher absorption of water. In vitro degradation experiments showed that the 
PU-PEG600 network degraded completely in 35 days, whereas PU-PCL530 lost about 
3.5% of weight during this period. Mechanical measurements revealed that both 
polymers displayed rubber-like behavior. The lack of yield points in stress-stain curves 
demonstrated again the amorphous character. The PU-PEG600 and PU-PCL530 networks 
in this study are potentially suited for scaffolds for soft tissue. 
Chapter 5 describes the synthesis of  poly (ester-urethanes), comprising activated N-
hydroxysuccinimide (NHS) pendant esters, which were prepared from the NHS-activated 
ester of caprolactam blocked lysine diisocyanate (Chapter 2) and polycaprolactone. The 
NHS-activated ester offered an enabled technology to prepare bio-active polyurethanes. 
First, hexyl amine was used, as model compound, to substitute the NHS-group, 
demonstrating the ability of the concept. Along the same line, an amino-functional, cell-150 
 
adhesion promoting peptide, GRGDG, was coupled onto polyurethane backbones. NMR, 
IR and elemental analysis proved the successful coupling of both, hexyl amine and 
GRGDG peptide. XPS and water contact angle measurement of spin-coated glass slides 
confirmed the presence of the grafted peptides, showing a strong change of the surface 
property of polymer. The GRGDG peptides promoted adhesion of HDF cells, even in the 
serum-free circumstance. Since these polyurethanes were applied by a (spin) coating 
technique, they may be used as functional coatings on the implantable devices to promote 
cell adhesion. PU-NHS can offer a platform to prepare a library of functional 
polyurethanes. 
Chapter 6 explores the possibility for introducing a biotin moiety onto our homemade 
blocked lysine diisocyanate, with and without a nontoxic long spacer, and to synthesize 
corresponding polyurethanes. The presence of biotin on polymers would allow 
immobilization of various biomolecules, like peptides or protein, through biotin-avidin 
interactions. In a first step the pendant ester group of blocked lysine diisocyanate was 
converted into a primary amino or hydroxyl group. The pendant amino group was used to 
couple biotin and, as a result, biotinylated blocked lysine diisocyanate (BLDI-C6-biotin) 
was obtained. The pendant hydroxyl group was nosylated by 4-nitrobenzenesulfonyl 
chloride, forming BLDI-C6-ONs. This compound was used as an initiator for the ring 
opening polymerization of oxazolines. A primary amino group at the end of BLDI-C6-
PMOX was obtained by end-capping the living polymer with hexamethylene tetramine. 
Next, biotin was coupled onto the BLDI-PMOX, to form a BLDI-PMOX-biotin. The 
polymerization of the biotinylated blocked lysine diisocyantes with PCL530 yielded the 
corresponding polyurethanes.  151 
 
Samenvatting 
 
Dankzij het brede pallet aan chemische en fysische eigenschappen worden polyurthanen 
(PUs) veelvuldig toegepast in coatings, schuimen, vezels, engineering plastics en 
biomedische materialen. Het gebruik in biomedische materialen neemt sterk toe vanwege 
de vergrijzing van de bevolking en omdat men het tegenwoordig niet meer accepteert om 
te leven met een gebrek vanwege slijtage of een ongeluk.      
Er zijn twee klassen van biomedische materialen in gebruik. Een voor langdurig gebruik, 
zoals in slangetjes, die stabiel blijven onder fysiologische condities. Voor tissue 
engineering daarentegen, is een gecontroleerde degradatie vereist. Polyurethanen kunnen, 
afhankelijk van hun samenstelling, aan al deze eisen voldoen.   
Polyurethanen zijn eenvoudig te bereiden uit diisocyanaten (DIs) met polyolen of 
polyamines, met en zonder katalysator respectievelijk. Er zijn echter voor biomedische 
toepassingen nog een aantal beperkingen aan de huidige PUs. Vanwege hun toxiciteit 
mogen er geen restanten van de diisocyanaten meer aanwezig zijn in het polymeer. Nog 
belangrijker is echter dat, vanwege de hoge reactiviteit, het niet mogelijk is om 
functionele groepen te introduceren met actieve waterstof atomen, zoals hydroxyl-, 
amino- of zuurgroepen, met behoud van de isocyanaatgroepen. Het tijdelijk blokkeren 
van de isocyanaatgroepen zou voor al die problemen een aantrekkelijke oplossing kunnen 
bieden, terwijl toch dezelfde PUs gemaakt zouden kunnen worden. De geblokte 
isocyanaten zouden dan eerst gemodificeerd kunnen worden met bioactieve groepen, om 
ze dan te gebruiken voor de synthese van PUs, zij het met een wat lagere reactiesnelheid.  
Onder 100 
oC zijn geblokte isocyanaten stabiel en zouden dan gemodificeerd kunnen 
worden en boven de 100 
oC kunnen dan met deze gemodificeerde geblokte isocyanaten 
weer polyurethanen gemaakt worden.    
Dit proefschrift beschrijft de synthese van lineaire en gecrosslinkte polyurethanen, op 
basis van caprolactam geblokt lysine diisocyanaat (BLDI), die voorzien werden van bio-
functionele zijgroepen. Hiervoor is een nieuwe synthetische methode ontwikkeld om 
BLDI te maken. Door gebruik te maken van de hogere stabiliteit van de geblokte 
isocyanaten en van de aanwezigheid van de ester zijgroep is onderzocht of bio-152 
 
functionele groepen, zoals GRGDG en biotin, in PUs ingebouwd konden worden. Er is 
gekozen om amorfe polyurethaan netwerken te maken om te voorkomen dat er tijdens en 
na de degradatie van het implantaat kristallijne restanten achter blijven. Om de bio-
compatibiliteit van deze materialen vast te stellen zijn experimenten verricht met humane 
cellen.  
Hoofdstuk 2 beschrijft een efficiënte route om caprolactam geblokt lysine diisocyanate 
methyl ester (BLDI-OMe) te maken en om deze te derivatiseren. De synthese van BLDI-
OMe was gebaseerd op de zeer selectieve reactie van primaire amines met carbonyl 
biscaprolactam (CBC). In deze selectieve reactie werd door de amino groepen van lysine 
een van de twee caprolactamringen van CBC gesubstitueerd, waarbij BLDI-OMe in hoge 
opbrengst gevormd werd. De structuur en zuiverheid (> 99%) werden bepaald met 
1H-
NMR, 
13C-NMR, element analyses en HPLC. De succesvolle reacties van octanol met 
BLDI-OMe, waarbij caprolactam selectief gesubstitueerd kon worden zonder dat de ester 
reageerde, toonde aan dat de bereiding van lineaire polyurethanen met een ester zijgroep 
mogelijk zou moeten zijn. Het was daarbij essentieel om geen katalysator te gebruiken, 
omdat met een katalysator de ester reactief werd. Cruciaal voor het onderzoek in dit 
proefschrift was dat we condities gevonden hebben om de ester van BLDI-OMe te 
hydrolyseren zonder de geblokt isocyanaatgroepen aan te tasten. Dus, afhankelijk van de 
condities konden we of de geblokte isocyanaat of de ester groep laten reageren. De 
zuurgroep kon vervolgens omgezet worden in een N-hydroxysuccinimide geactiveerde 
ester. De geactiveerde ester bood de mogelijkheid om diverse nucleofielen te reageren, 
zoals aangetoond werd met de model stof hexylamine. 
In  hoofdstuk 3 wordt de verschil in reactiviteit van de caprolactam geblokte 
isocyanaatgroep en de estergroep aangetoond door polyurethanen te maken met polyols. 
Hiervoor werden polycaprolactone (PCL) en poly(ethyleen glycol) (PEG) geselecteerd 
als representanten van twee klassen van PUs. Lineaire poly(ester-urethanen) werden 
succesvol bereid van PCL en BLDI-OMe, zowel in oplossing als in bulk. Pas boven 180 
oC trad er in bulk vertakking op. Dus, afhankelijk van de omstandigheden kunnen lineaire 
of vertakte of zelfs gecrosslinkte polyurethanen gemaakt worden met hetzelfde 
monomeren mengsel.     153 
 
Met poly(ethyleen glycol) konden, in tegenstelling tot PCL, geen lineaire polyurethanen 
gemaakt worden. Zelfs bij 125 
oC, de deblokkeertemperatuur van geblokte isocyanaten, 
was de reactiviteit van de PEG-hydroxyl groepen met de estergroep al te hoog om 
lineaire PUs te verkrijgen. Dit bood echter een goede mogelijkheid om meteen 
gecrosslinkte PUs te maken, hetgeen de doelstelling van dit onderzoek was.   
Hoofdstuk 4 beschrijft de synthese van amorfe polyurethaannetwerken, gebaseerd op 
polyolen en BDLI-OMe in een een-staps technologie. Na het mengen van de monomeren 
werd de crosslinking uitgevoerd gedurende 48h bij 160 
oC onder vacuüm. PEG600, 
PEG1000, PCL530 en PCL 1250 werden geselecteerd om niet-kristallijne PU-netwerken 
te maken. Alleen met PEG600 en PCL530 werden amorfe netwerken verkregen, dat 
aangetoond werd door hun transparantie en bevestigd werd met DSC. Deze polymeren 
zwollen in chloroform, maar losten niet op, hetgeen de netwerkstructuur aantoonde. 
Omdat PU-PEG600 veel hydrofieler was dan PU-PCL530 absorbeerde dit polymeer 
netwerk ook veel meer water. In vitro experimenten toonden aan dat PU-PEG600 in 35 
dagen volledig hydrolyseerde, terwijl PU-PCL530 slecht 3.5wt% gewicht verloor in die 
periode. De mechanische metingen lieten zien dat deze polymeer netwerken een rubber-
achting gedrag hadden. Het ontbreken van een yieldpunt in de stress-stain curven 
demonstreerde eveneens het amorfe gedrag. Deze polyurethaan netwerken uit deze studie 
zijn in potentie geschikt voor tissue engineering. 
Hoofdstuk 5 beschrijft de synthese van poly(ester-urethanen) met N-hydroxysuccinimide 
geactiveerde ester zijgroepen, die gemaakt werden uitgaande van de N-hydrosuccinimide 
(NHS) geactiveerd BLDI (hoofdstuk 2) en polycaprolactone. PUs met NHS-geactiveerd 
esters boden de mogelijk om bioactieve groepen te introduceren. Nadat de inbouw van 
hexylamine, als model stof, was aangetoond is vervolgens het celadhesie bevorderend 
peptide GRGDG gekoppeld aan het polymeer. Met NMR, IR en element analyses werd 
aangetoond dat de koppeling succesvol verlopen was. XPS en contacthoek metingen aan 
gespincoate glasplaatjes bevestigde de koppeling door de grote verandering van het 
oppervlak van de coating. De GRGDG peptiden bevorderde99999n de adhesie van HDF 
cellen, zelfs onder serum-vrije condities. Omdat deze monsters aangebracht werden via 
een coating techniek, kunnen deze materialen ook gebuikt worden om implantaten te 154 
 
coaten om cel adhesie te bevorderen. Deze PU-NHS bieden een platform om een 
bibliotheek van bio-functionele polyurethanen te maken.    
In hoofdstuk 6 beschrijft de koppeling van biotin aan onze caprolactam geblokte lysine 
diisocyanaat, via een korte of lange niet-toxische spacer, waarmee vervolgens 
polyurethanen bereid werden. De inbouw van biotin in polyurethanen biedt de 
mogelijkheid om, via biotin-avidin  interacties, een scala aan bio-moleculen, zoals 
peptiden en eiwitten, in te bouwen. De eerste stap was om de zuurgroep van BLDI-
COOH om te zetten in een hydroxyl- of aminofunctionaliteit. De zuurgroep van biotin 
werd vervolgens aan de amino zijgroep gekoppeld  via een amide binding, waarbij BLDI-
C6-biotin gevormd werd. De hydroxyl zijgroep van BLDI-C6-OH werd met 4-
nitrobenzeensulfonylchloride omgezet in het overeenkomstige nosylaat. Dit nosylaat 
werd gebruikt als initiator voor de ringopeningspolymerisatie van 2-methyl-2-oxazoline. 
Een aminogroep aan het einde van PMOX werd verkregen door de polymerisatie te 
termineren met hexamethyleen tetramine. Vervolgens werd biotin gekoppeld aan de 
amino eindgroep onder de vorming van BDLI-PMOX-biotin. De polymerisatie van de 
nieuwe geblokte isocyanaten met PCL leverde biotin gefunctionaliseerde polyurethanen 
op.  155 
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